0001956955 2026-01-01 2026-09-30 0001956955 2026-11-05 0001956955 2026-09-30 0001956955 2025-12-31 0001956955 us-gaap:RelatedPartyMember 2026-09-30 0001956955 2026-07-01 2026-09-30 0001956955 2025-07-01 2025-09-30 0001956955 2025-01-01 2025-09-30 0001956955 us-gaap:RelatedPartyMember 2026-07-01 2026-09-30 0001956955 us-gaap:RelatedPartyMember 2026-01-01 2026-09-30 0001956955 us-gaap:CommonStockMember 2024-12-31 0001956955 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001956955 UMAC:StocksToBeIssuedMember 2024-12-31 0001956955 us-gaap:RetainedEarningsMember 2024-12-31 0001956955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001956955 2024-12-31 0001956955 us-gaap:CommonStockMember 2025-03-31 0001956955 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001956955 UMAC:StocksToBeIssuedMember 2025-03-31 0001956955 us-gaap:RetainedEarningsMember 2025-03-31 0001956955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001956955 2025-03-31 0001956955 us-gaap:CommonStockMember 2025-06-30 0001956955 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001956955 UMAC:StocksToBeIssuedMember 2025-06-30 0001956955 us-gaap:RetainedEarningsMember 2025-06-30 0001956955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0001956955 2025-06-30 0001956955 us-gaap:CommonStockMember 2025-12-31 0001956955 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001956955 UMAC:StocksToBeIssuedMember 2025-12-31 0001956955 us-gaap:RetainedEarningsMember 2025-12-31 0001956955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001956955 us-gaap:CommonStockMember 2026-03-31 0001956955 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001956955 UMAC:StocksToBeIssuedMember 2026-03-31 0001956955 us-gaap:RetainedEarningsMember 2026-03-31 0001956955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-31 0001956955 2026-03-31 0001956955 us-gaap:CommonStockMember 2026-06-30 0001956955 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001956955 UMAC:StocksToBeIssuedMember 2026-06-30 0001956955 us-gaap:RetainedEarningsMember 2026-06-30 0001956955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-06-30 0001956955 2026-06-30 0001956955 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001956955 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001956955 UMAC:StocksToBeIssuedMember 2025-01-01 2025-03-31 0001956955 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001956955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001956955 2025-01-01 2025-03-31 0001956955 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001956955 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001956955 UMAC:StocksToBeIssuedMember 2025-04-01 2025-06-30 0001956955 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001956955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-04-01 2025-06-30 0001956955 2025-04-01 2025-06-30 0001956955 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0001956955 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0001956955 UMAC:StocksToBeIssuedMember 2025-07-01 2025-09-30 0001956955 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001956955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-07-01 2025-09-30 0001956955 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001956955 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001956955 UMAC:StocksToBeIssuedMember 2026-01-01 2026-03-31 0001956955 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001956955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-03-31 0001956955 2026-01-01 2026-03-31 0001956955 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0001956955 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0001956955 UMAC:StocksToBeIssuedMember 2026-04-01 2026-06-30 0001956955 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0001956955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-04-01 2026-06-30 0001956955 2026-04-01 2026-06-30 0001956955 us-gaap:CommonStockMember 2026-07-01 2026-09-30 0001956955 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0001956955 UMAC:StocksToBeIssuedMember 2026-07-01 2026-09-30 0001956955 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0001956955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-07-01 2026-09-30 0001956955 us-gaap:CommonStockMember 2025-09-30 0001956955 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001956955 UMAC:StocksToBeIssuedMember 2025-09-30 0001956955 us-gaap:RetainedEarningsMember 2025-09-30 0001956955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-09-30 0001956955 2025-09-30 0001956955 us-gaap:CommonStockMember 2026-09-30 0001956955 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0001956955 UMAC:StocksToBeIssuedMember 2026-09-30 0001956955 us-gaap:RetainedEarningsMember 2026-09-30 0001956955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-09-30 0001956955 2025-01-01 2025-12-31 0001956955 UMAC:WarrantLiabilityMember 2026-09-30 0001956955 UMAC:WarrantLiabilityMember 2025-12-31 0001956955 us-gaap:GeographicDistributionForeignMember 2026-01-01 2026-09-30 0001956955 us-gaap:GeographicDistributionForeignMember 2025-01-01 2025-09-30 0001956955 UMAC:ShippingAndHandlingCostsMember 2026-01-01 2026-09-30 0001956955 UMAC:ShippingAndHandlingCostsMember 2025-01-01 2025-09-30 0001956955 UMAC:CommonStockInvestmentMember 2026-09-30 0001956955 us-gaap:FairValueInputsLevel1Member UMAC:CommonStockInvestmentMember 2026-09-30 0001956955 us-gaap:FairValueInputsLevel2Member UMAC:CommonStockInvestmentMember 2026-09-30 0001956955 us-gaap:FairValueInputsLevel3Member UMAC:CommonStockInvestmentMember 2026-09-30 0001956955 UMAC:PreFundedWarrantsMember 2026-09-30 0001956955 us-gaap:FairValueInputsLevel1Member UMAC:PreFundedWarrantsMember 2026-09-30 0001956955 us-gaap:FairValueInputsLevel2Member UMAC:PreFundedWarrantsMember 2026-09-30 0001956955 us-gaap:FairValueInputsLevel3Member UMAC:PreFundedWarrantsMember 2026-09-30 0001956955 UMAC:NonPublicWarrantsMember 2026-09-30 0001956955 us-gaap:FairValueInputsLevel1Member UMAC:NonPublicWarrantsMember 2026-09-30 0001956955 us-gaap:FairValueInputsLevel2Member UMAC:NonPublicWarrantsMember 2026-09-30 0001956955 us-gaap:FairValueInputsLevel3Member UMAC:NonPublicWarrantsMember 2026-09-30 0001956955 UMAC:TotalShortTermInvestmentsMember 2026-09-30 0001956955 us-gaap:FairValueInputsLevel1Member UMAC:TotalShortTermInvestmentsMember 2026-09-30 0001956955 us-gaap:FairValueInputsLevel2Member UMAC:TotalShortTermInvestmentsMember 2026-09-30 0001956955 us-gaap:FairValueInputsLevel3Member UMAC:TotalShortTermInvestmentsMember 2026-09-30 0001956955 UMAC:RotorLabContingentConsiderationMember 2026-09-30 0001956955 us-gaap:FairValueInputsLevel1Member UMAC:RotorLabContingentConsiderationMember 2026-09-30 0001956955 us-gaap:FairValueInputsLevel2Member UMAC:RotorLabContingentConsiderationMember 2026-09-30 0001956955 us-gaap:FairValueInputsLevel3Member UMAC:RotorLabContingentConsiderationMember 2026-09-30 0001956955 UMAC:NonPublicWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2026-01-01 2026-09-30 0001956955 UMAC:NonPublicWarrantsMember us-gaap:MeasurementInputSharePriceMember 2026-01-01 2026-09-30 0001956955 UMAC:NonPublicWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2026-01-01 2026-09-30 0001956955 UMAC:NonPublicWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-01-01 2026-09-30 0001956955 UMAC:NonPublicWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2026-01-01 2026-09-30 0001956955 us-gaap:FairValueInputsLevel3Member UMAC:NonPublicWarrantsInvestmentMember 2025-12-31 0001956955 us-gaap:FairValueInputsLevel3Member UMAC:NonPublicWarrantsInvestmentMember 2026-01-01 2026-09-30 0001956955 us-gaap:FairValueInputsLevel3Member UMAC:NonPublicWarrantsInvestmentMember 2026-09-30 0001956955 us-gaap:CommonStockMember 2026-09-30 0001956955 us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001956955 UMAC:PreFundedWarrantsMember 2026-01-01 2026-09-30 0001956955 UMAC:NonPublicWarrantsMember 2026-01-01 2026-09-30 0001956955 us-gaap:PreferredStockMember 2026-09-30 0001956955 us-gaap:PreferredStockMember 2026-01-01 2026-09-30 0001956955 UMAC:RetailRevenueMember 2026-07-01 2026-09-30 0001956955 UMAC:RetailRevenueMember 2025-07-01 2025-09-30 0001956955 UMAC:EnterpriseRevenueMember 2026-07-01 2026-09-30 0001956955 UMAC:EnterpriseRevenueMember 2025-07-01 2025-09-30 0001956955 UMAC:RetailRevenueMember 2026-01-01 2026-09-30 0001956955 UMAC:RetailRevenueMember 2025-01-01 2025-09-30 0001956955 UMAC:EnterpriseRevenueMember 2026-01-01 2026-09-30 0001956955 UMAC:EnterpriseRevenueMember 2025-01-01 2025-09-30 0001956955 UMAC:RotorLabMember 2026-01-01 2026-09-30 0001956955 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-09-30 0001956955 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-09-30 0001956955 us-gaap:RestrictedStockMember 2026-01-01 2026-09-30 0001956955 us-gaap:RestrictedStockMember 2025-01-01 2025-09-30 0001956955 us-gaap:WarrantMember 2026-01-01 2026-09-30 0001956955 us-gaap:WarrantMember 2025-01-01 2025-09-30 0001956955 UMAC:RotorLabMember us-gaap:CommonStockMember UMAC:RotorLabPurchaseAgreementMember 2025-09-01 2025-09-03 0001956955 UMAC:RotorLabMember UMAC:ContingentSharesMember UMAC:RotorLabPurchaseAgreementMember 2025-09-01 2025-09-03 0001956955 UMAC:RotorLabMember 2025-09-01 2025-09-03 0001956955 UMAC:RotorLabMember 2025-09-03 0001956955 UMAC:RotorLabMember 2026-09-30 0001956955 UMAC:RotorLabMember 2025-09-03 0001956955 UMAC:RotorLabMember 2026-09-03 0001956955 UMAC:PrepaidInsuranceMember 2026-09-30 0001956955 UMAC:PrepaidInsuranceMember 2025-12-31 0001956955 UMAC:PrepaidBenefitsMember 2026-09-30 0001956955 UMAC:PrepaidBenefitsMember 2025-12-31 0001956955 UMAC:PrepaidOtherMember 2026-09-30 0001956955 UMAC:PrepaidOtherMember 2025-12-31 0001956955 UMAC:InterestReceivableMember 2026-09-30 0001956955 UMAC:InterestReceivableMember 2025-12-31 0001956955 UMAC:RentSecurityDepositsMember 2026-09-30 0001956955 UMAC:SecuredConvertiblePromissoryNoteAgreementMember 2026-07-31 0001956955 UMAC:SecuredConvertiblePromissoryNoteAgreementMember 2026-07-30 2026-07-31 0001956955 UMAC:SecuredConvertiblePromissoryNoteAgreementMember 2026-01-01 2026-09-30 0001956955 us-gaap:ComputerEquipmentMember 2026-09-30 0001956955 us-gaap:ComputerEquipmentMember 2025-12-31 0001956955 UMAC:MotorProductionEquipmentMember 2026-09-30 0001956955 UMAC:MotorProductionEquipmentMember 2025-12-31 0001956955 us-gaap:OfficeEquipmentMember 2026-09-30 0001956955 us-gaap:OfficeEquipmentMember 2025-12-31 0001956955 us-gaap:LeaseholdImprovementsMember 2026-09-30 0001956955 us-gaap:LeaseholdImprovementsMember 2025-12-31 0001956955 UMAC:OrlandoFloridaMember UMAC:RotorRiotMember 2024-02-16 0001956955 UMAC:OrlandoFloridaMember UMAC:RotorRiotMember 2026-01-01 2026-09-30 0001956955 UMAC:OrlandoFloridaMember UMAC:RotorRiotMember 2025-01-01 2025-09-30 0001956955 UMAC:OrlandoFLMember UMAC:RotorRiotMember UMAC:June2025AdditionalSpaceMember 2025-08-01 0001956955 UMAC:OrlandoFLMember UMAC:RotorRiotMember UMAC:June2025AdditionalSpaceMember 2026-01-01 2026-09-30 0001956955 UMAC:OrlandoFLMember UMAC:RotorRiotMember UMAC:June2025AdditionalSpaceMember 2025-01-01 2025-09-30 0001956955 UMAC:OrlandoFLMember UMAC:RotorRiotMember UMAC:October2025AdditionalSpaceMember 2025-12-01 0001956955 UMAC:OrlandoFLMember UMAC:RotorRiotMember UMAC:October2025AdditionalSpaceMember 2026-01-01 2026-09-30 0001956955 UMAC:OrlandoFLMember UMAC:RotorRiotMember UMAC:October2025AdditionalSpaceMember 2025-01-01 2025-09-30 0001956955 UMAC:OrlandoFL1Member 2026-01-02 0001956955 UMAC:OrlandoFL1Member 2026-01-01 2026-09-30 0001956955 UMAC:OrlandoFL1Member 2025-01-01 2025-09-30 0001956955 UMAC:OrlandoFL2Member 2026-02-01 0001956955 UMAC:OrlandoFL2Member 2026-01-01 2026-09-30 0001956955 UMAC:OrlandoFL2Member 2025-01-01 2025-09-30 0001956955 UMAC:CanberraAustraliaMember UMAC:RotorRiotMember 2025-09-03 0001956955 UMAC:CanberraAustraliaMember UMAC:RotorRiotMember 2026-01-01 2026-09-30 0001956955 UMAC:CanberraAustraliaMember UMAC:RotorRiotMember 2025-01-01 2025-09-30 0001956955 UMAC:NewLeaseArrangementsMember 2026-09-30 0001956955 UMAC:Year2026Member 2026-09-30 0001956955 UMAC:Year2027Member 2026-09-30 0001956955 UMAC:Year2028Member 2026-09-30 0001956955 UMAC:Year2029Member 2026-09-30 0001956955 UMAC:Year2030Member 2026-09-30 0001956955 UMAC:UMACMember 2026-09-30 0001956955 UMAC:RotorRiotMember 2026-09-30 0001956955 us-gaap:PatentsMember 2026-09-30 0001956955 us-gaap:TradeNamesMember 2026-09-30 0001956955 us-gaap:CustomerRelationshipsMember 2026-09-30 0001956955 us-gaap:NoncompeteAgreementsMember 2026-09-30 0001956955 us-gaap:TrademarksMember 2026-09-30 0001956955 UMAC:EmployeesMember UMAC:EquityIncentivePlan2022Member UMAC:January2026IssuanceMember 2026-01-01 2026-01-02 0001956955 UMAC:ExecutiveOfficersMember UMAC:EquityIncentivePlan2022Member UMAC:January232026IssuanceMember 2026-01-22 2026-01-23 0001956955 UMAC:CertainEmployeesMember UMAC:EquityIncentivePlan2022Member UMAC:January232026IssuanceMember 2026-01-22 2026-01-23 0001956955 UMAC:CertainBoardMembersMember 2026-03-12 2026-03-13 0001956955 UMAC:CertainBoardMembersMember 2026-05-19 2026-05-20 0001956955 UMAC:ConsultantMember UMAC:EquityIncentivePlan2022Member UMAC:January2026IssuanceMember 2026-01-01 2026-01-02 0001956955 UMAC:CommonSharesIssuedForServicesMember 2026-05-21 2026-05-22 0001956955 UMAC:SeveralEmployeesMember 2026-01-01 2026-09-30 0001956955 UMAC:SeveralEmployeesMember us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001956955 2026-01-08 2026-01-09 0001956955 UMAC:PublicOfferingMember 2026-03-18 2026-03-19 0001956955 UMAC:PublicOfferingMember UMAC:PlacementAgentFeesMember 2026-03-18 2026-03-19 0001956955 UMAC:PublicOfferingMember UMAC:OtherOfferingExpensesMember 2026-03-18 2026-03-19 0001956955 UMAC:AtTheMarketOfferingMember 2026-05-28 2026-05-29 0001956955 UMAC:NonEmployeeDirectorsMember UMAC:EquityIncentivePlan2022Member UMAC:January2025IssuanceMember 2025-01-13 2025-01-14 0001956955 UMAC:ExecutiveOfficersAndCertainEmployeesMember UMAC:EquityIncentivePlan2022Member UMAC:February2025IssuanceMember 2025-02-02 2025-02-03 0001956955 UMAC:ExecutiveOfficersAndCertainEmployeesMember UMAC:EquityIncentivePlan2022Member UMAC:February2025IssuanceMember 2025-01-01 2025-09-30 0001956955 UMAC:WarrantExercisesMember us-gaap:CommonStockMember 2025-02-01 2025-02-28 0001956955 UMAC:PublicOfferingMember 2025-05-05 2025-05-06 0001956955 UMAC:PublicOfferingMember UMAC:PlacementAgentFeesMember 2025-05-05 2025-05-06 0001956955 UMAC:PublicOfferingMember UMAC:OtherOfferingExpensesMember 2025-05-05 2025-05-06 0001956955 UMAC:PublicOfferingMember 2025-05-06 0001956955 UMAC:NonEmployeeDirectorsMember UMAC:EquityIncentivePlan2022Member UMAC:May2025IssuanceMember 2025-05-18 2025-05-19 0001956955 UMAC:NonEmployeeDirectorsMember UMAC:EquityIncentivePlan2022Member UMAC:May2025IssuanceMember 2025-01-01 2025-09-30 0001956955 UMAC:ConsultantMember UMAC:EquityIncentivePlan2022Member UMAC:May2025IssuanceMember 2025-05-18 2025-05-19 0001956955 UMAC:ConsultantMember UMAC:EquityIncentivePlan2022Member UMAC:May2025IssuanceMember 2025-01-01 2025-09-30 0001956955 UMAC:AdvisoryBoardMembersMember 2025-05-21 2025-05-22 0001956955 srt:ChiefExecutiveOfficerMember UMAC:EquityIncentivePlan2022Member 2025-06-29 2025-06-30 0001956955 UMAC:DominariSecuritiesLLCMember 2025-07-14 2025-07-15 0001956955 UMAC:DominariSecuritiesLLCMember 2025-07-15 0001956955 UMAC:EquityIncentivePlan2022Member 2025-07-30 2025-08-02 0001956955 UMAC:EquityIncentivePlan2022Member 2025-08-06 2025-08-07 0001956955 UMAC:EquityIncentivePlan2022Member 2025-01-01 2025-09-30 0001956955 UMAC:EquityIncentivePlan2022OneMember 2025-08-18 2025-08-19 0001956955 UMAC:EquityIncentivePlan2022OneMember 2025-01-01 2025-09-30 0001956955 UMAC:EquityIncentivePlan2022TwoMember 2025-08-18 2025-08-19 0001956955 UMAC:EquityIncentivePlan2022TwoMember 2025-01-01 2025-09-30 0001956955 UMAC:EquityIncentivePlan2022ThreeMember 2025-09-01 2025-09-02 0001956955 UMAC:EquityIncentivePlan2022ThreeMember 2025-01-01 2025-09-30 0001956955 2025-09-01 2025-09-03 0001956955 2025-09-23 2025-09-24 0001956955 2025-09-24 0001956955 2025-09-01 2025-09-30 0001956955 UMAC:SeveralEmployeesMember 2025-01-01 2025-09-30 0001956955 UMAC:SeveralEmployeesMember us-gaap:CommonStockMember 2025-01-01 2025-09-30 0001956955 UMAC:CertainEmployeesMember us-gaap:StockOptionMember 2026-01-01 2026-09-30 0001956955 UMAC:CertainEmployeesMember us-gaap:StockOptionMember 2025-01-01 2025-09-30 0001956955 us-gaap:StockOptionMember 2026-01-01 2026-09-30 0001956955 us-gaap:StockOptionMember 2025-01-01 2025-09-30 0001956955 us-gaap:StockOptionMember 2026-09-30 0001956955 us-gaap:RestrictedStockMember 2026-01-01 2026-09-30 0001956955 us-gaap:RestrictedStockMember 2025-01-01 2025-09-30 0001956955 us-gaap:RestrictedStockMember 2026-09-30 0001956955 us-gaap:StockOptionMember 2025-12-31 0001956955 us-gaap:StockOptionMember 2025-01-01 2025-12-31 0001956955 srt:MinimumMember us-gaap:StockOptionMember 2026-09-30 0001956955 srt:MaximumMember us-gaap:StockOptionMember 2026-09-30 0001956955 srt:MinimumMember us-gaap:StockOptionMember 2026-01-01 2026-09-30 0001956955 srt:MaximumMember us-gaap:StockOptionMember 2026-01-01 2026-09-30 0001956955 us-gaap:RestrictedStockMember 2025-12-31 0001956955 us-gaap:RestrictedStockUnitsRSUMember 2025-12-31 0001956955 us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-09-30 0001956955 us-gaap:RestrictedStockUnitsRSUMember 2026-09-30 0001956955 UMAC:IndependentDirector1Member 2026-03-12 2026-03-13 0001956955 UMAC:IndependentDirector2Member 2026-03-12 2026-03-13 0001956955 UMAC:IndependentDirector3Member 2026-03-12 2026-03-13 0001956955 2026-03-12 2026-03-13 0001956955 UMAC:CEOAndTwoIndependentDirectorsMember 2026-03-30 2026-04-02 0001956955 UMAC:TealDronesMember 2026-01-01 2026-01-31 0001956955 UMAC:TealDronesMember 2026-01-01 2026-09-30 0001956955 UMAC:TealDronesMember 2026-09-30 0001956955 UMAC:AllanEvansMember 2026-07-23 2026-07-24 iso4217:USD shares iso4217:USD shares pure UMAC:Integer false 2026 Q3 --12-31 0001956955 1 10-Q true 2026-09-30 false 001-41961 Unusual Machines, Inc. NV 66-0927642 5728 Major Blvd Suite 250 Orlando FL 32819 720 383-8983 Common Stock, par value $0.01 per share UMAC NYSE Yes Yes Non-accelerated Filer true true false false false 51911702 161965505 103261397 53391766 39214909 45000000 0 18703356 1779423 42622077 5316648 5000000 0 23259023 9748483 1370481 190622 351312208 159511482 8500523 2233891 3617334 2607256 243551 197785 15596105 15596105 2393977 2561895 30351490 23196932 381663698 182708414 6055909 1506793 114491 638125 972234 456429 3000000 2847000 10142634 5448347 146772 146772 2741969 2173626 2888741 2320398 13031375 7768745 0.01 0.01 500000000 500000000 49982430 49982430 37759911 37759911 499827 377596 445760785 229665734 -77652637 -55107131 24348 3470 368632323 174939669 381663698 182708414 1900000 13903032 2134588 38721336 6300857 8986728 1294200 25348791 4168984 4916304 840388 13372545 2131873 2012744 636705 5380364 1343584 350548 39369 994649 110002 613614 373539 1983665 883513 10238161 4730063 28265622 15151160 64859 22449 204996 63635 13279926 5802125 36829296 17551894 -8363622 -4961737 -23456751 -15420021 1700977 715489 4313216 942755 -18381680 5849713 -12773139 5849713 0 0 9532673 0 -0 -0 153000 -0 -622 0 -7858 0 -0 -0 648 -0 -16681325 6565202 911244 6792468 -25044947 1603465 -22545507 -8627553 -25044947 1603465 -22545507 -8627553 -10397 0 24348 0 -25055344 1603465 -22521159 -8627553 -0.50 0.05 -0.49 -0.38 -0.50 0.05 -0.49 -0.38 49968207 30002179 46094557 22610516 49968207 30581194 46094557 22610516 2000000.0 4200000 15122018 151221 50580235 0 -35913514 0 14817942 483546 4835 -4835 0 0 0 1224606 12246 2424720 2436966 1883433 1883433 22940 22940 -3266279 -3266279 16830170 168302 54906493 0 -39179793 0 15895002 208336 2082 -2082 0 0 0 94650 947 366923 367870 4630 46 -46 0 0 0 150000 1500 -1500 0 0 0 8000000 80000 36416000 36496000 576831 576831 4936497 4936497 -6964739 -6964739 25287786 252877 97199116 0 -46144532 0 51307461 589232 5892 -5892 0 0 0 25250 253 133487 133740 1539 15 -15 0 0 0 5000000 50000 44851000 44901000 656642 6566 5916345 5922911 8500 85 42415 42500 114960 114960 1987600 1987600 1603465 1603465 2278 2278 31568949 315688 150239016 0 -44541067 2278 106015915 37759911 377596 229665734 0 -55107131 3470 174939669 745883 7460 -7460 0 0 0 0 74600 747 259587 260334 40000 400 -400 0 0 0 0 8823529 88235 138711758 138799993 350000 3500 3391500 3395000 291412 291412 3648567 3648567 10282994 10282994 19431 19431 47793923 477938 375960698 0 -44824137 22901 331637400 8352 84 -84 0 0 0 0 46230 467 326784 327251 108000 1080 -1080 2000000 20000 58178764 58198764 2239605 2239605 3405957 3405957 -7783553 -7783553 15314 15314 49956505 499569 440110644 0 -52607690 38215 388040738 25925 258 162528 162786 2595874 2595874 2891739 2891739 -25044947 -25044947 -13867 -13867 49982430 499827 445760785 0 -77652637 24348 368632323 -22545507 -8627553 390717 63635 15073154 9522261 -12773139 5849713 9532673 -0 0 12146 153000 0 16923933 122696 37305429 1746100 13510540 6016951 1225625 165529 74071 -8144 5000000 -0 4549114 406399 -523634 1137953 -73554146 -11394292 0 93054 82499998 11000000 20082674 0 6481450 1550687 7980 -0 -68906754 -12457633 149999993 40000000 0 48500000 60000000 0 750373 501610 3395000 2479466 13001236 7103000 201144130 84378076 58683230 60526149 20878 2278 103261397 3757323 161965505 64285750 <p id="xdx_80D_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zpQ5ZujgsnG8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Note 1 – <span id="xdx_823_z7wUddEENaFh">Organization and nature of business</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unusual Machines, Inc. (“the Company”) is a Nevada corporation engaged in the commercial drone industry.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 3, 2025, the Company acquired Rotor Lab Pty. Ltd., an Australian company (“Rotor Lab). See Note 3 for additional information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_801_eus-gaap--SignificantAccountingPoliciesTextBlock_zELRcHBPbfK4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Note 2 – <span id="xdx_82F_zV5tCNtrjFhl">Summary of significant accounting policies</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p id="xdx_845_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zVlGxoIf1pe4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86F_zpFrmpCQD7X5">Principles of Consolidation</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements include accounts of the Company and its wholly owned subsidiaries including UMAC IP Holdings Corp., Unusual Machines of Florida, Inc, Fat Shark, Rotor Riot and Rotor Lab since acquired on September 3, 2025. Intercompany transactions and balances have been eliminated upon consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_849_eus-gaap--ConsolidationPolicyTextBlock_zMRXZZWHuT6i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86E_z5QXFWHsSn7c">Basis of Presentation</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated condensed financial statements of the Company included herein have been prepared, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with Generally Accepted Accounting Principles (“GAAP”) have been condensed or omitted from this Quarterly Report, as is permitted by such rules and regulations. Accordingly, these condensed financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K filed with the SEC on March 12, 2026. The results for any interim period are not necessarily indicative of results for any future period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_845_eus-gaap--UseOfEstimates_zkmyjLzASXGc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_860_zmW8sZBh51l">Use of Estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results could differ from those estimates, and such results could be material.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The financial statements include some amounts that are based on management’s best estimates and judgments. Significant estimates reflected in these consolidated condensed financial statements include those used to (i) determine stock-based compensation, (ii) the fair value of assets acquired and liabilities assumed in business combinations, the fair value of shares issued as consideration and the fair value of contingent consideration in business combinations, (iii) reserves and allowances related to accounts receivable, and inventory, (iv) the evaluation of long-lived assets, including intangibles and goodwill, for impairment, (v) the present value of lease liabilities and related right of use assets, (vi) the fair value of short-term investments including the value of unexercised warrants received, (vii) the warranty liability and sales returns reserves, and (viii) the deferred tax asset valuation allowance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p id="xdx_841_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zMsUSuwb0pD" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_860_zVn2L1y8XRQb">Cash and Cash Equivalents</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considers all highly liquid debt instruments and other short-term investments with maturities of three months or less, when purchased, to be cash equivalents. The Company maintains cash deposits in multiple commercial banks and financial services companies. These financial institutions are insured by the Federal Deposit Insurance Corporation up to $250,000. The Company’s cash balance may at times exceed these limits. At September 30, 2026 and December 31, 2025, the Company had approximately $<span id="xdx_905_eus-gaap--CashUninsuredAmount_iI_pn5n6_c20260930_zQsw5D10RHve" title="Cash uninsured amount">161.7</span> million and $<span id="xdx_908_eus-gaap--CashUninsuredAmount_iI_pn5n6_c20251231_zkcsj6aommdc" title="Cash uninsured amount">102.6</span> million, respectively, in excess of federally insured limits. The Company continually monitors its positions with, and the credit quality of the financial institutions with which it invests.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p id="xdx_84D_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zaFFhmW0A6ed" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_866_zQj5S7s1bsvd">Accounts Receivable, net</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company carries its accounts receivable at invoiced amounts. The Company follows ASC 326, Financial Instruments – Credit Losses and has early adopted in fiscal year 2025, ASU 2025-05, under which the Company evaluates all credit losses as of the reporting date. On a periodic basis, the Company evaluates its accounts receivable and establishes an allowance for credit losses based on a history of past write-offs and collections and current credit conditions. Accounts are written-off as uncollectible at the discretion of management. At September 30, 2026 and December 31, 2025, the Company considers accounts receivable to be fully collectible; accordingly, <span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_do_c20260101__20260930_zwisQc4BZAe8" title="Credit losses"><span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_do_c20250101__20251231_zPlwx6eEMUrb" title="Allowance for credit losses">no</span></span> allowance for credit losses has been established.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_848_eus-gaap--FinanceLoansAndLeasesReceivablePolicy_zhpRebWgGzgg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_867_zog8emMsmyu7">Note Receivable</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for its note receivable in accordance with ASC 310, Receivables. The note receivable is carried at cost and is evaluated for credit losses in accordance with ASC 326, Financial Instruments – Credit Losses. The Company evaluates embedded features within convertible notes under ASC 815, Derivatives and Hedging, to determine whether any such features require separate accounting as embedded derivatives. The Company reassesses its conclusions regarding embedded features at each reporting date as facts and circumstances change.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84D_eus-gaap--EquityMethodInvestmentsPolicy_zWPSlbbwbz7g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_867_zbqxvdE4p8b5">Short-Term Equity Investments at Fair Value</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company measures its investments in equity securities, consisting of common stock, preferred stock, and non-public warrants at fair value with unrealized changes in value recognized in net income (loss) per ASC 321. The Company has established an Equity Investment Valuation and Quarterly Assessment Policy to ensure consistent application of the applicable accounting guidance, including the evaluation of fair value, observable price changes, and impairment indicators. This policy serves as the basis for management's quarterly investment valuation assessments and related accounting conclusions. The Company holds less than a 5% equity interest in each of the companies it invested in as of September 30, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_847_eus-gaap--EquityMethodInvestmentsIssuancesPolicy_zxipIswcp8I9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86B_zyzSfSggfQw3">Short-Term Equity Investments at Cost</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for certain equity investments in privately held companies that do not have readily determinable fair values using the measurement alternative under ASC 321, Investments – Equity Securities. Under the measurement alternative, these investments are measured at cost, less impairment, and adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer. The Company evaluates these investments at each reporting date to identify observable transactions that may require an adjustment to the carrying amount and indicators of impairment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_848_eus-gaap--InventoryPolicyTextBlock_z5TfKDNHDWGe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86E_zOyE3Qgem3Tb">Inventory</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventories, which consist of finished goods and raw materials, are stated at the lower of cost or net realizable value, and are measured using the first-in, first-out method. Cost components include direct materials, direct labor, an allocation of rent expense and depreciation for manufactured products, as well as in-bound freight. At each balance sheet date, the Company evaluates the net realizable value of its inventory using various reference measures including current product selling prices, as well as evaluating for excess quantities and obsolescence.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84A_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zNJ628rR9Xzd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_869_zt9210aULxU">Property and equipment, net</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment is stated at cost, net of accumulated depreciation. Depreciation is provided utilizing the straight-line method over the estimated useful lives which includes computer and office equipment of three to five years, motor production equipment of ten to fifteen years and tenant improvements of five to fifteen years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i></i></p> <p id="xdx_841_eus-gaap--LesseeLeasesPolicyTextBlock_zSszk7qQdG96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86E_zbAB4CC6ZYNe">Leases</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company applies Accounting Standards Codification (ASC) 842, “Leases” which requires the recognition of assets and liabilities associated with lease agreements. The Company recognized a lease liability obligation and a right-of-use asset for the facilities leases in Orlando, FL and for the Canberra Australia lease related to the Rotor Lab acquisition as discussed in Note 3.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company determines if a contract is a lease or contains a lease at inception. Operating lease liabilities are measured, on each reporting date, based on the present value of the future minimum lease payments over the remaining lease term. The Company’s leases do not provide an implicit rate. Therefore, the Company used an effective discount rate of 8.24% based on its last proposed debt financings. Operating lease assets are measured by adjusting the lease liability for lease incentives, initial direct costs incurred and asset impairments. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term with the operating lease asset reduced by the amount of the expense. The Company has elected to account for lease and non-lease components together as a single lease component for all underlying assets. Lease terms do not include an option to renew.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p id="xdx_847_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z8xeVrYOozr7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_868_zHQRiMqXSoda">Fair Values, Inputs and Valuation Techniques for Financial Assets and Liabilities, and Related Disclosures</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value measurements and disclosure guidance defines fair value and establishes a framework for measuring fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. In accordance with this guidance, the Company has categorized its recurring basis financial assets and liabilities into a three-level fair value hierarchy based on the priority of the inputs to the valuation technique.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The guidance establishes three levels of the fair value hierarchy as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Level 1</i>: Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Level 2</i>: Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Level 3</i>: Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table details the fair value measurements of the Company’s financial assets and liabilities as of September 30, 2026:</p> <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zhen5Q9gi3O3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Financial assets and liabilities)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BB_zui2PdPddM4g" style="display: none">Schedule of financial assets and liabilities</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Short term investments – assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 40%; text-align: left">Common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_z0XZjr8ixpN9" style="width: 11%; text-align: right" title="Assets, fair value">48,965,766</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zTAZMmQGTyV" style="width: 11%; text-align: right" title="Assets, fair value">48,965,766</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zLJMAKPcmt77" style="width: 11%; text-align: right" title="Assets, fair value">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zjZOE6OIioq4" style="width: 11%; text-align: right" title="Assets, fair value">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Pre-funded warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember_z8wFVlejnCT" style="text-align: right" title="Assets, fair value">3,686,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z6EAQUaplpS1" style="text-align: right" title="Assets, fair value">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zn0KS3pimZ09" style="text-align: right" title="Assets, fair value">3,686,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z668XfxliQv9" style="text-align: right" title="Assets, fair value">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Non-public warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember_z0qt8NPsCtdl" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">740,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z19urq4aSERc" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zqsPH8zcwm9h" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zY4LkuJmXIWe" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">740,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Total short-term investments – assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--TotalShortTermInvestmentsMember_zwWDzhpa7U37" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">53,391,766</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--TotalShortTermInvestmentsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zOLfppWlAkDe" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">48,965,766</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--TotalShortTermInvestmentsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zr1rytVDasub" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">3,686,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--TotalShortTermInvestmentsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zEW29K9ztG2h" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">740,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Contingent consideration from Rotor Lab acquisition</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember_zZO3ulWeFej8" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets, fair value">3,000,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zIVSk4OalyPd" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets, fair value">3,000,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zJavLMBZTv58" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets, fair value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zK968cfZ6WRi" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets, fair value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zR3WfoyVbq0i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company calculated the fair value for common stock for short-term investments based on the quoted trading price as of the close of the market multiplied by the total shares held by the Company as of September 30, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company calculated the fair value for pre-funded warrants for short-term investments based on the quoted trading price as of the close of the market multiplied by the total common equivalent shares held by the Company as of September 30, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the non-public warrants investment in 2026 was determined using a Black-Scholes pricing model which values the warrants based on the stock price at the valuation date, the expected life of the warrant, the estimated volatility of the stock of the investee, and the risk-free interest rate over the expected life of the warrant.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company used the following inputs related to the non-public warrants fair value as of September 30, 2026:</p> <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfServicingLiabilitiesAtFairValueTextBlock_z6pZtMZm7UL6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Assumptions)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BB_z0QW7QfzWwQ" style="display: none">Schedule of assumptions used</span></td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Supplemental Information</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Non-public Warrants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: left">Expected term of the warrants (years)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90C_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zOiMUPKauMu9" title="Assumptions used">1.00</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Stock price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zl3EgGvCE5Jb" title="Assumptions used">4.56</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Warrant exercise price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_901_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zvCMS3V2zv57" title="Assumptions used">6.00</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zk8q1mWOQFGj" title="Assumptions used">4.54%</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zABej5Eo0j22" title="Assumptions used">102.76%</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AA_zxuiArua51o4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The contingent consideration from the Rotor Lab acquisition was based on management’s estimate at the acquisition date of $<span id="xdx_90D_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_pp0p0_c20251231_zgAuUQZRQyW6" title="Contingent consideration">2,847,000</span>, which is based on the fair value of contingent consideration determined using the Monte-Carlo variable scenario model which values the liability at the measurement date using certain assumptions including the expected revenue over the calculation period, a discount rate applied to revenue projections, the risk-free interest rate over the earnout period and certain estimates and probabilities of different outcomes. The Company updated the expected contingent consideration from the Rotor Lab acquisition to $<span id="xdx_909_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_pp0p0_c20260930_zw1gFOmyr1yl" title="Contingent consideration">3,000,000</span> as of September 30, 2026 based on actual sales during the period. See Note 3 and Note 14 for additional information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Changes in Level 3 financial instruments are as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_zA5Qbgnjl7Lh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Changes in Level 3 financial instruments)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B3_zVod3edn8gH9" style="display: none">Schedule of level 3 financial instruments</span></td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-size: 10pt"><b>December 31,</b></span></td> <td> </td> <td> </td> <td colspan="2"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Purchases,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Issuances and</b></p></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-size: 10pt"><b>Change in</b></span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-size: 10pt"><b>September 30,</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2025</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Settlements</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Fair Value</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2026</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 40%"><span style="font-size: 10pt">Non-public warrants investment</span></td> <td style="width: 2%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_c20260101__20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zpq9tM84w2tc" style="width: 11%; text-align: right" title="Assets, fair beginning value"><span style="font-size: 10pt">1,135,000</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_d0_c20260101__20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zwJecNibMkq4" style="width: 11%; text-align: right" title="Purchases, issuances and settlements"><span style="font-size: 10pt">–</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_c20260101__20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zfdkGJdWEsUc" style="width: 11%; text-align: right" title="Change in fair value"><span style="font-size: 10pt">(395,000</span></td> <td style="width: 1%"><span style="font-size: 10pt">)</span></td> <td style="width: 2%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_c20260101__20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zLE7OiuhpfO" style="width: 11%; text-align: right" title="Assets, fair ending value"><span style="font-size: 10pt">740,000</span></td> <td style="width: 1%"> </td></tr> </table> <p id="xdx_8A2_zV9y1BohnA7l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s financial instruments mainly consist of cash, receivables, short-term investments, other current assets, accounts payable, and accrued expenses. The carrying amounts of cash, receivables, other current assets, accounts payable, and accrued expenses approximate fair value due to the short-term nature of these instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Short Term Investments</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our short-term investments consisting of investments accounted for at fair value and investments accounted for at cost were as follows as of September 30, 2026:</p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_zOBGPGlPVxQ3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Fair value of investments)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BB_zNq7Ca633yB2" style="display: none">Schedule of short-term investments</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold">Short-term investments at fair value</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cumulative Unrealized Gains (Losses)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 49%; text-align: left">Common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iI_c20260930__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_ztBklvGawLyf" style="width: 13%; text-align: right">60,649,998</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--DebtAndEquitySecuritiesUnrealizedGainLoss_c20260101__20260930__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_zipIpSpjKuoe" style="width: 13%; text-align: right" title="Cumulative unrealized gains (losses)">(11,684,231</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--InvestmentOwnedAtFairValue_iI_c20260930__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_zsi8LtDhd1Sb" style="width: 13%; text-align: right" title="Investments owned at fair value">48,965,766</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Pre-funded warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember_zvr0z4mUmvfe" style="text-align: right">2,850,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--DebtAndEquitySecuritiesUnrealizedGainLoss_c20260101__20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember_zgr2CObVlcO2" style="text-align: right" title="Cumulative unrealized gains (losses)">836,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--InvestmentOwnedAtFairValue_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember_zcvipENFHIih" style="text-align: right" title="Investments owned at fair value">3,686,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Non-public warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember_zZDrY8rDFANk" style="border-bottom: Black 1pt solid; text-align: right">195,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--DebtAndEquitySecuritiesUnrealizedGainLoss_c20260101__20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember_zuZ1Uw4ZGkl9" style="border-bottom: Black 1pt solid; text-align: right" title="Cumulative unrealized gains (losses)">545,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--InvestmentOwnedAtFairValue_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember_ztbeG2lQP2zl" style="border-bottom: Black 1pt solid; text-align: right" title="Investments owned at fair value">740,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98A_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iI_c20260930_zr1LxakBJfn7" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">63,694,998</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--DebtAndEquitySecuritiesUnrealizedGainLoss_c20260101__20260930_zNkvHwS8B2s5" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Cumulative unrealized gains (losses)">(10,303,231</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--InvestmentOwnedAtFairValue_iI_c20260930_zNX7EkyAhG3a" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Investments owned at fair value">53,391,766</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"></td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold">Short-term investments at cost</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Impairment / Other</p> <p style="text-align: center; margin-top: 0; margin-bottom: 0">Adjustments</p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjusted Cost</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 49%; text-align: left">Common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--InvestmentOwnedAtCost_iI_c20260930__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_zzQu8sJJHAT4" style="width: 13%; text-align: right" title="Investments owned at cost">10,000,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetImpairmentCharges_d0_c20260101__20260930__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_z7fK6uQQAeld" style="width: 13%; text-align: right" title="Impairment charges">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--AdjustedInvestmentOwnedAtCost_iI_c20260930__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_zoTndogBkQA2" style="width: 13%; text-align: right" title="Investment owned at cost, adjusted">10,000,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Preferred stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtCost_iI_c20260930__us-gaap--FinancialInstrumentAxis__us-gaap--PreferredStockMember_zAj6Gs12nyRe" style="text-align: right" title="Investments owned at cost">5,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AssetImpairmentCharges_d0_c20260101__20260930__us-gaap--FinancialInstrumentAxis__us-gaap--PreferredStockMember_zponNJl20zL5" style="text-align: right" title="Impairment charges">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--AdjustedInvestmentOwnedAtCost_iI_c20260930__us-gaap--FinancialInstrumentAxis__us-gaap--PreferredStockMember_zuPbTtNP6U21" style="text-align: right" title="Investment owned at cost, adjusted">5,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Pre-funded warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--InvestmentOwnedAtCost_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember_zu5Xu6dXTyN4" style="border-bottom: Black 1pt solid; text-align: right" title="Investments owned at cost">30,000,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--AssetImpairmentCharges_d0_c20260101__20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember_zQW3m68KXtf7" style="border-bottom: Black 1pt solid; text-align: right" title="Impairment charges">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_ecustom--AdjustedInvestmentOwnedAtCost_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember_zkO2ZfkdGV47" style="border-bottom: Black 1pt solid; text-align: right" title="Investment owned at cost, adjusted">30,000,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--InvestmentOwnedAtCost_iI_c20260930_zcs5jOIjg4k8" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Investments owned at cost">45,000,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetImpairmentCharges_d0_c20260101__20260930_zmLB8B6kC7pd" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Impairment charges">–</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98F_ecustom--AdjustedInvestmentOwnedAtCost_iI_c20260930_z7tCggtnY7ha" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Investment owned at cost, adjusted">45,000,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A7_z744VpME0Wak" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84C_eus-gaap--StandardProductWarrantyPolicy_z0m7OVFMrbN2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_861_z88uyiGsfa7i">Accrued Warranty</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fat Shark generally provides a one-year warranty on all of its products, except in certain European countries where it can be two years for some consumer-focused products from the date of shipment. If a defect arises during the warranty period, Fat Shark will either (i) repair the affected product at no charge using new parts or parts that are equivalent to new in performance and reliability; (ii) exchange the affected product with a functionally equivalent product; or (iii) refund the original purchase price for the affected product. Allowances for estimated warranty costs are recorded during the period of sale. The determination of such allowances requires the Company to make estimates of product warranty claim rates and expected costs to repair or to replace the products under warranty. The Company currently establishes warranty reserves based on historical warranty costs for each product line combined with liability estimates based on the prior 24 months’ sales activities. If actual return rates and/or repair and replacement costs differ significantly from the Company’s estimates, adjustments to recognize the additional cost of sales may be required in future periods. Historically the warranty accrual and the expense amounts have been immaterial. The warranty liability is included in accrued expenses on the accompanying consolidated balance sheets and amounted to $<span id="xdx_908_eus-gaap--AccruedLiabilitiesCurrent_iI_c20260930_z13KQwaDdLA7" title="Accrued expenses">6,577</span> and $<span id="xdx_902_eus-gaap--AccruedLiabilitiesCurrent_iI_c20251231_zych1v5lvpHf" title="Accrued expenses">19,602</span> as of September 30, 2026 and December 31, 2025, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Rotor Riot does not provide any warranty of any kind for any of the equipment it sells or otherwise distributes. Consumers assume all risk for any products purchased or received from Rotor Riot.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Rotor Lab does not provide any warranty, but does provide for a seven day defect period. Rotor Lab has not had any material defects for products sold.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective September 2025, Unusual Machines, the parent company which manufactures motors has a limited warranty in which it warrants to customers that their products will be free from defects in material and workmanship under normal use and service for up to 90 days. The limited warranty covers manufacturing defects and premature failures and extends only to the original customer and is non-transferrable. The warranty liability is included in accrued expenses on the accompanying consolidated balance sheets and amounted to $<span id="xdx_908_eus-gaap--AccruedLiabilitiesCurrent_iI_c20260930__us-gaap--NatureOfExpenseAxis__custom--WarrantLiabilityMember_zfMUaRvAFzge" title="Accrued liabilities">317,009</span> as of September 30, 2026, and $<span id="xdx_902_eus-gaap--AccruedLiabilitiesCurrent_iI_c20251231__us-gaap--NatureOfExpenseAxis__custom--WarrantLiabilityMember_zSKtvvHXeJtb" title="Accrued liabilities">0</span> as of December 31, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_zL3j7hLTEyng" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86C_z0uqwhmSa2He">Revenue Recognition</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company will recognize revenue in accordance with ASC 606, “Revenue from Contracts with Customers”, issued by the Financial Accounting Standards Board (“FASB”). This standard includes a comprehensive evaluation of factors to be considered regarding revenue recognition including:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Step 1: Identify the contract with a customer;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Step 2: Identify the performance obligations in the contract;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Step 3: Determine the transaction price;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Step 4: Allocate the transaction price to the performance obligations in the contract; and</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Step 5: Recognize revenue when (or as) the Company satisfies a performance obligation at a point in time.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company receives revenues from the sale of drone and drone parts to enterprise customers and distributors (“Enterprise Revenue”) and individual consumers (“Retail Revenue”). Revenue is recognized at a point in time when the products are shipped and the price is fixed or determinable, no other significant obligations of the Company exist and collectability is probable. Revenue is recognized when the title to the products has been passed to the customer, which is the date the products are shipped to the customer. This is the date the performance obligation has been met. The Company’s retail return policy allows for certain non-custom or built-to-order products to be returned up to 15 days after the original order is placed so long as it meets specific requirements as outlined in its return policy. The Company’s enterprise return policy allows for returns related to defective product so long as it meets the requirements in its policy. The historical sales returns for retail customers is de minimis and the Company does not have a specific sales return allowance for retail orders. The Company had returns for enterprise orders of $288,000 for the nine-month period ended September 30, 2026. A sales return allowance has not been recorded to date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84E_ecustom--DisaggregationOfRevenuePolicyTextBlock_ziowYSV7VAtj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Disaggregation of Revenue</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the Company’s revenue disaggregated by revenue type for the period ended:</p> <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--DisaggregationOfRevenueTableTextBlock_zhfKbvwvuNQe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Disaggregated by revenue)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B7_z6pLXT1OYOl9" style="display: none">Schedule of disaggregated by revenue</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three months Ended<br/> September 30</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Retail revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20260701__20260930__srt--ProductOrServiceAxis__custom--RetailRevenueMember_z59ZdSESHga2" style="width: 13%; text-align: right" title="Total revenue">1,346,107</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--Revenues_c20250701__20250930__srt--ProductOrServiceAxis__custom--RetailRevenueMember_zsBcZDTcMEYf" style="width: 13%; text-align: right" title="Total revenue">1,158,449</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Enterprise revenue</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--Revenues_c20260701__20260930__srt--ProductOrServiceAxis__custom--EnterpriseRevenueMember_zYH0bmvqNJR" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">12,556,925</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--Revenues_c20250701__20250930__srt--ProductOrServiceAxis__custom--EnterpriseRevenueMember_zqDRlYbzFBR3" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">976,139</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20260701__20260930_zv7ROjSYz93f" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">13,903,032</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20250701__20250930_z9S22hOIDikj" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">2,134,588</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the Company’s revenue disaggregated by revenue type for the period ended:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the Nine months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Retail revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20260101__20260930__srt--ProductOrServiceAxis__custom--RetailRevenueMember_zSM9lmbcYO11" style="width: 13%; text-align: right" title="Total revenue">4,521,031</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_c20250101__20250930__srt--ProductOrServiceAxis__custom--RetailRevenueMember_zy79pcHsg2k6" style="width: 13%; text-align: right" title="Total revenue">5,012,473</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Enterprise revenue</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20260101__20260930__srt--ProductOrServiceAxis__custom--EnterpriseRevenueMember_zBEHt2lICbz5" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">34,200,305</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--Revenues_c20250101__20250930__srt--ProductOrServiceAxis__custom--EnterpriseRevenueMember_z5Ojgdfwud7k" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">1,288,384</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--Revenues_c20260101__20260930_zfLxCF3yqwjd" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">38,721,336</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_c20250101__20250930_zvvedg91ZULb" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">6,300,857</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zrx8LwBLoEi4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company had revenue outside the United States of approximately $<span id="xdx_90F_eus-gaap--Revenues_pn5n6_c20260101__20260930__us-gaap--GeographicDistributionAxis__us-gaap--GeographicDistributionForeignMember_zWwk8shkNtil" title="Foreign sales revenue">1.5</span> million and $<span id="xdx_905_eus-gaap--Revenues_pn4n6_c20250101__20250930__us-gaap--GeographicDistributionAxis__us-gaap--GeographicDistributionForeignMember_zEISmam0Sq42" title="Foreign sales revenue">0.25</span> million for the nine months ended September 30, 2026 and 2025, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p id="xdx_841_ecustom--RevenueRecognitionDeferredRevenue1_z9TNaV5QnHRe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_862_ziC3RlCyzJu7">Deferred Revenue</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred revenue relates to orders placed and payment received, but not yet fulfilled. All deferred revenue is expected to be recognized within one year. Deferred revenue related to orders placed, but not yet fulfilled totaled $<span id="xdx_90F_eus-gaap--DeferredRevenueCurrent_iI_pp0p0_c20260930_zTnjRnZpvEti" title="Deferred revenue, current">114,491</span> and $<span id="xdx_908_eus-gaap--DeferredRevenueCurrent_iI_pp0p0_c20251231_zmxYe2spb8ki" title="Deferred revenue, current">638,125</span> as of September 30, 2026 and December 31, 2025, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84F_eus-gaap--CostOfSalesPolicyTextBlock_zNn69egbRTGj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86F_zLlbyZWGNll4">Cost of Goods Sold</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of goods sold includes inventory costs which includes an allocation for labor and rent for our manufactured products, direct packaging costs and production related depreciation, if any. Depreciation included in cost of goods sold for the nine months ended September 30, 2026 and 2025 was $<span id="xdx_90C_eus-gaap--CostOfGoodsAndServicesSoldDepreciation_pp0p0_c20260101__20260930_zGeSKrKOTtk2" title="Cost of goods sold depreciation">185,431</span> and $<span id="xdx_90A_eus-gaap--CostOfGoodsAndServicesSoldDepreciation_pp0p0_c20250101__20250930_zDrzU8IcZOgd">0</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84B_ecustom--ShippingAndHandlingCostsPolicyTextBlock_zhtQThTryZM7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_867_z37r8VLlhVc4">Shipping and Handling Costs</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shipping and handling costs incurred for products shipped to customers are included in operations expenses and amounted to $<span id="xdx_908_eus-gaap--SellingAndMarketingExpense_c20260101__20260930__us-gaap--NatureOfExpenseAxis__custom--ShippingAndHandlingCostsMember_z76RIgS716af" title="Shipping and handling costs">873,225</span> and $<span id="xdx_900_eus-gaap--SellingAndMarketingExpense_c20250101__20250930__us-gaap--NatureOfExpenseAxis__custom--ShippingAndHandlingCostsMember_zwzFRRAtwq7d" title="Shipping and handling costs">226,530</span> for the nine months ended September 30, 2026 and 2025, respectively. Shipping and handling costs charged to customers are included in sales.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p id="xdx_849_eus-gaap--ResearchAndDevelopmentExpensePolicy_z5BbBkPUxAC6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_860_zrLJEOOWy7Ge">Research and Development</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research and development expenses include payroll, employee benefits, and other headcount-related expenses associated with product development. Research and development expenses also include third-party development costs, materials, and are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zwaPEAh4sfQ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86F_z0rkB6GQb9m7">Income Taxes</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for income taxes using an asset and liability approach, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events. A valuation allowance is established to reduce deferred tax assets to their estimated realizable value when, in the opinion of management, it is more likely than not that some portion or all of the deferred income tax assets will not be realizable in the future. The Company maintains a valuation allowance against its deferred tax assets when it is more likely than not that such deferred tax assets will not be realized. Certain deferred tax liabilities are not available as a source of future taxable income in assessing the realizability of the Company’s deferred tax assets and, accordingly, remain recognized. For the three months ended September 30, 2026, the net change in deferred taxes and the related valuation allowance was immaterial and, accordingly, no income tax expense was recorded.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes benefits of uncertain tax positions if it is more likely than not that such positions will be sustained upon examination based solely on their technical merits, as the largest amount of benefit that is more likely than not to be realized upon the ultimate settlement. The Company’s policy is to recognize interest and penalties related to unrecognized tax benefits as a part of income tax expense.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_844_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zLW3iGKpWwdg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_868_z2wmKr0pQRI8">Stock-Based Compensation</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stock options are valued using the estimated grant-date fair value method of accounting in accordance with ASC Topic 718, Compensation – Stock Compensation. Fair value is determined based on the Black-Scholes Model using inputs reflecting our estimates of expected volatility based on comparative companies through December 31, 2025, and historical volatility beginning of January 1, 2026, expected term using the simplified method and future dividends. The Company recognizes forfeitures as they occur. The fair value of stock grants is based on our stock price on the date of grant. Compensation costs are recognized on a straight-line basis over the requisite service period which is the vesting term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p id="xdx_849_eus-gaap--DerivativesPolicyTextBlock_zBPyifN0qo56" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86D_zlyZf82wzDMc">Warrants</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for warrants to purchase shares of its common stock in accordance with the guidance in ASC 480, <i>Distinguishing Liabilities from Equity</i> (“ASC 480”) and ASC 815, <i>Derivatives and Hedging</i> (“ASC 815”). The Company classifies warrants issued for the purchase of shares of its common stock as either equity or liability instruments based on an assessment of the specific terms and conditions of each respective contract. The assessment considers whether the warrants are freestanding financial instruments or embedded in a host instrument, whether the warrants meet the definition of a liability pursuant to ASC 480, whether the warrants meet the definition of a derivative under ASC 815, and whether the warrants meet all of the requirements for equity classification under ASC 815. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants classified as liabilities are recognized as a non-cash gain or loss in the consolidated statements of operations and comprehensive loss.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84F_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zXgXZdJBoLnk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_868_zZDTg8rbTns9">Foreign Currency</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s wholly owned subsidiary’s functional currency is the Australia dollar (AUD). For financial reporting purposes, the Australia dollar has been translated into the Company’s reporting currency, which is the United States dollar (USD). Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenue and expenses are translated at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity (deficit) as “Accumulated other comprehensive income (loss).” Gains and losses resulting from foreign currency translations are included in the statement of operations and comprehensive income (loss) as a component of other comprehensive income (loss). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars to USD after the balance sheet date. Transaction gains and losses from transactions denominated in a foreign currency are recognized in other income (expense) in the statement of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Changes in the cumulative translation adjustments were as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfComprehensiveIncomeLossTableTextBlock_zRpsSsgcmbck" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Cumulative translation adjustments)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B8_zDWBfBFe72Kk" style="display: none">Schedule of cumulative translation adjustments</span></td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">Balance as of December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><span id="xdx_90D_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20260101__20260930_zzRQBACPlm97" title="Beginning balance">3,470</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Foreign currency translation adjustment related to Rotor Lab</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_905_ecustom--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax1_c20260101__20260930__srt--CounterpartyNameAxis__custom--RotorLabMember_zouogGvBCbZ7" title="Foreign currency translation adjustment related to Rotor Lab">20,878</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Balance as of September 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20260101__20260930_zzmSpFhkf3e2" title="Ending balance">24,348</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zxiUUtvFP59a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_zhRhdy1Bf6R6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_865_z9wxqI44a7n4">Net Loss per Share</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic and diluted net loss per share is calculated based on the weighted-average of common shares outstanding in accordance with FASB ASC Topic 260, <i>Earnings per Share</i>. Diluted net loss per share is calculated based on the weighted-average number of common shares outstanding plus the effect of dilutive potential common shares. When the Company reports a net loss, the calculation of diluted net loss per share excludes potential common shares as the effect would be anti-dilutive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the reconciliation of basic to diluted weighted average shares used in computing net income per share of common stock attributable to common stockholders.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zXBzYWQ7Q4wc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Earnings per share)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BA_zUSJYtGPoXr6" style="display: none">Schedule of income per share</span></td> <td> </td> <td colspan="2" id="xdx_49E_20260701__20260930_zIBAIfSpXls2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" id="xdx_49B_20250701__20250930_zXC9MslV2ja7" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" id="xdx_491_20260101__20260930_zfXi0FjKl4Re" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" id="xdx_498_20250101__20250930_z6C37pjqy8U9" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="6" style="text-align: center"><span style="font-size: 10pt"><b>For the Three months Ended</b></span></td> <td> </td> <td> </td> <td colspan="6" style="text-align: center"><span style="font-size: 10pt"><b>For the Nine months Ended</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>September 30</b></span></td> <td> </td> <td> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>September 30</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2026</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2025</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2026</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2025</b></span></td> <td> </td></tr> <tr id="xdx_40E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zXBGxbnCWTal" style="vertical-align: bottom; background-color: #EEEEEE"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt; width: 40%"><span style="font-size: 10pt">Weighted average shares used in computing net income per share of common stock, basic</span></td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"><span style="font-size: 10pt">49,968,207</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"><span style="font-size: 10pt">30,002,179</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"><span style="font-size: 10pt">46,094,557</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"><span style="font-size: 10pt">22,610,516</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-size: 10pt">Add incremental shares:</span></td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr id="xdx_40F_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_d0_z80Nsz4wkROh" style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-size: 10pt">Stock based awards (options and restricted stock units)</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">257,303</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">–</span></td> <td> </td></tr> <tr id="xdx_401_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_d0_z7r2iVN6wo1a" style="vertical-align: bottom; background-color: white"> <td><span style="font-size: 10pt">Warrants</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">–</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">321,712</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">–</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">–</span></td> <td> </td></tr> <tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_z6ZbljP5M0x4" style="vertical-align: bottom; background-color: #EEEEEE"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Weighted average shares used in computing net income per share of common stock, diluted</span></td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 10pt">49,968,207</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 10pt">30,581,194</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 10pt">46,094,557</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 10pt">22,610,516</span></td> <td> </td></tr> </table> <p id="xdx_8A2_z4WII0u9Dqoc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the potentially dilutive shares that were excluded for the nine months ended September 30, 2026 and the nine months ended September 30, 2025 from the computation of diluted net loss per share of common stock attributable to common stockholders, because their effect was anti-dilutive:</p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zijDliBApo92" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Antidilutive shares)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B2_zR7gfLpuT2Ad" style="display: none">Schedule of anti dilutive shares</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">For the Nine months Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">For the Nine months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Unvested stock options</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_z7sGvvMYz3T2" style="width: 13%; text-align: right" title="Antidilutive shares">3,412,793</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zbSrCd9p73Q" style="width: 13%; text-align: right" title="Antidilutive shares">682,600</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Unvested restricted stock awards</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_ziOYNNVOblbe" style="text-align: right" title="Antidilutive shares">726,667</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_zY2FvYXsl3s8" style="text-align: right" title="Antidilutive shares">550,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20260101__20260930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zSkv0Ej88ype" style="text-align: right" title="Antidilutive shares">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z60IJJ7ijHC8" style="text-align: right" title="Antidilutive shares">1,154,473</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260930_zyJFOAWrls0b" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive shares">4,139,460</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250930_zcSrieGlANec" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive shares">2,387,073</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_z6r7wMlrZ8Wf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_842_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zYuDS14b4Fka" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86A_zhSoOOeYAmSl">Segment Reporting</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operating segments are defined as components of an enterprise for which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision making group, in deciding how to allocate resources and in assessing performance. Unusual Machines, which sells drones and drone-related components, operates as a <span id="xdx_906_eus-gaap--NumberOfReportableSegments_dxL_uInteger_c20260101__20260930_zBSkdpbHtr64" title="::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl1173">single</span></span> reportable segment entity. Our chief operating decision maker, our Chief Executive Officer, reviews financial information presented on a consolidated basis for purposes of making operating decisions and assessing financial performance. The Chief Executive Officer primarily evaluates consolidated total revenues and gross margin, consistent with amounts presented in the consolidated statements of operations, in assessing the Company’s performance, and evaluates the Company’s cash position, consistent with amounts presented in the consolidated balance sheets, when making decisions regarding investing and financing activities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zWV7vYglYdzg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_860_zZ3XHsBZOrTk">Recent Accounting Pronouncements</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November 2024, the FASB issued ASU No. 2024-03, “Disaggregation of Income Statement Expenses” which requires disaggregated disclosure of income statement expenses into specified categories in disclosures within the footnotes to the financial statements. The standard is effective for annual reporting periods beginning after December 15, 2026. The Company is currently evaluating the effect of this ASU on the consolidated financial statements and disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In May 2025, the FASB issued ASU No. 2025-4, “Compensation – Stock Compensation and Revenue From Contracts With Customers” which provides clarifications to share-based consideration payable to a customer. The standard is effective for annual reporting periods beginning after December 15, 2026. The Company is currently evaluating the effect of this ASU on the consolidated financial statements and disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_845_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zVlGxoIf1pe4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86F_zpFrmpCQD7X5">Principles of Consolidation</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements include accounts of the Company and its wholly owned subsidiaries including UMAC IP Holdings Corp., Unusual Machines of Florida, Inc, Fat Shark, Rotor Riot and Rotor Lab since acquired on September 3, 2025. Intercompany transactions and balances have been eliminated upon consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_849_eus-gaap--ConsolidationPolicyTextBlock_zMRXZZWHuT6i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86E_z5QXFWHsSn7c">Basis of Presentation</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated condensed financial statements of the Company included herein have been prepared, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with Generally Accepted Accounting Principles (“GAAP”) have been condensed or omitted from this Quarterly Report, as is permitted by such rules and regulations. Accordingly, these condensed financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K filed with the SEC on March 12, 2026. The results for any interim period are not necessarily indicative of results for any future period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_845_eus-gaap--UseOfEstimates_zkmyjLzASXGc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_860_zmW8sZBh51l">Use of Estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results could differ from those estimates, and such results could be material.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The financial statements include some amounts that are based on management’s best estimates and judgments. Significant estimates reflected in these consolidated condensed financial statements include those used to (i) determine stock-based compensation, (ii) the fair value of assets acquired and liabilities assumed in business combinations, the fair value of shares issued as consideration and the fair value of contingent consideration in business combinations, (iii) reserves and allowances related to accounts receivable, and inventory, (iv) the evaluation of long-lived assets, including intangibles and goodwill, for impairment, (v) the present value of lease liabilities and related right of use assets, (vi) the fair value of short-term investments including the value of unexercised warrants received, (vii) the warranty liability and sales returns reserves, and (viii) the deferred tax asset valuation allowance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p id="xdx_841_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zMsUSuwb0pD" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_860_zVn2L1y8XRQb">Cash and Cash Equivalents</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considers all highly liquid debt instruments and other short-term investments with maturities of three months or less, when purchased, to be cash equivalents. The Company maintains cash deposits in multiple commercial banks and financial services companies. These financial institutions are insured by the Federal Deposit Insurance Corporation up to $250,000. The Company’s cash balance may at times exceed these limits. At September 30, 2026 and December 31, 2025, the Company had approximately $<span id="xdx_905_eus-gaap--CashUninsuredAmount_iI_pn5n6_c20260930_zQsw5D10RHve" title="Cash uninsured amount">161.7</span> million and $<span id="xdx_908_eus-gaap--CashUninsuredAmount_iI_pn5n6_c20251231_zkcsj6aommdc" title="Cash uninsured amount">102.6</span> million, respectively, in excess of federally insured limits. The Company continually monitors its positions with, and the credit quality of the financial institutions with which it invests.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> 161700000 102600000 <p id="xdx_84D_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zaFFhmW0A6ed" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_866_zQj5S7s1bsvd">Accounts Receivable, net</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company carries its accounts receivable at invoiced amounts. The Company follows ASC 326, Financial Instruments – Credit Losses and has early adopted in fiscal year 2025, ASU 2025-05, under which the Company evaluates all credit losses as of the reporting date. On a periodic basis, the Company evaluates its accounts receivable and establishes an allowance for credit losses based on a history of past write-offs and collections and current credit conditions. Accounts are written-off as uncollectible at the discretion of management. At September 30, 2026 and December 31, 2025, the Company considers accounts receivable to be fully collectible; accordingly, <span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_do_c20260101__20260930_zwisQc4BZAe8" title="Credit losses"><span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_do_c20250101__20251231_zPlwx6eEMUrb" title="Allowance for credit losses">no</span></span> allowance for credit losses has been established.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0 0 <p id="xdx_848_eus-gaap--FinanceLoansAndLeasesReceivablePolicy_zhpRebWgGzgg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_867_zog8emMsmyu7">Note Receivable</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for its note receivable in accordance with ASC 310, Receivables. The note receivable is carried at cost and is evaluated for credit losses in accordance with ASC 326, Financial Instruments – Credit Losses. The Company evaluates embedded features within convertible notes under ASC 815, Derivatives and Hedging, to determine whether any such features require separate accounting as embedded derivatives. The Company reassesses its conclusions regarding embedded features at each reporting date as facts and circumstances change.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84D_eus-gaap--EquityMethodInvestmentsPolicy_zWPSlbbwbz7g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_867_zbqxvdE4p8b5">Short-Term Equity Investments at Fair Value</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company measures its investments in equity securities, consisting of common stock, preferred stock, and non-public warrants at fair value with unrealized changes in value recognized in net income (loss) per ASC 321. The Company has established an Equity Investment Valuation and Quarterly Assessment Policy to ensure consistent application of the applicable accounting guidance, including the evaluation of fair value, observable price changes, and impairment indicators. This policy serves as the basis for management's quarterly investment valuation assessments and related accounting conclusions. The Company holds less than a 5% equity interest in each of the companies it invested in as of September 30, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_847_eus-gaap--EquityMethodInvestmentsIssuancesPolicy_zxipIswcp8I9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86B_zyzSfSggfQw3">Short-Term Equity Investments at Cost</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for certain equity investments in privately held companies that do not have readily determinable fair values using the measurement alternative under ASC 321, Investments – Equity Securities. Under the measurement alternative, these investments are measured at cost, less impairment, and adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer. The Company evaluates these investments at each reporting date to identify observable transactions that may require an adjustment to the carrying amount and indicators of impairment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_848_eus-gaap--InventoryPolicyTextBlock_z5TfKDNHDWGe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86E_zOyE3Qgem3Tb">Inventory</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventories, which consist of finished goods and raw materials, are stated at the lower of cost or net realizable value, and are measured using the first-in, first-out method. Cost components include direct materials, direct labor, an allocation of rent expense and depreciation for manufactured products, as well as in-bound freight. At each balance sheet date, the Company evaluates the net realizable value of its inventory using various reference measures including current product selling prices, as well as evaluating for excess quantities and obsolescence.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84A_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zNJ628rR9Xzd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_869_zt9210aULxU">Property and equipment, net</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment is stated at cost, net of accumulated depreciation. Depreciation is provided utilizing the straight-line method over the estimated useful lives which includes computer and office equipment of three to five years, motor production equipment of ten to fifteen years and tenant improvements of five to fifteen years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i></i></p> <p id="xdx_841_eus-gaap--LesseeLeasesPolicyTextBlock_zSszk7qQdG96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86E_zbAB4CC6ZYNe">Leases</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company applies Accounting Standards Codification (ASC) 842, “Leases” which requires the recognition of assets and liabilities associated with lease agreements. The Company recognized a lease liability obligation and a right-of-use asset for the facilities leases in Orlando, FL and for the Canberra Australia lease related to the Rotor Lab acquisition as discussed in Note 3.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company determines if a contract is a lease or contains a lease at inception. Operating lease liabilities are measured, on each reporting date, based on the present value of the future minimum lease payments over the remaining lease term. The Company’s leases do not provide an implicit rate. Therefore, the Company used an effective discount rate of 8.24% based on its last proposed debt financings. Operating lease assets are measured by adjusting the lease liability for lease incentives, initial direct costs incurred and asset impairments. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term with the operating lease asset reduced by the amount of the expense. The Company has elected to account for lease and non-lease components together as a single lease component for all underlying assets. Lease terms do not include an option to renew.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p id="xdx_847_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z8xeVrYOozr7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_868_zHQRiMqXSoda">Fair Values, Inputs and Valuation Techniques for Financial Assets and Liabilities, and Related Disclosures</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value measurements and disclosure guidance defines fair value and establishes a framework for measuring fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. In accordance with this guidance, the Company has categorized its recurring basis financial assets and liabilities into a three-level fair value hierarchy based on the priority of the inputs to the valuation technique.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The guidance establishes three levels of the fair value hierarchy as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Level 1</i>: Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Level 2</i>: Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Level 3</i>: Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table details the fair value measurements of the Company’s financial assets and liabilities as of September 30, 2026:</p> <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zhen5Q9gi3O3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Financial assets and liabilities)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BB_zui2PdPddM4g" style="display: none">Schedule of financial assets and liabilities</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Short term investments – assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 40%; text-align: left">Common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_z0XZjr8ixpN9" style="width: 11%; text-align: right" title="Assets, fair value">48,965,766</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zTAZMmQGTyV" style="width: 11%; text-align: right" title="Assets, fair value">48,965,766</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zLJMAKPcmt77" style="width: 11%; text-align: right" title="Assets, fair value">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zjZOE6OIioq4" style="width: 11%; text-align: right" title="Assets, fair value">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Pre-funded warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember_z8wFVlejnCT" style="text-align: right" title="Assets, fair value">3,686,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z6EAQUaplpS1" style="text-align: right" title="Assets, fair value">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zn0KS3pimZ09" style="text-align: right" title="Assets, fair value">3,686,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z668XfxliQv9" style="text-align: right" title="Assets, fair value">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Non-public warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember_z0qt8NPsCtdl" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">740,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z19urq4aSERc" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zqsPH8zcwm9h" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zY4LkuJmXIWe" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">740,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Total short-term investments – assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--TotalShortTermInvestmentsMember_zwWDzhpa7U37" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">53,391,766</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--TotalShortTermInvestmentsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zOLfppWlAkDe" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">48,965,766</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--TotalShortTermInvestmentsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zr1rytVDasub" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">3,686,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--TotalShortTermInvestmentsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zEW29K9ztG2h" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">740,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Contingent consideration from Rotor Lab acquisition</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember_zZO3ulWeFej8" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets, fair value">3,000,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zIVSk4OalyPd" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets, fair value">3,000,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zJavLMBZTv58" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets, fair value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zK968cfZ6WRi" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets, fair value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zR3WfoyVbq0i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company calculated the fair value for common stock for short-term investments based on the quoted trading price as of the close of the market multiplied by the total shares held by the Company as of September 30, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company calculated the fair value for pre-funded warrants for short-term investments based on the quoted trading price as of the close of the market multiplied by the total common equivalent shares held by the Company as of September 30, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the non-public warrants investment in 2026 was determined using a Black-Scholes pricing model which values the warrants based on the stock price at the valuation date, the expected life of the warrant, the estimated volatility of the stock of the investee, and the risk-free interest rate over the expected life of the warrant.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company used the following inputs related to the non-public warrants fair value as of September 30, 2026:</p> <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfServicingLiabilitiesAtFairValueTextBlock_z6pZtMZm7UL6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Assumptions)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BB_z0QW7QfzWwQ" style="display: none">Schedule of assumptions used</span></td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Supplemental Information</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Non-public Warrants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: left">Expected term of the warrants (years)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90C_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zOiMUPKauMu9" title="Assumptions used">1.00</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Stock price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zl3EgGvCE5Jb" title="Assumptions used">4.56</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Warrant exercise price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_901_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zvCMS3V2zv57" title="Assumptions used">6.00</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zk8q1mWOQFGj" title="Assumptions used">4.54%</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zABej5Eo0j22" title="Assumptions used">102.76%</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AA_zxuiArua51o4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The contingent consideration from the Rotor Lab acquisition was based on management’s estimate at the acquisition date of $<span id="xdx_90D_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_pp0p0_c20251231_zgAuUQZRQyW6" title="Contingent consideration">2,847,000</span>, which is based on the fair value of contingent consideration determined using the Monte-Carlo variable scenario model which values the liability at the measurement date using certain assumptions including the expected revenue over the calculation period, a discount rate applied to revenue projections, the risk-free interest rate over the earnout period and certain estimates and probabilities of different outcomes. The Company updated the expected contingent consideration from the Rotor Lab acquisition to $<span id="xdx_909_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_pp0p0_c20260930_zw1gFOmyr1yl" title="Contingent consideration">3,000,000</span> as of September 30, 2026 based on actual sales during the period. See Note 3 and Note 14 for additional information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Changes in Level 3 financial instruments are as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_zA5Qbgnjl7Lh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Changes in Level 3 financial instruments)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B3_zVod3edn8gH9" style="display: none">Schedule of level 3 financial instruments</span></td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-size: 10pt"><b>December 31,</b></span></td> <td> </td> <td> </td> <td colspan="2"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Purchases,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Issuances and</b></p></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-size: 10pt"><b>Change in</b></span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-size: 10pt"><b>September 30,</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2025</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Settlements</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Fair Value</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2026</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 40%"><span style="font-size: 10pt">Non-public warrants investment</span></td> <td style="width: 2%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_c20260101__20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zpq9tM84w2tc" style="width: 11%; text-align: right" title="Assets, fair beginning value"><span style="font-size: 10pt">1,135,000</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_d0_c20260101__20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zwJecNibMkq4" style="width: 11%; text-align: right" title="Purchases, issuances and settlements"><span style="font-size: 10pt">–</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_c20260101__20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zfdkGJdWEsUc" style="width: 11%; text-align: right" title="Change in fair value"><span style="font-size: 10pt">(395,000</span></td> <td style="width: 1%"><span style="font-size: 10pt">)</span></td> <td style="width: 2%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_c20260101__20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zLE7OiuhpfO" style="width: 11%; text-align: right" title="Assets, fair ending value"><span style="font-size: 10pt">740,000</span></td> <td style="width: 1%"> </td></tr> </table> <p id="xdx_8A2_zV9y1BohnA7l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s financial instruments mainly consist of cash, receivables, short-term investments, other current assets, accounts payable, and accrued expenses. The carrying amounts of cash, receivables, other current assets, accounts payable, and accrued expenses approximate fair value due to the short-term nature of these instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Short Term Investments</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our short-term investments consisting of investments accounted for at fair value and investments accounted for at cost were as follows as of September 30, 2026:</p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_zOBGPGlPVxQ3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Fair value of investments)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BB_zNq7Ca633yB2" style="display: none">Schedule of short-term investments</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold">Short-term investments at fair value</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cumulative Unrealized Gains (Losses)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 49%; text-align: left">Common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iI_c20260930__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_ztBklvGawLyf" style="width: 13%; text-align: right">60,649,998</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--DebtAndEquitySecuritiesUnrealizedGainLoss_c20260101__20260930__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_zipIpSpjKuoe" style="width: 13%; text-align: right" title="Cumulative unrealized gains (losses)">(11,684,231</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--InvestmentOwnedAtFairValue_iI_c20260930__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_zsi8LtDhd1Sb" style="width: 13%; text-align: right" title="Investments owned at fair value">48,965,766</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Pre-funded warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember_zvr0z4mUmvfe" style="text-align: right">2,850,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--DebtAndEquitySecuritiesUnrealizedGainLoss_c20260101__20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember_zgr2CObVlcO2" style="text-align: right" title="Cumulative unrealized gains (losses)">836,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--InvestmentOwnedAtFairValue_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember_zcvipENFHIih" style="text-align: right" title="Investments owned at fair value">3,686,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Non-public warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember_zZDrY8rDFANk" style="border-bottom: Black 1pt solid; text-align: right">195,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--DebtAndEquitySecuritiesUnrealizedGainLoss_c20260101__20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember_zuZ1Uw4ZGkl9" style="border-bottom: Black 1pt solid; text-align: right" title="Cumulative unrealized gains (losses)">545,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--InvestmentOwnedAtFairValue_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember_ztbeG2lQP2zl" style="border-bottom: Black 1pt solid; text-align: right" title="Investments owned at fair value">740,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98A_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iI_c20260930_zr1LxakBJfn7" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">63,694,998</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--DebtAndEquitySecuritiesUnrealizedGainLoss_c20260101__20260930_zNkvHwS8B2s5" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Cumulative unrealized gains (losses)">(10,303,231</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--InvestmentOwnedAtFairValue_iI_c20260930_zNX7EkyAhG3a" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Investments owned at fair value">53,391,766</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"></td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold">Short-term investments at cost</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Impairment / Other</p> <p style="text-align: center; margin-top: 0; margin-bottom: 0">Adjustments</p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjusted Cost</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 49%; text-align: left">Common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--InvestmentOwnedAtCost_iI_c20260930__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_zzQu8sJJHAT4" style="width: 13%; text-align: right" title="Investments owned at cost">10,000,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetImpairmentCharges_d0_c20260101__20260930__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_z7fK6uQQAeld" style="width: 13%; text-align: right" title="Impairment charges">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--AdjustedInvestmentOwnedAtCost_iI_c20260930__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_zoTndogBkQA2" style="width: 13%; text-align: right" title="Investment owned at cost, adjusted">10,000,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Preferred stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtCost_iI_c20260930__us-gaap--FinancialInstrumentAxis__us-gaap--PreferredStockMember_zAj6Gs12nyRe" style="text-align: right" title="Investments owned at cost">5,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AssetImpairmentCharges_d0_c20260101__20260930__us-gaap--FinancialInstrumentAxis__us-gaap--PreferredStockMember_zponNJl20zL5" style="text-align: right" title="Impairment charges">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--AdjustedInvestmentOwnedAtCost_iI_c20260930__us-gaap--FinancialInstrumentAxis__us-gaap--PreferredStockMember_zuPbTtNP6U21" style="text-align: right" title="Investment owned at cost, adjusted">5,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Pre-funded warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--InvestmentOwnedAtCost_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember_zu5Xu6dXTyN4" style="border-bottom: Black 1pt solid; text-align: right" title="Investments owned at cost">30,000,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--AssetImpairmentCharges_d0_c20260101__20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember_zQW3m68KXtf7" style="border-bottom: Black 1pt solid; text-align: right" title="Impairment charges">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_ecustom--AdjustedInvestmentOwnedAtCost_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember_zkO2ZfkdGV47" style="border-bottom: Black 1pt solid; text-align: right" title="Investment owned at cost, adjusted">30,000,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--InvestmentOwnedAtCost_iI_c20260930_zcs5jOIjg4k8" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Investments owned at cost">45,000,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetImpairmentCharges_d0_c20260101__20260930_zmLB8B6kC7pd" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Impairment charges">–</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98F_ecustom--AdjustedInvestmentOwnedAtCost_iI_c20260930_z7tCggtnY7ha" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Investment owned at cost, adjusted">45,000,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A7_z744VpME0Wak" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zhen5Q9gi3O3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Financial assets and liabilities)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BB_zui2PdPddM4g" style="display: none">Schedule of financial assets and liabilities</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Short term investments – assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 40%; text-align: left">Common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_z0XZjr8ixpN9" style="width: 11%; text-align: right" title="Assets, fair value">48,965,766</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zTAZMmQGTyV" style="width: 11%; text-align: right" title="Assets, fair value">48,965,766</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zLJMAKPcmt77" style="width: 11%; text-align: right" title="Assets, fair value">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zjZOE6OIioq4" style="width: 11%; text-align: right" title="Assets, fair value">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Pre-funded warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember_z8wFVlejnCT" style="text-align: right" title="Assets, fair value">3,686,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z6EAQUaplpS1" style="text-align: right" title="Assets, fair value">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zn0KS3pimZ09" style="text-align: right" title="Assets, fair value">3,686,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z668XfxliQv9" style="text-align: right" title="Assets, fair value">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Non-public warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember_z0qt8NPsCtdl" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">740,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z19urq4aSERc" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zqsPH8zcwm9h" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zY4LkuJmXIWe" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">740,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Total short-term investments – assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--TotalShortTermInvestmentsMember_zwWDzhpa7U37" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">53,391,766</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--TotalShortTermInvestmentsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zOLfppWlAkDe" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">48,965,766</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--TotalShortTermInvestmentsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zr1rytVDasub" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">3,686,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--TotalShortTermInvestmentsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zEW29K9ztG2h" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">740,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Contingent consideration from Rotor Lab acquisition</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember_zZO3ulWeFej8" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets, fair value">3,000,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zIVSk4OalyPd" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets, fair value">3,000,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zJavLMBZTv58" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets, fair value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260930__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zK968cfZ6WRi" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets, fair value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 48965766 48965766 0 0 3686000 0 3686000 0 740000 0 0 740000 53391766 48965766 3686000 740000 3000000 3000000 0 0 <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfServicingLiabilitiesAtFairValueTextBlock_z6pZtMZm7UL6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Assumptions)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BB_z0QW7QfzWwQ" style="display: none">Schedule of assumptions used</span></td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Supplemental Information</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Non-public Warrants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: left">Expected term of the warrants (years)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90C_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zOiMUPKauMu9" title="Assumptions used">1.00</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Stock price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zl3EgGvCE5Jb" title="Assumptions used">4.56</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Warrant exercise price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_901_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zvCMS3V2zv57" title="Assumptions used">6.00</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zk8q1mWOQFGj" title="Assumptions used">4.54%</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zABej5Eo0j22" title="Assumptions used">102.76%</span></td><td style="text-align: left"> </td></tr> </table> 1.00 4.56 6.00 4.54% 102.76% 2847000 3000000 <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_zA5Qbgnjl7Lh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Changes in Level 3 financial instruments)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B3_zVod3edn8gH9" style="display: none">Schedule of level 3 financial instruments</span></td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-size: 10pt"><b>December 31,</b></span></td> <td> </td> <td> </td> <td colspan="2"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Purchases,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Issuances and</b></p></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-size: 10pt"><b>Change in</b></span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-size: 10pt"><b>September 30,</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2025</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Settlements</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Fair Value</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2026</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 40%"><span style="font-size: 10pt">Non-public warrants investment</span></td> <td style="width: 2%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_c20260101__20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zpq9tM84w2tc" style="width: 11%; text-align: right" title="Assets, fair beginning value"><span style="font-size: 10pt">1,135,000</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_d0_c20260101__20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zwJecNibMkq4" style="width: 11%; text-align: right" title="Purchases, issuances and settlements"><span style="font-size: 10pt">–</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_c20260101__20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zfdkGJdWEsUc" style="width: 11%; text-align: right" title="Change in fair value"><span style="font-size: 10pt">(395,000</span></td> <td style="width: 1%"><span style="font-size: 10pt">)</span></td> <td style="width: 2%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_c20260101__20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zLE7OiuhpfO" style="width: 11%; text-align: right" title="Assets, fair ending value"><span style="font-size: 10pt">740,000</span></td> <td style="width: 1%"> </td></tr> </table> 1135000 0 -395000 740000 <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_zOBGPGlPVxQ3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Fair value of investments)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BB_zNq7Ca633yB2" style="display: none">Schedule of short-term investments</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold">Short-term investments at fair value</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cumulative Unrealized Gains (Losses)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 49%; text-align: left">Common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iI_c20260930__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_ztBklvGawLyf" style="width: 13%; text-align: right">60,649,998</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--DebtAndEquitySecuritiesUnrealizedGainLoss_c20260101__20260930__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_zipIpSpjKuoe" style="width: 13%; text-align: right" title="Cumulative unrealized gains (losses)">(11,684,231</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--InvestmentOwnedAtFairValue_iI_c20260930__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_zsi8LtDhd1Sb" style="width: 13%; text-align: right" title="Investments owned at fair value">48,965,766</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Pre-funded warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember_zvr0z4mUmvfe" style="text-align: right">2,850,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--DebtAndEquitySecuritiesUnrealizedGainLoss_c20260101__20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember_zgr2CObVlcO2" style="text-align: right" title="Cumulative unrealized gains (losses)">836,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--InvestmentOwnedAtFairValue_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember_zcvipENFHIih" style="text-align: right" title="Investments owned at fair value">3,686,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Non-public warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember_zZDrY8rDFANk" style="border-bottom: Black 1pt solid; text-align: right">195,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--DebtAndEquitySecuritiesUnrealizedGainLoss_c20260101__20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember_zuZ1Uw4ZGkl9" style="border-bottom: Black 1pt solid; text-align: right" title="Cumulative unrealized gains (losses)">545,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--InvestmentOwnedAtFairValue_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember_ztbeG2lQP2zl" style="border-bottom: Black 1pt solid; text-align: right" title="Investments owned at fair value">740,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98A_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iI_c20260930_zr1LxakBJfn7" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">63,694,998</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--DebtAndEquitySecuritiesUnrealizedGainLoss_c20260101__20260930_zNkvHwS8B2s5" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Cumulative unrealized gains (losses)">(10,303,231</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--InvestmentOwnedAtFairValue_iI_c20260930_zNX7EkyAhG3a" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Investments owned at fair value">53,391,766</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"></td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold">Short-term investments at cost</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Impairment / Other</p> <p style="text-align: center; margin-top: 0; margin-bottom: 0">Adjustments</p></td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjusted Cost</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 49%; text-align: left">Common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--InvestmentOwnedAtCost_iI_c20260930__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_zzQu8sJJHAT4" style="width: 13%; text-align: right" title="Investments owned at cost">10,000,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetImpairmentCharges_d0_c20260101__20260930__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_z7fK6uQQAeld" style="width: 13%; text-align: right" title="Impairment charges">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--AdjustedInvestmentOwnedAtCost_iI_c20260930__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_zoTndogBkQA2" style="width: 13%; text-align: right" title="Investment owned at cost, adjusted">10,000,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Preferred stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtCost_iI_c20260930__us-gaap--FinancialInstrumentAxis__us-gaap--PreferredStockMember_zAj6Gs12nyRe" style="text-align: right" title="Investments owned at cost">5,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AssetImpairmentCharges_d0_c20260101__20260930__us-gaap--FinancialInstrumentAxis__us-gaap--PreferredStockMember_zponNJl20zL5" style="text-align: right" title="Impairment charges">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--AdjustedInvestmentOwnedAtCost_iI_c20260930__us-gaap--FinancialInstrumentAxis__us-gaap--PreferredStockMember_zuPbTtNP6U21" style="text-align: right" title="Investment owned at cost, adjusted">5,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Pre-funded warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--InvestmentOwnedAtCost_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember_zu5Xu6dXTyN4" style="border-bottom: Black 1pt solid; text-align: right" title="Investments owned at cost">30,000,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--AssetImpairmentCharges_d0_c20260101__20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember_zQW3m68KXtf7" style="border-bottom: Black 1pt solid; text-align: right" title="Impairment charges">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_ecustom--AdjustedInvestmentOwnedAtCost_iI_c20260930__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember_zkO2ZfkdGV47" style="border-bottom: Black 1pt solid; text-align: right" title="Investment owned at cost, adjusted">30,000,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--InvestmentOwnedAtCost_iI_c20260930_zcs5jOIjg4k8" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Investments owned at cost">45,000,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetImpairmentCharges_d0_c20260101__20260930_zmLB8B6kC7pd" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Impairment charges">–</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98F_ecustom--AdjustedInvestmentOwnedAtCost_iI_c20260930_z7tCggtnY7ha" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Investment owned at cost, adjusted">45,000,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 60649998 -11684231 48965766 2850000 836000 3686000 195000 545000 740000 63694998 -10303231 53391766 10000000 0 10000000 5000000 0 5000000 30000000 0 30000000 45000000 0 45000000 <p id="xdx_84C_eus-gaap--StandardProductWarrantyPolicy_z0m7OVFMrbN2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_861_z88uyiGsfa7i">Accrued Warranty</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fat Shark generally provides a one-year warranty on all of its products, except in certain European countries where it can be two years for some consumer-focused products from the date of shipment. If a defect arises during the warranty period, Fat Shark will either (i) repair the affected product at no charge using new parts or parts that are equivalent to new in performance and reliability; (ii) exchange the affected product with a functionally equivalent product; or (iii) refund the original purchase price for the affected product. Allowances for estimated warranty costs are recorded during the period of sale. The determination of such allowances requires the Company to make estimates of product warranty claim rates and expected costs to repair or to replace the products under warranty. The Company currently establishes warranty reserves based on historical warranty costs for each product line combined with liability estimates based on the prior 24 months’ sales activities. If actual return rates and/or repair and replacement costs differ significantly from the Company’s estimates, adjustments to recognize the additional cost of sales may be required in future periods. Historically the warranty accrual and the expense amounts have been immaterial. The warranty liability is included in accrued expenses on the accompanying consolidated balance sheets and amounted to $<span id="xdx_908_eus-gaap--AccruedLiabilitiesCurrent_iI_c20260930_z13KQwaDdLA7" title="Accrued expenses">6,577</span> and $<span id="xdx_902_eus-gaap--AccruedLiabilitiesCurrent_iI_c20251231_zych1v5lvpHf" title="Accrued expenses">19,602</span> as of September 30, 2026 and December 31, 2025, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Rotor Riot does not provide any warranty of any kind for any of the equipment it sells or otherwise distributes. Consumers assume all risk for any products purchased or received from Rotor Riot.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Rotor Lab does not provide any warranty, but does provide for a seven day defect period. Rotor Lab has not had any material defects for products sold.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective September 2025, Unusual Machines, the parent company which manufactures motors has a limited warranty in which it warrants to customers that their products will be free from defects in material and workmanship under normal use and service for up to 90 days. The limited warranty covers manufacturing defects and premature failures and extends only to the original customer and is non-transferrable. The warranty liability is included in accrued expenses on the accompanying consolidated balance sheets and amounted to $<span id="xdx_908_eus-gaap--AccruedLiabilitiesCurrent_iI_c20260930__us-gaap--NatureOfExpenseAxis__custom--WarrantLiabilityMember_zfMUaRvAFzge" title="Accrued liabilities">317,009</span> as of September 30, 2026, and $<span id="xdx_902_eus-gaap--AccruedLiabilitiesCurrent_iI_c20251231__us-gaap--NatureOfExpenseAxis__custom--WarrantLiabilityMember_zSKtvvHXeJtb" title="Accrued liabilities">0</span> as of December 31, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> 6577 19602 317009 0 <p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_zL3j7hLTEyng" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86C_z0uqwhmSa2He">Revenue Recognition</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company will recognize revenue in accordance with ASC 606, “Revenue from Contracts with Customers”, issued by the Financial Accounting Standards Board (“FASB”). This standard includes a comprehensive evaluation of factors to be considered regarding revenue recognition including:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Step 1: Identify the contract with a customer;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Step 2: Identify the performance obligations in the contract;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Step 3: Determine the transaction price;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Step 4: Allocate the transaction price to the performance obligations in the contract; and</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Step 5: Recognize revenue when (or as) the Company satisfies a performance obligation at a point in time.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company receives revenues from the sale of drone and drone parts to enterprise customers and distributors (“Enterprise Revenue”) and individual consumers (“Retail Revenue”). Revenue is recognized at a point in time when the products are shipped and the price is fixed or determinable, no other significant obligations of the Company exist and collectability is probable. Revenue is recognized when the title to the products has been passed to the customer, which is the date the products are shipped to the customer. This is the date the performance obligation has been met. The Company’s retail return policy allows for certain non-custom or built-to-order products to be returned up to 15 days after the original order is placed so long as it meets specific requirements as outlined in its return policy. The Company’s enterprise return policy allows for returns related to defective product so long as it meets the requirements in its policy. The historical sales returns for retail customers is de minimis and the Company does not have a specific sales return allowance for retail orders. The Company had returns for enterprise orders of $288,000 for the nine-month period ended September 30, 2026. A sales return allowance has not been recorded to date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84E_ecustom--DisaggregationOfRevenuePolicyTextBlock_ziowYSV7VAtj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Disaggregation of Revenue</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the Company’s revenue disaggregated by revenue type for the period ended:</p> <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--DisaggregationOfRevenueTableTextBlock_zhfKbvwvuNQe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Disaggregated by revenue)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B7_z6pLXT1OYOl9" style="display: none">Schedule of disaggregated by revenue</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three months Ended<br/> September 30</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Retail revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20260701__20260930__srt--ProductOrServiceAxis__custom--RetailRevenueMember_z59ZdSESHga2" style="width: 13%; text-align: right" title="Total revenue">1,346,107</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--Revenues_c20250701__20250930__srt--ProductOrServiceAxis__custom--RetailRevenueMember_zsBcZDTcMEYf" style="width: 13%; text-align: right" title="Total revenue">1,158,449</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Enterprise revenue</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--Revenues_c20260701__20260930__srt--ProductOrServiceAxis__custom--EnterpriseRevenueMember_zYH0bmvqNJR" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">12,556,925</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--Revenues_c20250701__20250930__srt--ProductOrServiceAxis__custom--EnterpriseRevenueMember_zqDRlYbzFBR3" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">976,139</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20260701__20260930_zv7ROjSYz93f" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">13,903,032</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20250701__20250930_z9S22hOIDikj" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">2,134,588</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the Company’s revenue disaggregated by revenue type for the period ended:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the Nine months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Retail revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20260101__20260930__srt--ProductOrServiceAxis__custom--RetailRevenueMember_zSM9lmbcYO11" style="width: 13%; text-align: right" title="Total revenue">4,521,031</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_c20250101__20250930__srt--ProductOrServiceAxis__custom--RetailRevenueMember_zy79pcHsg2k6" style="width: 13%; text-align: right" title="Total revenue">5,012,473</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Enterprise revenue</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20260101__20260930__srt--ProductOrServiceAxis__custom--EnterpriseRevenueMember_zBEHt2lICbz5" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">34,200,305</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--Revenues_c20250101__20250930__srt--ProductOrServiceAxis__custom--EnterpriseRevenueMember_z5Ojgdfwud7k" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">1,288,384</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--Revenues_c20260101__20260930_zfLxCF3yqwjd" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">38,721,336</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_c20250101__20250930_zvvedg91ZULb" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">6,300,857</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zrx8LwBLoEi4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company had revenue outside the United States of approximately $<span id="xdx_90F_eus-gaap--Revenues_pn5n6_c20260101__20260930__us-gaap--GeographicDistributionAxis__us-gaap--GeographicDistributionForeignMember_zWwk8shkNtil" title="Foreign sales revenue">1.5</span> million and $<span id="xdx_905_eus-gaap--Revenues_pn4n6_c20250101__20250930__us-gaap--GeographicDistributionAxis__us-gaap--GeographicDistributionForeignMember_zEISmam0Sq42" title="Foreign sales revenue">0.25</span> million for the nine months ended September 30, 2026 and 2025, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--DisaggregationOfRevenueTableTextBlock_zhfKbvwvuNQe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Disaggregated by revenue)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B7_z6pLXT1OYOl9" style="display: none">Schedule of disaggregated by revenue</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three months Ended<br/> September 30</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Retail revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20260701__20260930__srt--ProductOrServiceAxis__custom--RetailRevenueMember_z59ZdSESHga2" style="width: 13%; text-align: right" title="Total revenue">1,346,107</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--Revenues_c20250701__20250930__srt--ProductOrServiceAxis__custom--RetailRevenueMember_zsBcZDTcMEYf" style="width: 13%; text-align: right" title="Total revenue">1,158,449</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Enterprise revenue</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--Revenues_c20260701__20260930__srt--ProductOrServiceAxis__custom--EnterpriseRevenueMember_zYH0bmvqNJR" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">12,556,925</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--Revenues_c20250701__20250930__srt--ProductOrServiceAxis__custom--EnterpriseRevenueMember_zqDRlYbzFBR3" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">976,139</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20260701__20260930_zv7ROjSYz93f" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">13,903,032</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20250701__20250930_z9S22hOIDikj" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">2,134,588</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the Company’s revenue disaggregated by revenue type for the period ended:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the Nine months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Retail revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20260101__20260930__srt--ProductOrServiceAxis__custom--RetailRevenueMember_zSM9lmbcYO11" style="width: 13%; text-align: right" title="Total revenue">4,521,031</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_c20250101__20250930__srt--ProductOrServiceAxis__custom--RetailRevenueMember_zy79pcHsg2k6" style="width: 13%; text-align: right" title="Total revenue">5,012,473</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Enterprise revenue</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20260101__20260930__srt--ProductOrServiceAxis__custom--EnterpriseRevenueMember_zBEHt2lICbz5" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">34,200,305</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--Revenues_c20250101__20250930__srt--ProductOrServiceAxis__custom--EnterpriseRevenueMember_z5Ojgdfwud7k" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">1,288,384</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--Revenues_c20260101__20260930_zfLxCF3yqwjd" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">38,721,336</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_c20250101__20250930_zvvedg91ZULb" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">6,300,857</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1346107 1158449 12556925 976139 13903032 2134588 4521031 5012473 34200305 1288384 38721336 6300857 1500000 250000 <p id="xdx_841_ecustom--RevenueRecognitionDeferredRevenue1_z9TNaV5QnHRe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_862_ziC3RlCyzJu7">Deferred Revenue</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred revenue relates to orders placed and payment received, but not yet fulfilled. All deferred revenue is expected to be recognized within one year. Deferred revenue related to orders placed, but not yet fulfilled totaled $<span id="xdx_90F_eus-gaap--DeferredRevenueCurrent_iI_pp0p0_c20260930_zTnjRnZpvEti" title="Deferred revenue, current">114,491</span> and $<span id="xdx_908_eus-gaap--DeferredRevenueCurrent_iI_pp0p0_c20251231_zmxYe2spb8ki" title="Deferred revenue, current">638,125</span> as of September 30, 2026 and December 31, 2025, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 114491 638125 <p id="xdx_84F_eus-gaap--CostOfSalesPolicyTextBlock_zNn69egbRTGj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86F_zLlbyZWGNll4">Cost of Goods Sold</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of goods sold includes inventory costs which includes an allocation for labor and rent for our manufactured products, direct packaging costs and production related depreciation, if any. Depreciation included in cost of goods sold for the nine months ended September 30, 2026 and 2025 was $<span id="xdx_90C_eus-gaap--CostOfGoodsAndServicesSoldDepreciation_pp0p0_c20260101__20260930_zGeSKrKOTtk2" title="Cost of goods sold depreciation">185,431</span> and $<span id="xdx_90A_eus-gaap--CostOfGoodsAndServicesSoldDepreciation_pp0p0_c20250101__20250930_zDrzU8IcZOgd">0</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 185431 0 <p id="xdx_84B_ecustom--ShippingAndHandlingCostsPolicyTextBlock_zhtQThTryZM7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_867_z37r8VLlhVc4">Shipping and Handling Costs</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shipping and handling costs incurred for products shipped to customers are included in operations expenses and amounted to $<span id="xdx_908_eus-gaap--SellingAndMarketingExpense_c20260101__20260930__us-gaap--NatureOfExpenseAxis__custom--ShippingAndHandlingCostsMember_z76RIgS716af" title="Shipping and handling costs">873,225</span> and $<span id="xdx_900_eus-gaap--SellingAndMarketingExpense_c20250101__20250930__us-gaap--NatureOfExpenseAxis__custom--ShippingAndHandlingCostsMember_zwzFRRAtwq7d" title="Shipping and handling costs">226,530</span> for the nine months ended September 30, 2026 and 2025, respectively. Shipping and handling costs charged to customers are included in sales.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> 873225 226530 <p id="xdx_849_eus-gaap--ResearchAndDevelopmentExpensePolicy_z5BbBkPUxAC6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_860_zrLJEOOWy7Ge">Research and Development</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research and development expenses include payroll, employee benefits, and other headcount-related expenses associated with product development. Research and development expenses also include third-party development costs, materials, and are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zwaPEAh4sfQ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86F_z0rkB6GQb9m7">Income Taxes</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for income taxes using an asset and liability approach, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events. A valuation allowance is established to reduce deferred tax assets to their estimated realizable value when, in the opinion of management, it is more likely than not that some portion or all of the deferred income tax assets will not be realizable in the future. The Company maintains a valuation allowance against its deferred tax assets when it is more likely than not that such deferred tax assets will not be realized. Certain deferred tax liabilities are not available as a source of future taxable income in assessing the realizability of the Company’s deferred tax assets and, accordingly, remain recognized. For the three months ended September 30, 2026, the net change in deferred taxes and the related valuation allowance was immaterial and, accordingly, no income tax expense was recorded.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes benefits of uncertain tax positions if it is more likely than not that such positions will be sustained upon examination based solely on their technical merits, as the largest amount of benefit that is more likely than not to be realized upon the ultimate settlement. The Company’s policy is to recognize interest and penalties related to unrecognized tax benefits as a part of income tax expense.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_844_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zLW3iGKpWwdg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_868_z2wmKr0pQRI8">Stock-Based Compensation</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stock options are valued using the estimated grant-date fair value method of accounting in accordance with ASC Topic 718, Compensation – Stock Compensation. Fair value is determined based on the Black-Scholes Model using inputs reflecting our estimates of expected volatility based on comparative companies through December 31, 2025, and historical volatility beginning of January 1, 2026, expected term using the simplified method and future dividends. The Company recognizes forfeitures as they occur. The fair value of stock grants is based on our stock price on the date of grant. Compensation costs are recognized on a straight-line basis over the requisite service period which is the vesting term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p id="xdx_849_eus-gaap--DerivativesPolicyTextBlock_zBPyifN0qo56" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86D_zlyZf82wzDMc">Warrants</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for warrants to purchase shares of its common stock in accordance with the guidance in ASC 480, <i>Distinguishing Liabilities from Equity</i> (“ASC 480”) and ASC 815, <i>Derivatives and Hedging</i> (“ASC 815”). The Company classifies warrants issued for the purchase of shares of its common stock as either equity or liability instruments based on an assessment of the specific terms and conditions of each respective contract. The assessment considers whether the warrants are freestanding financial instruments or embedded in a host instrument, whether the warrants meet the definition of a liability pursuant to ASC 480, whether the warrants meet the definition of a derivative under ASC 815, and whether the warrants meet all of the requirements for equity classification under ASC 815. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants classified as liabilities are recognized as a non-cash gain or loss in the consolidated statements of operations and comprehensive loss.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84F_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zXgXZdJBoLnk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_868_zZDTg8rbTns9">Foreign Currency</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s wholly owned subsidiary’s functional currency is the Australia dollar (AUD). For financial reporting purposes, the Australia dollar has been translated into the Company’s reporting currency, which is the United States dollar (USD). Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenue and expenses are translated at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity (deficit) as “Accumulated other comprehensive income (loss).” Gains and losses resulting from foreign currency translations are included in the statement of operations and comprehensive income (loss) as a component of other comprehensive income (loss). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars to USD after the balance sheet date. Transaction gains and losses from transactions denominated in a foreign currency are recognized in other income (expense) in the statement of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Changes in the cumulative translation adjustments were as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfComprehensiveIncomeLossTableTextBlock_zRpsSsgcmbck" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Cumulative translation adjustments)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B8_zDWBfBFe72Kk" style="display: none">Schedule of cumulative translation adjustments</span></td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">Balance as of December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><span id="xdx_90D_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20260101__20260930_zzRQBACPlm97" title="Beginning balance">3,470</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Foreign currency translation adjustment related to Rotor Lab</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_905_ecustom--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax1_c20260101__20260930__srt--CounterpartyNameAxis__custom--RotorLabMember_zouogGvBCbZ7" title="Foreign currency translation adjustment related to Rotor Lab">20,878</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Balance as of September 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20260101__20260930_zzmSpFhkf3e2" title="Ending balance">24,348</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zxiUUtvFP59a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfComprehensiveIncomeLossTableTextBlock_zRpsSsgcmbck" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Cumulative translation adjustments)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B8_zDWBfBFe72Kk" style="display: none">Schedule of cumulative translation adjustments</span></td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">Balance as of December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><span id="xdx_90D_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_c20260101__20260930_zzRQBACPlm97" title="Beginning balance">3,470</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Foreign currency translation adjustment related to Rotor Lab</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_905_ecustom--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax1_c20260101__20260930__srt--CounterpartyNameAxis__custom--RotorLabMember_zouogGvBCbZ7" title="Foreign currency translation adjustment related to Rotor Lab">20,878</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Balance as of September 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20260101__20260930_zzmSpFhkf3e2" title="Ending balance">24,348</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 3470 20878 24348 <p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_zhRhdy1Bf6R6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_865_z9wxqI44a7n4">Net Loss per Share</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic and diluted net loss per share is calculated based on the weighted-average of common shares outstanding in accordance with FASB ASC Topic 260, <i>Earnings per Share</i>. Diluted net loss per share is calculated based on the weighted-average number of common shares outstanding plus the effect of dilutive potential common shares. When the Company reports a net loss, the calculation of diluted net loss per share excludes potential common shares as the effect would be anti-dilutive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the reconciliation of basic to diluted weighted average shares used in computing net income per share of common stock attributable to common stockholders.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zXBzYWQ7Q4wc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Earnings per share)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BA_zUSJYtGPoXr6" style="display: none">Schedule of income per share</span></td> <td> </td> <td colspan="2" id="xdx_49E_20260701__20260930_zIBAIfSpXls2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" id="xdx_49B_20250701__20250930_zXC9MslV2ja7" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" id="xdx_491_20260101__20260930_zfXi0FjKl4Re" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" id="xdx_498_20250101__20250930_z6C37pjqy8U9" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="6" style="text-align: center"><span style="font-size: 10pt"><b>For the Three months Ended</b></span></td> <td> </td> <td> </td> <td colspan="6" style="text-align: center"><span style="font-size: 10pt"><b>For the Nine months Ended</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>September 30</b></span></td> <td> </td> <td> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>September 30</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2026</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2025</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2026</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2025</b></span></td> <td> </td></tr> <tr id="xdx_40E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zXBGxbnCWTal" style="vertical-align: bottom; background-color: #EEEEEE"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt; width: 40%"><span style="font-size: 10pt">Weighted average shares used in computing net income per share of common stock, basic</span></td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"><span style="font-size: 10pt">49,968,207</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"><span style="font-size: 10pt">30,002,179</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"><span style="font-size: 10pt">46,094,557</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"><span style="font-size: 10pt">22,610,516</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-size: 10pt">Add incremental shares:</span></td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr id="xdx_40F_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_d0_z80Nsz4wkROh" style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-size: 10pt">Stock based awards (options and restricted stock units)</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">257,303</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">–</span></td> <td> </td></tr> <tr id="xdx_401_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_d0_z7r2iVN6wo1a" style="vertical-align: bottom; background-color: white"> <td><span style="font-size: 10pt">Warrants</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">–</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">321,712</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">–</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">–</span></td> <td> </td></tr> <tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_z6ZbljP5M0x4" style="vertical-align: bottom; background-color: #EEEEEE"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Weighted average shares used in computing net income per share of common stock, diluted</span></td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 10pt">49,968,207</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 10pt">30,581,194</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 10pt">46,094,557</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 10pt">22,610,516</span></td> <td> </td></tr> </table> <p id="xdx_8A2_z4WII0u9Dqoc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the potentially dilutive shares that were excluded for the nine months ended September 30, 2026 and the nine months ended September 30, 2025 from the computation of diluted net loss per share of common stock attributable to common stockholders, because their effect was anti-dilutive:</p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zijDliBApo92" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Antidilutive shares)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B2_zR7gfLpuT2Ad" style="display: none">Schedule of anti dilutive shares</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">For the Nine months Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">For the Nine months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Unvested stock options</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_z7sGvvMYz3T2" style="width: 13%; text-align: right" title="Antidilutive shares">3,412,793</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zbSrCd9p73Q" style="width: 13%; text-align: right" title="Antidilutive shares">682,600</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Unvested restricted stock awards</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_ziOYNNVOblbe" style="text-align: right" title="Antidilutive shares">726,667</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_zY2FvYXsl3s8" style="text-align: right" title="Antidilutive shares">550,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20260101__20260930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zSkv0Ej88ype" style="text-align: right" title="Antidilutive shares">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z60IJJ7ijHC8" style="text-align: right" title="Antidilutive shares">1,154,473</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260930_zyJFOAWrls0b" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive shares">4,139,460</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250930_zcSrieGlANec" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive shares">2,387,073</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_z6r7wMlrZ8Wf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zXBzYWQ7Q4wc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Earnings per share)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BA_zUSJYtGPoXr6" style="display: none">Schedule of income per share</span></td> <td> </td> <td colspan="2" id="xdx_49E_20260701__20260930_zIBAIfSpXls2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" id="xdx_49B_20250701__20250930_zXC9MslV2ja7" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" id="xdx_491_20260101__20260930_zfXi0FjKl4Re" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" id="xdx_498_20250101__20250930_z6C37pjqy8U9" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="6" style="text-align: center"><span style="font-size: 10pt"><b>For the Three months Ended</b></span></td> <td> </td> <td> </td> <td colspan="6" style="text-align: center"><span style="font-size: 10pt"><b>For the Nine months Ended</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>September 30</b></span></td> <td> </td> <td> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>September 30</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2026</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2025</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2026</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2025</b></span></td> <td> </td></tr> <tr id="xdx_40E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zXBGxbnCWTal" style="vertical-align: bottom; background-color: #EEEEEE"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt; width: 40%"><span style="font-size: 10pt">Weighted average shares used in computing net income per share of common stock, basic</span></td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"><span style="font-size: 10pt">49,968,207</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"><span style="font-size: 10pt">30,002,179</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"><span style="font-size: 10pt">46,094,557</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"><span style="font-size: 10pt">22,610,516</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-size: 10pt">Add incremental shares:</span></td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr id="xdx_40F_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_d0_z80Nsz4wkROh" style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-size: 10pt">Stock based awards (options and restricted stock units)</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">257,303</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">–</span></td> <td> </td></tr> <tr id="xdx_401_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_d0_z7r2iVN6wo1a" style="vertical-align: bottom; background-color: white"> <td><span style="font-size: 10pt">Warrants</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">–</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">321,712</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">–</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">–</span></td> <td> </td></tr> <tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_z6ZbljP5M0x4" style="vertical-align: bottom; background-color: #EEEEEE"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Weighted average shares used in computing net income per share of common stock, diluted</span></td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 10pt">49,968,207</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 10pt">30,581,194</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 10pt">46,094,557</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 10pt">22,610,516</span></td> <td> </td></tr> </table> 49968207 30002179 46094557 22610516 0 257303 0 0 0 321712 0 0 49968207 30581194 46094557 22610516 <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zijDliBApo92" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Antidilutive shares)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B2_zR7gfLpuT2Ad" style="display: none">Schedule of anti dilutive shares</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">For the Nine months Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">For the Nine months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Unvested stock options</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_z7sGvvMYz3T2" style="width: 13%; text-align: right" title="Antidilutive shares">3,412,793</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zbSrCd9p73Q" style="width: 13%; text-align: right" title="Antidilutive shares">682,600</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Unvested restricted stock awards</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_ziOYNNVOblbe" style="text-align: right" title="Antidilutive shares">726,667</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_zY2FvYXsl3s8" style="text-align: right" title="Antidilutive shares">550,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20260101__20260930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zSkv0Ej88ype" style="text-align: right" title="Antidilutive shares">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z60IJJ7ijHC8" style="text-align: right" title="Antidilutive shares">1,154,473</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260930_zyJFOAWrls0b" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive shares">4,139,460</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250930_zcSrieGlANec" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive shares">2,387,073</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 3412793 682600 726667 550000 0 1154473 4139460 2387073 <p id="xdx_842_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zYuDS14b4Fka" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86A_zhSoOOeYAmSl">Segment Reporting</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operating segments are defined as components of an enterprise for which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision making group, in deciding how to allocate resources and in assessing performance. Unusual Machines, which sells drones and drone-related components, operates as a <span id="xdx_906_eus-gaap--NumberOfReportableSegments_dxL_uInteger_c20260101__20260930_zBSkdpbHtr64" title="::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl1173">single</span></span> reportable segment entity. Our chief operating decision maker, our Chief Executive Officer, reviews financial information presented on a consolidated basis for purposes of making operating decisions and assessing financial performance. The Chief Executive Officer primarily evaluates consolidated total revenues and gross margin, consistent with amounts presented in the consolidated statements of operations, in assessing the Company’s performance, and evaluates the Company’s cash position, consistent with amounts presented in the consolidated balance sheets, when making decisions regarding investing and financing activities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zWV7vYglYdzg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_860_zZ3XHsBZOrTk">Recent Accounting Pronouncements</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November 2024, the FASB issued ASU No. 2024-03, “Disaggregation of Income Statement Expenses” which requires disaggregated disclosure of income statement expenses into specified categories in disclosures within the footnotes to the financial statements. The standard is effective for annual reporting periods beginning after December 15, 2026. The Company is currently evaluating the effect of this ASU on the consolidated financial statements and disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In May 2025, the FASB issued ASU No. 2025-4, “Compensation – Stock Compensation and Revenue From Contracts With Customers” which provides clarifications to share-based consideration payable to a customer. The standard is effective for annual reporting periods beginning after December 15, 2026. The Company is currently evaluating the effect of this ASU on the consolidated financial statements and disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_809_eus-gaap--AssetAcquisitionTextBlock_zWIzvNJbNAu7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Note 3 – <span id="xdx_824_zToPMNma2v23">Acquisitions</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Rotor Lab</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 3, 2025, the Company closed on the acquisition of Rotor Lab. Rotor Lab is an Australian developer and manufacturer of electric motors and propulsion systems for unmanned aerial systems (“UAS”). Its product line includes precision-wound electric motors across multiple classes, from sub-400W units for small UAS to high-power motors supporting large rotary and fixed wing platforms.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to the motor production facility in Australia, the Company built out a motor production facility in Orlando, FL and started producing motors for drones in the fourth quarter of 2025. The Company and Rotor Lab have been working together prior to the acquisition on co-developing several motor designs and sizes. The acquisition helps the Company accelerate their goals of building a resilient drone supply chain through their team and technology. In addition, Rotor Lab will continue to serve as the engineering center for the Company’s motor design, prototyping, and low to medium volume production of orders.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Business Combination was based on a share purchase agreement (the “Rotor Lab Purchase Agreement”) that was executed on June 12, 2025, subject to customary closing conditions and was completed on September 3, 2025. Under the terms of the Rotor Lab Purchase Agreement, the consideration paid for the acquired assets consisted of (i) the issuance of common stock for a value of $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_pn6n6_c20250901__20250903__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember__us-gaap--TransactionTypeAxis__custom--RotorLabPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zBuuGMGvjoXg" title="Stock issued for acquisition, value">4</span>.0 million based on the preceding 20 day average Volume Weighted Average Price (“VWAP”) of the Company’s stock from the date of the signing the Rotor Lab Purchase Agreement in June 2025, and (ii) the issuance of common stock (“Contingent Shares”) for up to a total value of an additional $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_pn6n6_c20250901__20250903__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember__us-gaap--TransactionTypeAxis__custom--RotorLabPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--ContingentSharesMember_z4L3p3vcVvpb" title="Stock issued for acquisition, value">3</span>.0 million based on the Company producing and recognizing revenue, dollar for dollar related to internally manufactured motors during the first two years after the acquisition closing date. The Contingent Shares will be calculated and issued based on the Company’s VWAP for the preceding 20 days on each anniversary date of the closing of the transaction.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The acquisition met the definition of a business combination under ASC 805, Business Combinations, and therefore the assets acquired, and liabilities assumed are accounted for at fair value. The Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20250901__20250903__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zG2aIYJ1mlu6" title="Stock issued for acquisition, shares">656,642</span> shares of its common stock based on the formula as noted above, which resulted in an initial purchase price of $<span id="xdx_90E_eus-gaap--BusinessCombinationConsiderationTransferredOther1_pp0p0_c20250901__20250903__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zGqOFAZiLNbg" title="Initial purchase price">5,922,911</span> based on the Company’s stock price of $<span id="xdx_90B_eus-gaap--BusinessAcquisitionSharePrice_iI_c20250903__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zcI80r6bhlrl" title="Initial purchase stock per price">9.02</span> on September 3, 2025, which was the closing date of the acquisition. The contingent purchase price has been initially recorded at $<span id="xdx_907_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_pp0p0_c20250903__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zdSGxVQtsEg9" title="Contingent consideration">2,847,000</span>. The fair value of contingent consideration was determined using the Monte-Carlo variable scenario model which values the liability at the measurement date using certain assumptions including the expected revenue over the calculation period, a discount rate applied to revenue projections, the risk-free interest rate over the earnout period and certain estimates and probabilities of different outcomes. The Company updated the estimated contingent consideration from the Rotor Lab acquisition to $<span id="xdx_905_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_pp0p0_c20260930__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zAlRBbj61hYb" title="Contingent consideration">3,000,000</span> as of September 30, 2026 based on actual sales during the period based on management’s updated estimate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Such fair value amounts are subject to adjustment during the one-year measurement period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following represents the fair value allocation of Rotor Lab Purchase Price:</p> <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zLWWZuxDOI45" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Acquisitions (Details - Fair value allocation)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B6_zC77U2IOAT9" style="display: none">Schedule of purchase fair value allocation</span></td><td> </td> <td colspan="2" id="xdx_493_20250903__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zQZnjsXKI5uj" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pp0p0_zygBQdBdoNKc" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 85%">Cash</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">93,054</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_pp0p0_zQFnyUqW0lV6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accounts receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">132,419</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_pp0p0_z3TvbQGCIG3j" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Inventories</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">36,888</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_pp0p0_zbjkfxk0ucU5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepaid expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,843</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pp0p0_zCog5QU05FNb" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Property and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">179,772</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_iI_pp0p0_zeeLYd7BI0Zf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Right of use asset – operating</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">58,524</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_iI_pp0p0_zffIeDJiveue" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Other current assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,266</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_iI_pp0p0_zJBznMOgNOUd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer Relationships</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">190,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_iI_pp0p0_zJvc9G4rRiL4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Non-Compete Agreements</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">233,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeNames_iI_pp0p0_zG0gXBTmsrj6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Trade Names</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--Goodwill_iI_pp0p0_z8JuwBrhOaVi" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Goodwill</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">8,193,199</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_pp0p0_z7lnlqWaLn91" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Total assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,194,965</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iI_pp0p0_zjCfD2HMx67" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Accounts payable and accrued liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">92,113</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iI_pp0p0_zGOwpcDsUP0b" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Deferred revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">183,666</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_iI_pp0p0_z0G4dNPr28wh" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Deferred tax liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">89,231</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_iI_pp0p0_zcbRmH2u7XBg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Operating lease liability – current and long-term</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">60,044</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_pp0p0_zaL9jMXPHHa6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Total liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">425,054</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Initial consideration</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--BusinessCombinationConsiderationTransferredOther1_pp0p0_c20250901__20250903__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zBAsY869DTA3" style="text-align: right" title="Initial purchase price">5,922,911</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_z2JgsLXyzNJ6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Contingent consideration</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,847,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_zZs2Vk5BNU3i" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">Total purchase price</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,769,911</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_z5UTOaZ5LKTj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 3, 2025, the Company acquired <span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20250903__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--RotorLabMember_zZpJc1f8nBg9" title="Acquired percenatge">100</span>% of the issued shares of Rotor Lab. For U.S. federal income tax purposes, the acquisition is treated as a stock purchase. The Company did not make an election under Section 338 of the Internal Revenue Code. As a result, the tax bases of Rotor Lab’s assets and liabilities carry over from their historical amounts, and no step-up in tax basis was recorded for U.S. tax purposes. Goodwill for tax purposes will be amortized over <span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20250903__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_ztVSNeyOb9H4" title="Amortization period">15</span> years. The measurement period has since ended, with the only adjustment being to update the Contingent consideration to the full $<span id="xdx_904_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_pn6n6_c20260903__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zZiujKaiIhNi" title="Contingent consideration">3,000,000</span> based on actual sales data.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 4000000 3000000 656642 5922911 9.02 2847000 3000000 <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zLWWZuxDOI45" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Acquisitions (Details - Fair value allocation)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B6_zC77U2IOAT9" style="display: none">Schedule of purchase fair value allocation</span></td><td> </td> <td colspan="2" id="xdx_493_20250903__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zQZnjsXKI5uj" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pp0p0_zygBQdBdoNKc" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 85%">Cash</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">93,054</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_pp0p0_zQFnyUqW0lV6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accounts receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">132,419</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_pp0p0_z3TvbQGCIG3j" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Inventories</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">36,888</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_pp0p0_zbjkfxk0ucU5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepaid expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,843</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pp0p0_zCog5QU05FNb" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Property and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">179,772</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_iI_pp0p0_zeeLYd7BI0Zf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Right of use asset – operating</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">58,524</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_iI_pp0p0_zffIeDJiveue" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Other current assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,266</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_iI_pp0p0_zJBznMOgNOUd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer Relationships</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">190,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_iI_pp0p0_zJvc9G4rRiL4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Non-Compete Agreements</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">233,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeNames_iI_pp0p0_zG0gXBTmsrj6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Trade Names</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--Goodwill_iI_pp0p0_z8JuwBrhOaVi" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Goodwill</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">8,193,199</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_pp0p0_z7lnlqWaLn91" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Total assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,194,965</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iI_pp0p0_zjCfD2HMx67" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Accounts payable and accrued liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">92,113</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iI_pp0p0_zGOwpcDsUP0b" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Deferred revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">183,666</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_iI_pp0p0_z0G4dNPr28wh" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Deferred tax liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">89,231</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_iI_pp0p0_zcbRmH2u7XBg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Operating lease liability – current and long-term</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">60,044</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_pp0p0_zaL9jMXPHHa6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Total liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">425,054</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Initial consideration</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--BusinessCombinationConsiderationTransferredOther1_pp0p0_c20250901__20250903__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zBAsY869DTA3" style="text-align: right" title="Initial purchase price">5,922,911</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_z2JgsLXyzNJ6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Contingent consideration</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,847,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_zZs2Vk5BNU3i" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">Total purchase price</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,769,911</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 93054 132419 36888 21843 179772 58524 10266 190000 233000 46000 8193199 9194965 92113 183666 89231 60044 425054 5922911 2847000 8769911 1 P15Y 3000000000000 <p id="xdx_803_eus-gaap--InventoryDisclosureTextBlock_z9eVq4aOIeug" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Note 4 – <span id="xdx_82A_zz1awnaT7hka">Inventories</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventories, which consist solely of raw materials and finished goods was as follows as of September 30, 2026 and December 31, 2025, respectively.</p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfUtilityInventoryTextBlock_zuxHjLnEgDde" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Inventories (Details - Inventories)"> <tr style="vertical-align: bottom"> <td> <span id="xdx_8B2_zMkG1CMb5S0a" style="display: none">Schedule of inventories</span></td><td> </td> <td colspan="2" id="xdx_496_20260930_z2xrLmWtbr7a" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49A_20251231_zNSBRNdXHjF5" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30,<br/> 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,<br/> 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_407_eus-gaap--InventoryRawMaterials_iI_maINzYg1_zl8QbxRBZMj2" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Raw materials</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">33,330,981</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">4,232,774</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--InventoryFinishedGoods_iI_maINzYg1_zNeFAIwfKG9g" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">9,291,096</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,083,874</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--InventoryNet_iTI_mtINzYg1_zEiiORXUuZNj" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total inventory</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">42,622,077</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,316,648</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_ztpSdV47tish" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the Company had prepaid deposits for inventory totaling $<span id="xdx_90B_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_c20260930_zS9jBdZpb1s7" title="Prepaid deposits for inventory">23,259,023</span> and $<span id="xdx_90F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_c20251231_z21YDnbGVDn" title="Prepaid deposits for inventory">9,748,483</span> as of September 30, 2026 and December 31, 2025, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfUtilityInventoryTextBlock_zuxHjLnEgDde" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Inventories (Details - Inventories)"> <tr style="vertical-align: bottom"> <td> <span id="xdx_8B2_zMkG1CMb5S0a" style="display: none">Schedule of inventories</span></td><td> </td> <td colspan="2" id="xdx_496_20260930_z2xrLmWtbr7a" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49A_20251231_zNSBRNdXHjF5" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30,<br/> 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,<br/> 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_407_eus-gaap--InventoryRawMaterials_iI_maINzYg1_zl8QbxRBZMj2" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Raw materials</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">33,330,981</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">4,232,774</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--InventoryFinishedGoods_iI_maINzYg1_zNeFAIwfKG9g" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">9,291,096</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,083,874</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--InventoryNet_iTI_mtINzYg1_zEiiORXUuZNj" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total inventory</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">42,622,077</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,316,648</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 33330981 4232774 9291096 1083874 42622077 5316648 23259023 9748483 <p id="xdx_809_eus-gaap--OtherCurrentAssetsTextBlock_zAd7iAKzo3yf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Note 5 – <span id="xdx_82D_zV1XFcisXNX">Other Current Assets</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Other current assets included as of:</p> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfOtherCurrentAssetsTableTextBlock_zgGHzy7WKbu5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Other Current Assets (Details)"> <tr style="vertical-align: bottom"> <td> <span id="xdx_8B3_zpNQbJ6jV0T2" style="display: none">Schedule of other current assets</span></td><td> </td> <td colspan="2" id="xdx_494_20260930_zSh010Wkgodf" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_494_20251231_zZqFc2bPLtG5" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--OtherAssetsCurrent_iI_pp0p0_hus-gaap--NatureOfExpenseAxis__custom--PrepaidInsuranceMember_zG1hlBgBbms1" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Prepaid insurance</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">613,864</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">101,689</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OtherAssetsCurrent_iI_pp0p0_d0_hus-gaap--NatureOfExpenseAxis__custom--PrepaidBenefitsMember_zR0AJvl9vPNb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepaid benefits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">48,606</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OtherAssetsCurrent_iI_pp0p0_hus-gaap--NatureOfExpenseAxis__custom--PrepaidOtherMember_zUAA0cFQrjL3" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Prepaid other</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">697,165</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">40,327</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--OtherAssetsCurrent_iI_pp0p0_d0_hus-gaap--NatureOfExpenseAxis__custom--InterestReceivableMember_zEm4Qp0gkrwc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Interest receivable</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">59,452</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OtherAssetsCurrent_iI_pp0p0_zzY9rNHV3Ge7" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total other current assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,370,481</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">190,622</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_z3ccbZds5w8b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Non-current other assets primarily include rent security deposits of $<span id="xdx_90E_eus-gaap--OtherAssetsNoncurrent_iI_c20260930__us-gaap--NatureOfExpenseAxis__custom--RentSecurityDepositsMember_z4bHfXmkVDC1" title="Other assets, non current">243,551</span> related to the operating leases for the Orlando, FL facilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfOtherCurrentAssetsTableTextBlock_zgGHzy7WKbu5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Other Current Assets (Details)"> <tr style="vertical-align: bottom"> <td> <span id="xdx_8B3_zpNQbJ6jV0T2" style="display: none">Schedule of other current assets</span></td><td> </td> <td colspan="2" id="xdx_494_20260930_zSh010Wkgodf" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_494_20251231_zZqFc2bPLtG5" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--OtherAssetsCurrent_iI_pp0p0_hus-gaap--NatureOfExpenseAxis__custom--PrepaidInsuranceMember_zG1hlBgBbms1" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Prepaid insurance</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">613,864</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">101,689</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OtherAssetsCurrent_iI_pp0p0_d0_hus-gaap--NatureOfExpenseAxis__custom--PrepaidBenefitsMember_zR0AJvl9vPNb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepaid benefits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">48,606</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OtherAssetsCurrent_iI_pp0p0_hus-gaap--NatureOfExpenseAxis__custom--PrepaidOtherMember_zUAA0cFQrjL3" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Prepaid other</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">697,165</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">40,327</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--OtherAssetsCurrent_iI_pp0p0_d0_hus-gaap--NatureOfExpenseAxis__custom--InterestReceivableMember_zEm4Qp0gkrwc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Interest receivable</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">59,452</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OtherAssetsCurrent_iI_pp0p0_zzY9rNHV3Ge7" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total other current assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,370,481</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">190,622</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 613864 101689 0 48606 697165 40327 59452 0 1370481 190622 243551 <p id="xdx_80E_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_z7oMzUDFaYXd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Note 6 – <span id="xdx_820_zTxPEoZQ9D69">Notes Receivable</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 31, 2026, the Company entered into a $<span id="xdx_90F_eus-gaap--ReceivablesNetCurrent_iI_c20260731__us-gaap--TransactionTypeAxis__custom--SecuredConvertiblePromissoryNoteAgreementMember_zmeRt94VUk0h" title="Note receivable">5,000,000</span> secured convertible promissory note agreement with Owl Autonomous Imaging, Inc. (“Owl”). The note bears simple interest at <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20260731__us-gaap--TransactionTypeAxis__custom--SecuredConvertiblePromissoryNoteAgreementMember_zcgSxBmN1wW5" title="Interest rate">7</span>% per annum, computed on an actual/365-day basis, and matures on <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20260730__20260731__us-gaap--TransactionTypeAxis__custom--SecuredConvertiblePromissoryNoteAgreementMember_zEu02kSzeDek" title="Maturity date">July 31, 2027</span>, unless earlier repaid, accelerated or converted. Owl may prepay the note at any time, together with accrued and unpaid interest.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The note provides the Company with the option to convert all or a portion of the outstanding principal and accrued interest into Owl equity securities upon a qualifying equity financing or, if the note remains unpaid, at or after maturity. <span id="xdx_907_ecustom--ReceivableDescription_c20260101__20260930__us-gaap--TransactionTypeAxis__custom--SecuredConvertiblePromissoryNoteAgreementMember_zzucXPa6ClE6">The conversion price is the lower of (i) 80% of the applicable equity financing price or preferred stock conversion price, representing a 20% discount, or (ii) the price determined using a $140 million valuation cap based on Owl’s fully diluted capitalization.</span> The note is secured by a first-priority security interest in specified tangible assets of Owl pursuant to a related security agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The note receivable is carried at amortized cost, including consideration of the conversion feature embedded within the note. As of September 30, 2026, the carrying value of the note receivable was $<span id="xdx_907_eus-gaap--NotesAndLoansReceivableNetCurrent_iI_c20260930_zhBt2rd5qaWf" title="Note receivable">5,000,000</span>. Interest accrued during the three and nine months ended September 30, 2026 was $<span id="xdx_906_eus-gaap--InterestExpenseDebt_c20260701__20260930_zkbG0V3f9i75" title="Interest accrued"><span id="xdx_90B_eus-gaap--InterestExpenseDebt_c20260101__20260930_zW8IVYP10iZa" title="Interest accrued">59,452</span></span> and was recorded within other current assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 5000000 0.07 2027-07-31 The conversion price is the lower of (i) 80% of the applicable equity financing price or preferred stock conversion price, representing a 20% discount, or (ii) the price determined using a $140 million valuation cap based on Owl’s fully diluted capitalization. 5000000 59452 59452 <p id="xdx_800_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zOaaIWkd1aG4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Note 7 – <span id="xdx_828_zGZkYg3Ukpsb">Property and Equipment, net</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment consist of assets with an estimated useful life greater than one year. Property and equipment are reported net of accumulated depreciation, and the reported values are periodically assessed for impairment. Property and equipment as of:</p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--PropertyPlantAndEquipmentTextBlock_zKvpgObiRsO6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment, net (Details)"> <tr style="vertical-align: bottom"> <td> <span id="xdx_8BC_zGnKlBotrse3" style="display: none">Schedule of property and equipment</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30,<br/> 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,<br/> 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Computer equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20260930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zwyS8takqFf8" style="width: 13%; text-align: right" title="Total property and equipment">829,285</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zsw6mZhbKCx4" style="width: 13%; text-align: right" title="Total property and equipment">35,973</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Motor production equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20260930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorProductionEquipmentMember_zsFXtuUTuo9k" style="text-align: right" title="Total property and equipment">6,301,428</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorProductionEquipmentMember_zDCYz71NjOe9" style="text-align: right" title="Total property and equipment">2,083,354</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Office equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20260930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zv4qbPQEoEJ1" style="text-align: right" title="Total property and equipment">237,021</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_d0_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zU9wyLhZmWwh" style="text-align: right" title="Total property and equipment">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Tenant improvements</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20260930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z6uOZPFPEYek" style="border-bottom: Black 1pt solid; text-align: right" title="Total property and equipment">1,382,324</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_d0_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zLtWDe80uFJ2" style="border-bottom: Black 1pt solid; text-align: right" title="Total property and equipment">149,280</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Total Property and Equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20260930_zILNZjDSJH2l" style="text-align: right" title="Total property and equipment">8,750,058</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20251231_z0ZXoVxzyJac" style="text-align: right" title="Total property and equipment">2,268,607</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20260930_z69qd90hLpeb" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">(249,535</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20251231_zQpfbEP6QVze" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">(34,716</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20260930_zZvren6xqsKi" style="border-bottom: Black 2.5pt double; text-align: right" title="Total property and equipment, net">8,500,523</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20251231_zmfjTz0kLsv9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total property and equipment, net">2,233,891</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_z40iXeejryqi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depreciation expense totaled $<span id="xdx_901_eus-gaap--Depreciation_c20260101__20260930_z3Gwg31We7Sl" title="Depreciation expense">214,529</span> and $<span id="xdx_907_eus-gaap--Depreciation_c20250101__20250930_zui0Nbko4r5a" title="Depreciation expense">2,369</span> for the nine months ended September 30, 2026 and 2025, respectively. A total of $<span id="xdx_906_eus-gaap--CostOfGoodsAndServicesSoldDepreciation_pp0p0_c20260101__20260930_zBW4mybFnjmk">185,431</span> and $<span id="xdx_907_eus-gaap--CostOfGoodsAndServicesSoldDepreciation_pp0p0_c20250101__20250930_zgJPUUltsyDb">0</span> of depreciation expense was recorded to cost of goods sold in related to the production of motors for the nine months ended September 30, 2026 and 2025, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--PropertyPlantAndEquipmentTextBlock_zKvpgObiRsO6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment, net (Details)"> <tr style="vertical-align: bottom"> <td> <span id="xdx_8BC_zGnKlBotrse3" style="display: none">Schedule of property and equipment</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30,<br/> 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,<br/> 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Computer equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20260930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zwyS8takqFf8" style="width: 13%; text-align: right" title="Total property and equipment">829,285</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zsw6mZhbKCx4" style="width: 13%; text-align: right" title="Total property and equipment">35,973</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Motor production equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20260930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorProductionEquipmentMember_zsFXtuUTuo9k" style="text-align: right" title="Total property and equipment">6,301,428</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorProductionEquipmentMember_zDCYz71NjOe9" style="text-align: right" title="Total property and equipment">2,083,354</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Office equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20260930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zv4qbPQEoEJ1" style="text-align: right" title="Total property and equipment">237,021</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_d0_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zU9wyLhZmWwh" style="text-align: right" title="Total property and equipment">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Tenant improvements</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20260930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z6uOZPFPEYek" style="border-bottom: Black 1pt solid; text-align: right" title="Total property and equipment">1,382,324</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_d0_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zLtWDe80uFJ2" style="border-bottom: Black 1pt solid; text-align: right" title="Total property and equipment">149,280</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Total Property and Equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20260930_zILNZjDSJH2l" style="text-align: right" title="Total property and equipment">8,750,058</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20251231_z0ZXoVxzyJac" style="text-align: right" title="Total property and equipment">2,268,607</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20260930_z69qd90hLpeb" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">(249,535</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20251231_zQpfbEP6QVze" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">(34,716</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20260930_zZvren6xqsKi" style="border-bottom: Black 2.5pt double; text-align: right" title="Total property and equipment, net">8,500,523</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20251231_zmfjTz0kLsv9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total property and equipment, net">2,233,891</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 829285 35973 6301428 2083354 237021 0 1382324 149280 8750058 2268607 249535 34716 8500523 2233891 214529 2369 185431 0 <p id="xdx_805_eus-gaap--LesseeOperatingLeasesTextBlock_zkgzF5Kk5h3j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Note 8 – <span id="xdx_828_zbeGBqvXaVla">Operating Leases</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has assumed in the February 2024 business combination of Rotor Riot, a five-year operating lease for approximately 6,900 square feet of warehouse and office space in Orlando, Florida. The lease commenced in November 2023 and expires in October 2028. The Company has valued the Right of Use Asset (“ROUA”) and the associated liability, as of February 16, 2024, at $<span id="xdx_90B_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20240216__srt--StatementGeographicalAxis__custom--OrlandoFloridaMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember_z5tpWwMgXLKl" title="Operating lease right-of-use asset">378,430</span>. Operating lease expense totaled $<span id="xdx_90E_eus-gaap--OperatingLeaseExpense_c20260101__20260930__srt--StatementGeographicalAxis__custom--OrlandoFloridaMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember_zDdPW85kmtGd" title="Operating lease expense">78,859</span> and $<span id="xdx_906_eus-gaap--OperatingLeaseExpense_c20250101__20250930__srt--StatementGeographicalAxis__custom--OrlandoFloridaMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember_zEL8KSHq20W6" title="Operating lease expense">78,859</span>, respectively for the nine months ended September 30, 2026 and 2025. A total of $<span id="xdx_90E_eus-gaap--CostOfGoodsAndServicesSold_c20260101__20260930__srt--StatementGeographicalAxis__custom--OrlandoFloridaMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember_zTBACM1Gl7e9" title="Operating lease expense">78,859</span> was recorded to costs of goods sold for the nine months ended September 30, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2025, Unusual Machines signed a lease agreement for an additional 17,000 square feet of warehouse/office space in Orlando, FL. This space will be used primarily for motor production. The lease commencement date is August 1, 2025 and currently runs through August 21, 2030. The Company has valued the ROUA and the associated liability, as of August 1, 2025, at $<span id="xdx_90F_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20250801__srt--StatementGeographicalAxis__custom--OrlandoFLMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember__us-gaap--TransactionTypeAxis__custom--June2025AdditionalSpaceMember_zHjhHbHts6p6" title="Operating lease right-of-use asset">973,443</span>. Operating lease expense totaled $<span id="xdx_904_eus-gaap--OperatingLeaseExpense_c20260101__20260930__srt--StatementGeographicalAxis__custom--OrlandoFLMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember__us-gaap--TransactionTypeAxis__custom--June2025AdditionalSpaceMember_zoQaxJ9lPHB4" title="Operating lease expense">190,293</span> and $<span id="xdx_90C_eus-gaap--OperatingLeaseExpense_c20250101__20250930__srt--StatementGeographicalAxis__custom--OrlandoFLMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember__us-gaap--TransactionTypeAxis__custom--June2025AdditionalSpaceMember_zveadzufCP8i" title="Operating lease expense">42,287</span>, respectively for the nine months ended September 30, 2026 and 2025. A total of $<span id="xdx_901_eus-gaap--CostOfGoodsAndServicesSold_c20260101__20260930__srt--StatementGeographicalAxis__custom--OrlandoFLMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember__us-gaap--TransactionTypeAxis__custom--June2025AdditionalSpaceMember_zedAwkIrnbz4" title="Cost of goods sold">190,293</span> was recorded to cost of goods sold for the nine months ended September 30, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2025, Unusual Machines signed a lease agreement for an additional 25,000 square feet of warehouse/office space in Orlando, FL. This space will be used primarily for order fulfillment and inventory storage. The lease commencement date is December 1, 2025 and currently runs through December 31, 2030. The Company has valued the ROUA and the associated liability, as of December 1, 2025, at $<span id="xdx_908_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20251201__srt--StatementGeographicalAxis__custom--OrlandoFLMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember__us-gaap--TransactionTypeAxis__custom--October2025AdditionalSpaceMember_zhrNzDIqUie5" title="Operating lease right-of-use asset">1,430,522</span>. Operating lease expense totaled $<span id="xdx_90F_eus-gaap--OperatingLeaseExpense_c20260101__20260930__srt--StatementGeographicalAxis__custom--OrlandoFLMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember__us-gaap--TransactionTypeAxis__custom--October2025AdditionalSpaceMember_z1vqz6cFgWY1" title="Operating lease expense">279,645</span> and $<span id="xdx_904_eus-gaap--OperatingLeaseExpense_c20250101__20250930__srt--StatementGeographicalAxis__custom--OrlandoFLMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember__us-gaap--TransactionTypeAxis__custom--October2025AdditionalSpaceMember_zzJlX6Fg6G77" title="Operating lease expense">0</span>, respectively for the nine months ended September 30, 2026 and 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 15, 2025, the Company parent entity entered into a three-year operating lease agreement for an additional 4,500 square feet of space in Orlando, FL. This space will be used for headset production. The lease commenced on January 1, 2026 and expires in December 2028. The Company has valued the ROUA and the associated liability, as of January 1, 2026, at $<span id="xdx_90E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20260102__srt--StatementGeographicalAxis__custom--OrlandoFL1Member_zT71DsZ82NTe">204,749</span>. Operating lease expense totaled $<span id="xdx_905_eus-gaap--OperatingLeaseExpense_c20260101__20260930__srt--StatementGeographicalAxis__custom--OrlandoFL1Member_zOgz3wmZ7mnd" title="Operating lease expense">57,949</span> and $<span id="xdx_90D_eus-gaap--OperatingLeaseExpense_c20250101__20250930__srt--StatementGeographicalAxis__custom--OrlandoFL1Member_zSC9Xb9wvSO" title="Operating lease expense">0</span>, respectively for the nine months ended September 30, 2026 and 2025. A total of $<span id="xdx_901_eus-gaap--CostOfGoodsAndServicesSold_c20260101__20260930__srt--StatementGeographicalAxis__custom--OrlandoFL1Member_zYrLNo9x2c38" title="Cost of goods sold">56,441</span> was recorded to cost of goods sold for the nine months ended September 30, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 10, 2025, the Company parent entity entered into a three-year operating lease agreement for an additional 9,125 square feet of space in Orlando, FL. This space will be used as the Company’s corporate headquarters. The lease commenced on January 1, 2026 and expires in February 2029. In addition, the Company executed an amendment on September 4, 2026 for an additional 10,264 square feet. The Company has valued the ROUA and the associated liability, as of February 1, 2026, at $<span id="xdx_90B_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20260201__srt--StatementGeographicalAxis__custom--OrlandoFL2Member_zqFQbqwxB4qj" title="Operating lease right-of-use asset">1,346,610</span>. Operating lease expense totaled $<span id="xdx_900_eus-gaap--OperatingLeaseExpense_c20260101__20260930__srt--StatementGeographicalAxis__custom--OrlandoFL2Member_zIOk9oqgnvW1" title="Operating lease expense">194,698</span> and $<span id="xdx_900_eus-gaap--OperatingLeaseExpense_c20250101__20250930__srt--StatementGeographicalAxis__custom--OrlandoFL2Member_zn3Z2vQYNET9" title="Operating lease expense">0</span>, respectively for the nine months ended September 30, 2026 and 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has assumed in the acquisition of Rotor Lab on September 3, 2025, a three-year operating lease of warehouse and office space in Canberra, Australia. The leased commenced in May 2024 and expires in April 2027. The Company has valued the ROUA and the associated liability, as of September 3, 2025, at $<span id="xdx_90B_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20250903__srt--StatementGeographicalAxis__custom--CanberraAustraliaMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember_zJo3Lnv4OA9e">58,524</span>. Operating lease expense totaled $<span id="xdx_909_eus-gaap--OperatingLeaseExpense_c20260101__20260930__srt--StatementGeographicalAxis__custom--CanberraAustraliaMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember_zm2htMnBD8X6">44,483</span> and $<span id="xdx_90A_eus-gaap--OperatingLeaseExpense_c20250101__20250930__srt--StatementGeographicalAxis__custom--CanberraAustraliaMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember_zBh0I8zgLgu7">3,271</span>, respectively for the nine months ended September 30, 2026 and 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a summary of the operating lease right-of-use assets and liabilities at September 30, 2026:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfOperatingLeaseRightOfUseTableTextBlock_z3JgHoO8Dbyj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating Leases (Details - Right-to-use)"> <tr style="vertical-align: bottom"> <td> <span id="xdx_8B1_zsh2qKH9nY4l" style="display: none">Schedule of operating lease right-of-use</span></td> <td> </td> <td colspan="2" id="xdx_496_20260930_zGWwhzG82fLg" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Operating Lease</b></span></td> <td> </td></tr> <tr id="xdx_40E_ecustom--OperatingLeaseRightOfUseAssetGross_iI_zWe66Ba1b6d8" style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 83%"><span style="font-size: 10pt">Operating lease right-of-use assets</span></td> <td style="width: 2%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td style="width: 13%; text-align: right"><span style="font-size: 10pt">4,437,863</span></td> <td style="width: 1%"> </td></tr> <tr id="xdx_40B_ecustom--OperatingLeaseRightOfUseAssetAccumulatedAmortization_iNI_di_zUMYQTz2rpNc" style="vertical-align: bottom; background-color: white"> <td><span style="font-size: 10pt">Less: accumulated amortization</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">(820,529</span></td> <td><span style="font-size: 10pt">)</span></td></tr> <tr id="xdx_409_eus-gaap--OperatingLeaseRightOfUseAsset_iI_zwOnvD2wuOJ3" style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-size: 10pt">Operating lease right-of-use assets, as of September 30, 2026</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">3,617,334</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr id="xdx_408_ecustom--OperatingLeaseLiabilityGross_iI_zt1PYKFhglRb" style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-size: 10pt">Operating lease liability</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">4,437,863</span></td> <td> </td></tr> <tr id="xdx_402_ecustom--OperatingLeaseLiabilityAccumulatedAmortization_iNI_di_zcY2iberLwod" style="vertical-align: bottom; background-color: white"> <td><span style="font-size: 10pt">Less: accumulated reduction</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">(723,660</span></td> <td><span style="font-size: 10pt">)</span></td></tr> <tr id="xdx_409_eus-gaap--OperatingLeaseLiability_iI_z36s54Frqfaf" style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-size: 10pt">Operating lease liability, as of September 30, 2026</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">3,714,203</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zgz1CvZuahHa" style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-size: 10pt">Current operating lease liability</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">972,234</span></td> <td> </td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zFzGyAS8It33" style="vertical-align: bottom; background-color: white"> <td><span style="font-size: 10pt">Non-current operating lease liability</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">2,741,969</span></td> <td> </td></tr> <tr id="xdx_40C_eus-gaap--OperatingLeaseLiability_iI_zmNZ8rlQpjXb" style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-size: 10pt">Total operating lease liability</span></td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 10pt">3,714,203</span></td> <td> </td></tr> </table> <p id="xdx_8AF_zxwnc5hfm3Th" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a summary of future lease payments required under the lease agreement:</p> <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zPQjULMKI8ud" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating Leases (Details - Lease maturity)"> <tr style="vertical-align: bottom"> <td style="text-align: left"> <span id="xdx_8B6_zRx6nHTA2Xwb" style="display: none">Schedule of future lease payments</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: left; font-weight: bold">Year</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Future Lease <br/> Payments</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Operating Lease <br/> Discount</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Operating Lease <br/> Liability</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 49%; text-align: left">2026</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2026Member_zQVz2R5xvpai" style="width: 13%; text-align: right" title="Future Lease Payments">331,255</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2026Member_z0rKjFxlSFs1" style="width: 13%; text-align: right" title="Operating Lease Discount">(88,975</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingLeaseLiability_iI_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2026Member_zk9idXhMZ5Li" style="width: 13%; text-align: right" title="Operating Lease Liability">242,280</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2027Member_zN86EnHWdmfl" style="text-align: right" title="Future Lease Payments">1,280,473</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2027Member_zXWt4vToUSLk" style="text-align: right" title="Operating Lease Discount">(308,868</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--OperatingLeaseLiability_iI_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2027Member_zPQqiUwl6cH4" style="text-align: right" title="Operating Lease Liability">971,605</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">2028</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2028Member_z2OjiaNXwQV2" style="text-align: right" title="Future Lease Payments">1,312,575</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2028Member_zheGMtj9ud74" style="text-align: right" title="Operating Lease Discount">(237,204</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--OperatingLeaseLiability_iI_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2028Member_zr4w6gZzErb2" style="text-align: right" title="Operating Lease Liability">1,075,370</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2029</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2029Member_ztThUWdQ616c" style="text-align: right" title="Future Lease Payments">968,441</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2029Member_zHElxIv6TyF" style="text-align: right" title="Operating Lease Discount">(96,377</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingLeaseLiability_iI_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2029Member_zyUYHQjOBn29" style="text-align: right" title="Operating Lease Liability">872,064</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">2030</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2030Member_zolnX7gJSvZh" style="border-bottom: Black 1pt solid; text-align: right" title="Future Lease Payments">585,355</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2030Member_zwaZ9rq3U4oj" style="border-bottom: Black 1pt solid; text-align: right" title="Operating Lease Discount">(32,471</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--OperatingLeaseLiability_iI_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2030Member_z53fRN12VpFh" style="border-bottom: Black 1pt solid; text-align: right" title="Operating Lease Liability">552,884</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_c20260930_zvVjrEIiaFO7" style="border-bottom: Black 2.5pt double; text-align: right" title="Future Lease Payments">4,478,099</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20260930_zzTtsVkXg9B9" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating Lease Discount">(763,895</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--OperatingLeaseLiability_iI_c20260930_zRtkBVKjaDDf" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating Lease Liability">3,714,203</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p id="xdx_8AF_zYL1xJl72zWi" style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--LeaseCostTableTextBlock_zO8t9aeY8nF1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating Leases (Details - Lease supplemental information)"> <tr style="vertical-align: bottom"> <td> <span id="xdx_8B3_zEaLAmACS0G" style="display: none">Schedule of supplemental information</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">Supplemental Information</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UMAC</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rotor Riot</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rotor Lab</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 49%; text-align: left">Weighted average remaining lease term (in years)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_909_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20260930__us-gaap--BusinessAcquisitionAxis__custom--UMACMember_zL6ZL5FfE4I8" title="Weighted average remaining lease term (in years)">3.60</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20260930__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember_z8Qb0HbSpefc" title="Weighted average remaining lease term (in years)">2.08</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90C_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20260930__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zI9EjxQdvbQc" title="Weighted average remaining lease term (in years)">0.58</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Weighted average discount rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20260930__us-gaap--BusinessAcquisitionAxis__custom--UMACMember_z27vKUNWUTjh" title="Weighted average discount rate">10.17</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20260930__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember_zC6zJkxpVVT2" title="Weighted average discount rate">11.49</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20260930__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zfevMLGQWPO8" title="Weighted average discount rate">11.49</span>%</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A1_zzXeCB2qUNsh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the nine months ended September 30, 2026, the Company commenced new lease arrangements resulting in the recognition of operating lease right-of-use assets and corresponding operating lease liabilities of $<span id="xdx_902_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn6n6_c20260930__us-gaap--TransactionTypeAxis__custom--NewLeaseArrangementsMember_zSkWeRw1dkKe"><span id="xdx_900_eus-gaap--OperatingLeaseLiability_iI_pn6n6_c20260930__us-gaap--TransactionTypeAxis__custom--NewLeaseArrangementsMember_zqEz6idQ4mQa">1</span></span>.6M. These additions represent noncash activities and, accordingly, are excluded from the consolidated statements of cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 378430 78859 78859 78859 973443 190293 42287 190293 1430522 279645 0 204749 57949 0 56441 1346610 194698 0 58524 44483 3271 <table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfOperatingLeaseRightOfUseTableTextBlock_z3JgHoO8Dbyj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating Leases (Details - Right-to-use)"> <tr style="vertical-align: bottom"> <td> <span id="xdx_8B1_zsh2qKH9nY4l" style="display: none">Schedule of operating lease right-of-use</span></td> <td> </td> <td colspan="2" id="xdx_496_20260930_zGWwhzG82fLg" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Operating Lease</b></span></td> <td> </td></tr> <tr id="xdx_40E_ecustom--OperatingLeaseRightOfUseAssetGross_iI_zWe66Ba1b6d8" style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 83%"><span style="font-size: 10pt">Operating lease right-of-use assets</span></td> <td style="width: 2%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td style="width: 13%; text-align: right"><span style="font-size: 10pt">4,437,863</span></td> <td style="width: 1%"> </td></tr> <tr id="xdx_40B_ecustom--OperatingLeaseRightOfUseAssetAccumulatedAmortization_iNI_di_zUMYQTz2rpNc" style="vertical-align: bottom; background-color: white"> <td><span style="font-size: 10pt">Less: accumulated amortization</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">(820,529</span></td> <td><span style="font-size: 10pt">)</span></td></tr> <tr id="xdx_409_eus-gaap--OperatingLeaseRightOfUseAsset_iI_zwOnvD2wuOJ3" style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-size: 10pt">Operating lease right-of-use assets, as of September 30, 2026</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">3,617,334</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr id="xdx_408_ecustom--OperatingLeaseLiabilityGross_iI_zt1PYKFhglRb" style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-size: 10pt">Operating lease liability</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">4,437,863</span></td> <td> </td></tr> <tr id="xdx_402_ecustom--OperatingLeaseLiabilityAccumulatedAmortization_iNI_di_zcY2iberLwod" style="vertical-align: bottom; background-color: white"> <td><span style="font-size: 10pt">Less: accumulated reduction</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">(723,660</span></td> <td><span style="font-size: 10pt">)</span></td></tr> <tr id="xdx_409_eus-gaap--OperatingLeaseLiability_iI_z36s54Frqfaf" style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-size: 10pt">Operating lease liability, as of September 30, 2026</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">3,714,203</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zgz1CvZuahHa" style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-size: 10pt">Current operating lease liability</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">972,234</span></td> <td> </td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zFzGyAS8It33" style="vertical-align: bottom; background-color: white"> <td><span style="font-size: 10pt">Non-current operating lease liability</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">2,741,969</span></td> <td> </td></tr> <tr id="xdx_40C_eus-gaap--OperatingLeaseLiability_iI_zmNZ8rlQpjXb" style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-size: 10pt">Total operating lease liability</span></td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-size: 10pt">3,714,203</span></td> <td> </td></tr> </table> 4437863 820529 3617334 4437863 723660 3714203 972234 2741969 3714203 <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zPQjULMKI8ud" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating Leases (Details - Lease maturity)"> <tr style="vertical-align: bottom"> <td style="text-align: left"> <span id="xdx_8B6_zRx6nHTA2Xwb" style="display: none">Schedule of future lease payments</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: left; font-weight: bold">Year</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Future Lease <br/> Payments</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Operating Lease <br/> Discount</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Operating Lease <br/> Liability</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 49%; text-align: left">2026</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2026Member_zQVz2R5xvpai" style="width: 13%; text-align: right" title="Future Lease Payments">331,255</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2026Member_z0rKjFxlSFs1" style="width: 13%; text-align: right" title="Operating Lease Discount">(88,975</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingLeaseLiability_iI_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2026Member_zk9idXhMZ5Li" style="width: 13%; text-align: right" title="Operating Lease Liability">242,280</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2027Member_zN86EnHWdmfl" style="text-align: right" title="Future Lease Payments">1,280,473</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2027Member_zXWt4vToUSLk" style="text-align: right" title="Operating Lease Discount">(308,868</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--OperatingLeaseLiability_iI_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2027Member_zPQqiUwl6cH4" style="text-align: right" title="Operating Lease Liability">971,605</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">2028</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2028Member_z2OjiaNXwQV2" style="text-align: right" title="Future Lease Payments">1,312,575</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2028Member_zheGMtj9ud74" style="text-align: right" title="Operating Lease Discount">(237,204</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--OperatingLeaseLiability_iI_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2028Member_zr4w6gZzErb2" style="text-align: right" title="Operating Lease Liability">1,075,370</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2029</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2029Member_ztThUWdQ616c" style="text-align: right" title="Future Lease Payments">968,441</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2029Member_zHElxIv6TyF" style="text-align: right" title="Operating Lease Discount">(96,377</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingLeaseLiability_iI_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2029Member_zyUYHQjOBn29" style="text-align: right" title="Operating Lease Liability">872,064</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">2030</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2030Member_zolnX7gJSvZh" style="border-bottom: Black 1pt solid; text-align: right" title="Future Lease Payments">585,355</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2030Member_zwaZ9rq3U4oj" style="border-bottom: Black 1pt solid; text-align: right" title="Operating Lease Discount">(32,471</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--OperatingLeaseLiability_iI_c20260930__us-gaap--LeaseContractualTermAxis__custom--Year2030Member_z53fRN12VpFh" style="border-bottom: Black 1pt solid; text-align: right" title="Operating Lease Liability">552,884</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_c20260930_zvVjrEIiaFO7" style="border-bottom: Black 2.5pt double; text-align: right" title="Future Lease Payments">4,478,099</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20260930_zzTtsVkXg9B9" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating Lease Discount">(763,895</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--OperatingLeaseLiability_iI_c20260930_zRtkBVKjaDDf" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating Lease Liability">3,714,203</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> 331255 88975 242280 1280473 308868 971605 1312575 237204 1075370 968441 96377 872064 585355 32471 552884 4478099 763895 3714203 <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--LeaseCostTableTextBlock_zO8t9aeY8nF1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating Leases (Details - Lease supplemental information)"> <tr style="vertical-align: bottom"> <td> <span id="xdx_8B3_zEaLAmACS0G" style="display: none">Schedule of supplemental information</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">Supplemental Information</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UMAC</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rotor Riot</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rotor Lab</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 49%; text-align: left">Weighted average remaining lease term (in years)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_909_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20260930__us-gaap--BusinessAcquisitionAxis__custom--UMACMember_zL6ZL5FfE4I8" title="Weighted average remaining lease term (in years)">3.60</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20260930__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember_z8Qb0HbSpefc" title="Weighted average remaining lease term (in years)">2.08</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90C_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20260930__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zI9EjxQdvbQc" title="Weighted average remaining lease term (in years)">0.58</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Weighted average discount rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20260930__us-gaap--BusinessAcquisitionAxis__custom--UMACMember_z27vKUNWUTjh" title="Weighted average discount rate">10.17</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20260930__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember_zC6zJkxpVVT2" title="Weighted average discount rate">11.49</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20260930__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zfevMLGQWPO8" title="Weighted average discount rate">11.49</span>%</td><td style="text-align: left"> </td></tr> </table> P3Y7M6D P2Y29D P0Y6M29D 0.1017 0.1149 0.1149 1000000 1000000 <p id="xdx_805_eus-gaap--IntangibleAssetsDisclosureTextBlock_zwyPsAgBrMkc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Note 9 – <span id="xdx_82B_zw8ZLvknLlc7">Goodwill and Intangible Assets</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Goodwill</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were no changes in the carrying amount of goodwill during the nine months ending September 30, 2026. The carrying value of goodwill was $<span id="xdx_906_eus-gaap--Goodwill_iI_c20260930_ziNEtMVD0Vaf" title="Goodwill">15,596,105</span> and $<span id="xdx_902_eus-gaap--Goodwill_iI_c20251231_zCJyU4oCoMW2" title="Goodwill">15,596,105</span> as of September 30, 2026 and December 31, 2025 respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Intangible Assets</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of September 30, 2026, the balances of intangible assets were as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_zMpeh72Nmkqa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details)"> <tr style="vertical-align: bottom"> <td> <span id="xdx_8BD_zV7BisSOzldb" style="display: none">Schedule of intangible assets</span></td><td> </td> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Type</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Gross Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated Amortization</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 32%; text-align: left">Patents/IP – Fat Shark</td><td style="width: 2%"> </td> <td style="width: 15%">Finite-lived</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zOyZZD2GBzR5" style="width: 13%; text-align: right" title="Intangible assets, gross">824,857</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zKxh7Q14qxm2" style="width: 13%; text-align: right" title="Accumulated amortization">(214,430</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_z5XGgHXlzkKj" style="width: 13%; text-align: right" title="Intangible assets, net">610,427</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Trademark – Rotor Riot</td><td> </td> <td>Indefinite-lived</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iI_c20260930__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zuGJl2U7RMBb" style="text-align: right" title="Intangible assets, gross">1,480,130</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iI_c20260930__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_z5i9KHBTuGpj" style="text-align: right" title="Intangible assets, net">1,480,130</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Trade name – Rotor Lab</td><td> </td> <td>Finite-lived</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zAQ20Mvu85cj" style="text-align: right" title="Intangible assets, gross">46,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zUwuNXQ5Ruil" style="text-align: right" title="Accumulated amortization">(9,967</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_ziuMXOI7rKDi" style="text-align: right" title="Intangible assets, net">36,033</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer relationships – Rotor Lab</td><td> </td> <td>Finite-lived</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zR1xX6wzkhA8" style="text-align: right" title="Intangible assets, gross">190,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z45IlC8Gp3O3" style="text-align: right" title="Accumulated amortization">(29,405</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zHKrJ315I4s4" style="text-align: right" title="Intangible assets, net">160,595</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Non-Compete Agreements – Rotor Lab</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt">Finite-lived</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zjALCtQ1mhZ3" style="border-bottom: Black 1pt solid; text-align: right" title="Intangible assets, gross">233,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zmU0qiigc9ya" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization">(126,208</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zNa9HVH6Yq25" style="border-bottom: Black 1pt solid; text-align: right" title="Intangible assets, net">106,792</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total intangible assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20260930_zWWQ6iSg2S97" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, gross">2,773,987</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_c20260930_z7wELtFi4Vnk" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization">(380,010</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20260930_zfiMNg6gH9nj" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, net">2,393,977</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zkOB8aLWydXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Patents and intellectual property relate to the patents and technology know-how from the acquisition of Fat Shark in February 2024. Patents are amortized over <span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_z2RYJ76BSu3j" title="Intangible asset, amortization period">10</span> years. Trademarks relate to the brand name and recognition of Rotor Riot from the acquisition in February 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Trade name for Rotor Lab is amortized over <span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zvwt24Q9N0Fh" title="Intangible asset, amortization period">5</span> years, customer relationships are amortized over <span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zBg7DUczFJib" title="Intangible asset, amortization period">7</span> years and non-compete agreements are amortized over <span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zTJovvah3oj2" title="Intangible asset, amortization period">2</span> years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Amortization expense for the nine months ended September 30, 2026 and 2025 was $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_c20260101__20260930_z7ZD19QXc9ua" title="Amortization expense">175,898</span> and $<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_c20250101__20250930_zGOj8NWFCko5" title="Amortization expense">61,266</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 15596105 15596105 <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_zMpeh72Nmkqa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details)"> <tr style="vertical-align: bottom"> <td> <span id="xdx_8BD_zV7BisSOzldb" style="display: none">Schedule of intangible assets</span></td><td> </td> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Type</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Gross Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated Amortization</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 32%; text-align: left">Patents/IP – Fat Shark</td><td style="width: 2%"> </td> <td style="width: 15%">Finite-lived</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zOyZZD2GBzR5" style="width: 13%; text-align: right" title="Intangible assets, gross">824,857</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zKxh7Q14qxm2" style="width: 13%; text-align: right" title="Accumulated amortization">(214,430</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_z5XGgHXlzkKj" style="width: 13%; text-align: right" title="Intangible assets, net">610,427</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Trademark – Rotor Riot</td><td> </td> <td>Indefinite-lived</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iI_c20260930__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zuGJl2U7RMBb" style="text-align: right" title="Intangible assets, gross">1,480,130</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iI_c20260930__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_z5i9KHBTuGpj" style="text-align: right" title="Intangible assets, net">1,480,130</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Trade name – Rotor Lab</td><td> </td> <td>Finite-lived</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zAQ20Mvu85cj" style="text-align: right" title="Intangible assets, gross">46,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zUwuNXQ5Ruil" style="text-align: right" title="Accumulated amortization">(9,967</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_ziuMXOI7rKDi" style="text-align: right" title="Intangible assets, net">36,033</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer relationships – Rotor Lab</td><td> </td> <td>Finite-lived</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zR1xX6wzkhA8" style="text-align: right" title="Intangible assets, gross">190,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z45IlC8Gp3O3" style="text-align: right" title="Accumulated amortization">(29,405</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zHKrJ315I4s4" style="text-align: right" title="Intangible assets, net">160,595</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Non-Compete Agreements – Rotor Lab</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt">Finite-lived</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zjALCtQ1mhZ3" style="border-bottom: Black 1pt solid; text-align: right" title="Intangible assets, gross">233,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zmU0qiigc9ya" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization">(126,208</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20260930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zNa9HVH6Yq25" style="border-bottom: Black 1pt solid; text-align: right" title="Intangible assets, net">106,792</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total intangible assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20260930_zWWQ6iSg2S97" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, gross">2,773,987</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_c20260930_z7wELtFi4Vnk" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization">(380,010</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20260930_zfiMNg6gH9nj" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, net">2,393,977</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 824857 214430 610427 1480130 1480130 46000 9967 36033 190000 29405 160595 233000 126208 106792 2773987 380010 2393977 P10Y P5Y P7Y P2Y 175898 61266 <p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zpgmLoBakpN9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Note 10 – <span id="xdx_82C_z3CQNFljGeTf">Stockholders’ Equity</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Common Stock</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">2026 Transactions</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Common stock for services issued to employees and directors</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 2, 2026, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20260101__20260102__srt--CounterpartyNameAxis__custom--EmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--January2026IssuanceMember_zGNrIG2104U7" title="Restricted stock issued, shares">70,000</span> restricted shares of common stock to certain employees of the Company. The shares of restricted stock were granted under the Company’s 2022 Equity Incentive Plan. The restricted shares issued to employees are subject to pro-rata forfeiture over a four-year period. The shares were valued at $13.57 per share, which was the quoted trading price of the Company’s common stock on the date of grant, respectively, for a total of $<span id="xdx_90A_eus-gaap--ShareBasedCompensation_c20260101__20260102__srt--CounterpartyNameAxis__custom--EmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--January2026IssuanceMember_zp4ur46DJBmk" title="Share-based compensation">949,900</span> to be recognized as stock compensation expense pro-rata over the vesting period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 23, 2026, the Company issued <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20260122__20260123__srt--CounterpartyNameAxis__custom--ExecutiveOfficersMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--January232026IssuanceMember_zdEg8eYEkedf">550,000</span> restricted shares of common stock to executive officers of the Company. The shares of restricted stock were granted under the Company’s 2022 Equity Incentive Plan. The restricted shares issued to executive officers are subject to pro rata forfeiture through December 31, 2026. The shares were valued at $16.70 per share, which was the quoted trading price of the Company’s common stock on the date of grant, respectively, for a total of $<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20260122__20260123__srt--CounterpartyNameAxis__custom--ExecutiveOfficersMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--January232026IssuanceMember_zN9RsauzswI7" title="Restricted stock granted, value">9,185,000</span> to be recognized as stock compensation expense pro-rata over the vesting period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 23, 2026, the Company issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20260122__20260123__srt--CounterpartyNameAxis__custom--CertainEmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--January232026IssuanceMember_zzzHfXZNDz98" title="Restricted stock granted, shares">120,000</span> restricted shares of common stock to certain employees of the Company. The shares of restricted stock were granted under the Company’s 2022 Equity Incentive Plan. The restricted shares issued to employees are subject to pro-rata forfeiture over a four-year period. The shares were valued at $16.70 per share, which was the quoted trading price of the Company’s common stock on the date of grant, respectively, for a total of $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20260122__20260123__srt--CounterpartyNameAxis__custom--CertainEmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--January232026IssuanceMember_zuBERoe0otfg">2,004,000</span> to be recognized as stock compensation expense pro-rata over the vesting period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 13, 2026, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20260312__20260313__srt--CounterpartyNameAxis__custom--CertainBoardMembersMember_z8QYLGovkyil">5,883</span> shares of common stock related to vested restricted stock units for our certain board members. The restricted stock units are valued at $20.40 per share, the closing price of our common stock as of the date of the grant, for a total value of $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20260312__20260313__srt--CounterpartyNameAxis__custom--CertainBoardMembersMember_zE5en51exgBk" title="Restricted stock granted, value">120,013</span> and expensed on the grant date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 20, 2026, the Company issued <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20260519__20260520__srt--CounterpartyNameAxis__custom--CertainBoardMembersMember_zoYYDQ3i6Ly4" title="Restricted stock granted, shares">8,352</span> shares of common stock related to vested restricted stock units for our certain board members. The restricted stock units are valued at $14.37 per share, the closing price of our common stock as of the date of the grant, for a total value of $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20260519__20260520__srt--CounterpartyNameAxis__custom--CertainBoardMembersMember_zeYKJWJRk3C" title="Restricted stock granted, value">120,018</span> and expensed on the grant date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Common stock issued for services to non-employees</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 2, 2026, the Company issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20260101__20260102__srt--CounterpartyNameAxis__custom--ConsultantMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--January2026IssuanceMember_z89gaEYPa3o" title="Stock issued for services, shares">40,000</span> restricted shares of common stock to a consultant for service performed. The shares of restricted stock were granted under the Company’s 2022 Equity Incentive Plan. The restricted shares issued to the consultant are subject to pro-rata forfeiture over a two-year period. The shares were valued at $13.57 per share, which was the quoted trading price of the Company’s common stock on the date of grant, respectively, for a total of $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20260101__20260102__srt--CounterpartyNameAxis__custom--ConsultantMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--January2026IssuanceMember_zUMekAiOA6A7" title="Stock issued for services, value">542,800</span> to be recognized as stock compensation expense pro-rata over the vesting period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 22, 2026, the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20260521__20260522__srt--CounterpartyNameAxis__custom--CommonSharesIssuedForServicesMember_zQorXvaXXRl2" title="Restricted stock granted, shares">108,000</span> shares of common stock related to vested restricted stock units for our advisory board members. The restricted stock units are valued at $16.78 per share, the closing price of our common stock as of the date of the grant, for a total value of $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20260521__20260522__srt--CounterpartyNameAxis__custom--CommonSharesIssuedForServicesMember_zZtE1ACDWoY5" title="Restricted stock granted, value">1,812,240</span> and expensed on the grant date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Common stock issued related to option exercises</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the nine months ended September 30, 2026, several employees of the Company exercised <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20260101__20260930__srt--CounterpartyNameAxis__custom--SeveralEmployeesMember_zTNXYAhyj8A5">146,755</span> of their vested stock options in which the Company issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20260101__20260930__srt--CounterpartyNameAxis__custom--SeveralEmployeesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zaHVHobnPQ77" title="Stock issued for options exercised">146,755</span> shares of common stock related to these exercises. The Company received total cash proceeds of $<span id="xdx_904_eus-gaap--ProceedsFromStockOptionsExercised_c20260101__20260930__srt--CounterpartyNameAxis__custom--SeveralEmployeesMember_zrbRDk5dKN9h" title="Proceeds from options exercised">750,373</span> related to the exercise of the stock options.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Common stock issued related to warrant exercises</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 9, 2026 the Company issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20260108__20260109_zOLYWRzIvUek" title="Stock issued for warrant exercises, shares">350,000</span> shares of common stock related to warrant holders exercising their warrants. The Company received gross proceeds of $<span id="xdx_900_eus-gaap--ProceedsFromWarrantExercises_c20260108__20260109_zJZsn0EK9bV9" title="Proceeds from warrant exercises">3,395,000</span> related to the warrant exercises. The Company cancelled the 350,000 warrants upon issuance of the common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Common stock issued related to public offering</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 19, 2026, in a confidentially marketed public offering the Company sold <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260318__20260319__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOfferingMember_z4ZzIP1Ro3wc" title="Stock issued new, shares">8,823,529</span> shares of common stock at $17.00 per share resulting in gross proceeds of $<span id="xdx_903_ecustom--GrossProceedsFromIssuanceOfCommonStock_c20260318__20260319__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOfferingMember_z2O3ybpGzQ2f" title="Gross proceeds from issuance of common stock">149,999,993</span>, prior to the payment of placement fees of $<span id="xdx_906_eus-gaap--PaymentsOfStockIssuanceCosts_c20260318__20260319__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOfferingMember__us-gaap--TransactionTypeAxis__custom--PlacementAgentFeesMember_zQ3cMrsoWsn6" title="Payments of stock issuance costss">10,500,000</span> and $<span id="xdx_90F_eus-gaap--PaymentsOfStockIssuanceCosts_c20260318__20260319__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOfferingMember__us-gaap--TransactionTypeAxis__custom--OtherOfferingExpensesMember_zhuBOYlfZ2E4" title="Payments of stock issuance costss">700,000</span> of other offering expenses resulting in net proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20260318__20260319__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOfferingMember_zBkOYoDnlso7" title="Proceeds from issuance of common stock">138,799,993</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 29, 2026, we completed an at the market offering for the sale of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260528__20260529__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketOfferingMember_zKEvNSVgDq9k" title="Stock issued new, shares">2,000,000</span> shares of Common Stock at a price of $30.00 per share for aggregate gross proceeds of approximately $<span id="xdx_90D_ecustom--GrossProceedsFromIssuanceOfCommonStock_pn6n6_c20260528__20260529__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketOfferingMember_zYs1Z2z2Sfxb" title="Gross proceeds from issuance of common stock">60</span>.0 million before deducting fees to the placement agent and other expenses payable by us in connection with the offering. The Company retained approximately $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn5n6_c20260528__20260529__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketOfferingMember_zxN2bOQxeoc1" title="Proceeds from issuance of common stock">58.2</span> million in net proceeds after offering expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">2025 Transactions</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 14, 2025, the Company issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250113__20250114__srt--CounterpartyNameAxis__custom--NonEmployeeDirectorsMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--January2025IssuanceMember_zOJLSfPhn5al" title="Restricted stock issued, shares">3,546</span> immediately vested restricted shares of common stock to non-employee directors of the Company. The shares of restricted stock were granted under the 2022 Equity Incentive Plan. The shares were valued at $11.99 per share, which was the value the Company’s common stock on the date of grant, respectively for a total of $<span id="xdx_903_eus-gaap--ShareBasedCompensation_c20250113__20250114__srt--CounterpartyNameAxis__custom--NonEmployeeDirectorsMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--January2025IssuanceMember_zozQ05ba0xQh" title="Share-based compensation">42,517</span> to be recognized as stock compensation expense on the grant date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 3, 2025, the Company issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250202__20250203__srt--CounterpartyNameAxis__custom--ExecutiveOfficersAndCertainEmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--February2025IssuanceMember_zL30UvDKPmZb" title="Restricted stock issued, shares">480,000</span> restricted shares of common stock to executive officers and certain employees of the Company. The shares of restricted stock were granted under the Company’s 2022 Equity Incentive Plan. The restricted shares issued to executive officers are subject to pro rata forfeiture through December 31, 2025. The restricted shares issued to certain employees are subject to pro-rata forfeiture over a four-year period. The shares were valued at $12.00 per share, which was the value of the Company’s common stock on the date of grant, respectively for a total of $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20250202__20250203__srt--CounterpartyNameAxis__custom--ExecutiveOfficersAndCertainEmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--February2025IssuanceMember_zFtwhL0njMu1" title="Restricted stock granted, value">5,760,000</span> to be recognized as stock compensation expense pro-rata over the vesting period. Stock compensation expense of $<span id="xdx_90A_eus-gaap--ShareBasedCompensation_c20250101__20250930__srt--CounterpartyNameAxis__custom--ExecutiveOfficersAndCertainEmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--February2025IssuanceMember_zVoC3znkLvpe" title="Share based compensation">4,154,839</span> was recognized during the nine months ended September 30, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2025, the Company issued <span id="xdx_904_eus-gaap--ConversionOfStockSharesIssued1_c20250201__20250228__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--WarrantExercisesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zf2xB7elCmrd" title="Conversion of stock, shares issued">1,224,606</span> shares of common stock related to warrant holders exercising their warrants at an exercise price of $<span id="xdx_900_eus-gaap--WarrantExercisePriceIncrease_c20250201__20250228__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--WarrantExercisesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zWXArcYrfLHi" title="Exercise price">1.99</span>. The Company received gross proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromWarrantExercises_c20250201__20250228__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--WarrantExercisesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_ztFKyGVDK1w8" title="Proceeds related to warrant exercises">2,436,966</span> related to the warrant exercises. The Company cancelled the <span id="xdx_903_eus-gaap--ConversionOfStockSharesConverted1_c20250201__20250228__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--WarrantExercisesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zRGeZL6NNSW3" title="Conversion of stock, shares converted">1,224,606</span> warrants upon issuance of the common shares.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 6, 2025, in a confidentially marketed public offering the Company sold <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250505__20250506__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOfferingMember_zekEA7srNvF5" title="Stock issued new, shares">8,000,000</span> shares of common stock at $5.00 per share resulting in gross proceeds of $<span id="xdx_903_ecustom--GrossProceedsFromIssuanceOfCommonStock_c20250505__20250506__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOfferingMember_zbSS0kjILVCj" title="Gross proceeds from issuance of common stock">40,000,000</span>, prior to payment of placement agent fees of $<span id="xdx_905_eus-gaap--PaymentsOfStockIssuanceCosts_c20250505__20250506__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOfferingMember__us-gaap--TransactionTypeAxis__custom--PlacementAgentFeesMember_zMOjtcXnuQnb" title="Payments of stock issuance costss">3,200,000</span> and $<span id="xdx_900_eus-gaap--PaymentsOfStockIssuanceCosts_c20250505__20250506__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOfferingMember__us-gaap--TransactionTypeAxis__custom--OtherOfferingExpensesMember_zQJ6u64rCKif" title="Payments of stock issuance costss">304,000</span> of other offering expenses resulting in net proceeds of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20250505__20250506__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOfferingMember_zem6lJ5sXO84" title="Proceeds from issuance of common stock">36,496,000</span>. Dominari Securities, LLC acted as the sole placement agent and also received a warrant to purchase <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20250506__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOfferingMember_z4eEjLkkDvya" title="Received warrant shares">640,000</span> shares of the Company’s common stock at $5.00 per share over a two-year period expiring on May 6, 2027.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 19, 2025, the Company issued <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250518__20250519__srt--CounterpartyNameAxis__custom--NonEmployeeDirectorsMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--May2025IssuanceMember_zzlW6CJr3BGd" title="Restricted stock issued, shares">33,336</span> immediately vested restricted shares of common stock to non-employee directors of the Company. The shares of restricted stock were granted under the 2022 Equity Incentive Plan. The shares were valued at $5.40 per share, which was the value the Company’s common stock on the date of grant, respectively for a total of approximately $<span id="xdx_90E_eus-gaap--ShareBasedCompensation_c20250101__20250930__srt--CounterpartyNameAxis__custom--NonEmployeeDirectorsMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--May2025IssuanceMember_zTGk4Wr8LNE" title="Share-based compensation">180,000</span> to be recognized as stock compensation expense during the nine months ended September 30, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 19, 2025, the Company issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250518__20250519__srt--CounterpartyNameAxis__custom--ConsultantMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--May2025IssuanceMember_z5wKZ3GL6tN7" title="Restricted stock issued, shares">4,630</span> immediately vested shares of common stock to a consultant of the Company related to services provided. The shares of common stock were granted under the 2022 Equity Incentive Plan. The shares were valued at $5.40 per share, which was the value the Company’s common stock on the date of grant, respectively for a total of approximately $<span id="xdx_905_eus-gaap--ShareBasedCompensation_c20250101__20250930__srt--CounterpartyNameAxis__custom--ConsultantMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--May2025IssuanceMember_z4RsYtxDiw02" title="Share-based compensation">25,000</span> to be recognized as stock compensation expense during the nine months ended September 30, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 22, 2025, the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250521__20250522__srt--CounterpartyNameAxis__custom--AdvisoryBoardMembersMember_zAPZREgbZTLg" title="Restricted stock granted, shares">150,000</span> shares of common stock related to vested restricted stock units for our advisory board members. The restricted stock units are valued at $4.40 per share, the closing price of our common stock as of the date of the grant, for a total value of $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20250521__20250522__srt--CounterpartyNameAxis__custom--AdvisoryBoardMembersMember_zfmzmnYaz46k" title="Restricted stock granted, value">660,000</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 30, 2025, the Board of Directors of the Company awarded the Company’s Chief Executive Officer <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250629__20250630__srt--CounterpartyNameAxis__srt--ChiefExecutiveOfficerMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member_zvrdAKyuX3d7" title="Restricted stock issued, shares">175,000</span> restricted shares of the Company’s common stock under the 2022 Equity Incentive Plan as a bonus related to the May 2025 public offering. The restricted shares are valued at $8.57 per share, the closing price of our common stock as of the date of the grant, for a total value of $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20250629__20250630__srt--CounterpartyNameAxis__srt--ChiefExecutiveOfficerMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member_zLWKyzFjAmKf" title="Restricted stock issued, value">1,499,750</span> that was recognized immediately based on the vesting of the awards for each of the Company’s Officers. The shares are subject to the Company’s clawback policy.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 15, 2025, in a registered direct offering the Company sold <span id="xdx_900_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250714__20250715__srt--CounterpartyNameAxis__custom--DominariSecuritiesLLCMember_zPNWzx1qZYmk" title="Shares of common stock sold">5,000,000</span> shares of common stock at $9.70 per share resulting in gross proceeds of $<span id="xdx_902_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20250714__20250715__srt--CounterpartyNameAxis__custom--DominariSecuritiesLLCMember_zvBKCLOcbLnh" title="Gross proceeds">48,500,000</span>, prior to the payment of placement fees of $<span id="xdx_907_eus-gaap--PaymentsOfStockIssuanceCosts_c20250714__20250715__srt--CounterpartyNameAxis__custom--DominariSecuritiesLLCMember_zcQPw1zW88a6" title="Payment of placement fees">3,395,000</span> and $<span id="xdx_90E_ecustom--OtherOfferingExpenses_c20250714__20250715__srt--CounterpartyNameAxis__custom--DominariSecuritiesLLCMember_zapF18o2QX0g" title="Other offering expenses">204,000</span> of other offering expenses resulting in net proceeds of $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20250714__20250715__srt--CounterpartyNameAxis__custom--DominariSecuritiesLLCMember_zLNG2bqJpwL8" title="Net proceeds">44,901,000</span>. Dominari Securities, LLC acted as the sole placement agent and also received a warrant to purchase <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250715__srt--CounterpartyNameAxis__custom--DominariSecuritiesLLCMember_zhVFkaJ18e5i" title="Shares of common stock sold">350,000</span> shares of the Company’s common stock at $9.70 per share over a two-year period expiring on May 6, 2027.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 1, 2025, the Company issued <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250730__20250802__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member_zVUyzaKvuPZf" title="Restricted stock granted, shares">150,000</span> shares of common stock related to the delivery of vested restricted stock units under the 2022 Equity Incentive Plan to certain executives of the Company as a bonus related to the May 2025 public offering. The shares were valued at $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20250730__20250802__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member_zftpYeTkeQfc" title="Restricted stock issued, value">1,285,500</span> based on the $8.57 based on the quoted trading price on grant date. The shares are subject to the Company’s clawback policy.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 7, 2025, the Company issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250806__20250807__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member_zfrSaNF5jJEl" title="Restricted stock issued, shares">100,000</span> restricted shares of common stock to certain employees of the Company. The shares of restricted stock were granted under the Company’s 2022 Equity Incentive Plan. The restricted shares issued to employees are subject to pro-rata forfeiture over a four-year period. The shares were valued at $9.59 per share, which was the quoted trading price of the Company’s common stock on the date of grant, respectively for a total of $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20250806__20250807__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member_zSrFYU1LSbv1" title="Restricted stock issued, value">959,000</span> to be recognized as stock compensation expense pro-rata over the vesting period. Stock compensation expense of $<span id="xdx_90C_eus-gaap--ShareBasedCompensation_c20250101__20250930__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member_zJqCV33DGkcd" title="Share-based compensation">35,638 </span>was recognized during the nine months ended September 30, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 19, 2025, the Company issued <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250818__20250819__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022OneMember_z60t7ziT8yke" title="Restricted stock issued, shares">9,232</span> immediately vested restricted shares of common stock to non-employee directors of the Company. The shares of restricted stock were granted under the 2022 Equity Incentive Plan. The shares were valued at $9.75 per share, which was the quoted trading price the Company’s common stock on the date of grant, respectively, for a total of approximately $<span id="xdx_900_eus-gaap--ShareBasedCompensation_c20250101__20250930__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022OneMember_zHkDWSeWWJee" title="Share-based compensation">90,000</span> to be recognized as stock compensation expense during the nine months ended September 30, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 19, 2025, the Company issued <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250818__20250819__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022TwoMember_zmZj1pyrHvzj" title="Shares of common stock sold">1,727</span> immediately vested shares of common stock to a consultant of the Company related to services provided. The shares of common stock were granted under the 2022 Equity Incentive Plan. The shares were valued at $9.75 per share, which was the quoted trading price the Company’s common stock on the date of grant, respectively for a total of approximately $<span id="xdx_906_eus-gaap--ShareBasedCompensation_c20250101__20250930__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022TwoMember_zxU7IiAdcK2d" title="Share-based compensation">15,000</span> which is recognized as stock compensation expense during the nine months ended September 30, 2025 and included in stock compensation expense – vested stock on the statement of stockholder’s equity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 2, 2025, the Company issued <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250901__20250902__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022ThreeMember_zlNzE4C5yVH1" title="Restricted stock issued, shares">280,000</span> restricted shares of common stock to certain employees of the Company. The shares of restricted stock were granted under the Company’s 2022 Equity Incentive Plan. The restricted shares issued to employees are subject to pro-rata forfeiture over a four-year period. The shares were valued at $9.16 per share, which was the value of the Company’s common stock on the date of grant, respectively for a total of $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20250901__20250902__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022ThreeMember_zLg9op2pMWxg" title="Restricted stock issued, value">2,564,800 </span>to be recognized as stock compensation expense pro-rata over the vesting period. Stock compensation expense of $<span id="xdx_909_eus-gaap--ShareBasedCompensation_c20250101__20250930__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022ThreeMember_zLZmhk8ttZW4" title="Share-based compensation">51,085</span> was recognized during the nine months ended September 30, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 3, 2025, the Company issued <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20250901__20250903_zrrafIVzQp5e" title="Shares of common stock issued">656,642</span> of common stock related to the closing of the Rotor Lab acquisition (see Note 3). The shares were valued at $9.02 per shares which was the closing trading price of the Company’s common stock on September 3, 2025, the closing date of the acquisition, resulting in an aggregate value of $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20250901__20250903_z9XZYBrIxBol" title="Issuance of common shares, value">5,922,911</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 24, 2025, the Company issued <span id="xdx_909_ecustom--IssuanceOfCommonSharesWarrantExercisesShares_c20250923__20250924_zo1nWUvNhzwe" title="Issuance of common shares - warrant exercises, shares">8,500</span> shares of common stock related to warrant holders exercising their warrants. The Company received gross proceeds of $<span id="xdx_90A_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_c20250923__20250924_zSPKHTce48h" title="Issuance of common shares - warrant exercises">42,500</span> related to the warrant exercises. The Company cancelled the <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250924_zET7F1jbwKW6" title="Warrants cancelled upon issuance of common shares">8,500</span> warrants upon issuance of the common shares.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In September 2025, the Company issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250901__20250930_z0UVY34HUjLk" title="Shares of common stock issued related to vesting of restricted stock units">50,000</span> shares of common stock related to the vesting of certain employee restricted stock units in which the Company issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250901__20250930_zBYZHzv0wRcj" title="Shares of common stock issued related to vesting of restricted stock units">50,000</span> shares of common stock related to the vesting of these restricted stock units.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the nine months ended September 30, 2025, several employees of the Company exercised <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20250101__20250930__srt--CounterpartyNameAxis__custom--SeveralEmployeesMember_zWk8sIcQDPD5">119,900</span> of their vested stock options in which the Company issued <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20250101__20250930__srt--CounterpartyNameAxis__custom--SeveralEmployeesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zmNuHWSpS7f7" title="Stock issued for options exercised">119,900</span> shares of common stock related to these exercises. The Company received total cash proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromStockOptionsExercised_c20250101__20250930_z01l1lBl9QXj" title="Proceeds from option exercises">501,610</span> related to the exercise of the stock options.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 70000 949900 550000 9185000 120000 2004000 5883 120013 8352 120018 40000 542800 108000 1812240 146755 146755 750373 350000 3395000 8823529 149999993 10500000 700000 138799993 2000000 60000000 58200000 3546 42517 480000 5760000 4154839 1224606 1.99 2436966 1224606 8000000 40000000 3200000 304000 36496000 640000 33336 180000 4630 25000 150000 660000 175000 1499750 5000000 48500000 3395000 204000 44901000 350000 150000 1285500 100000 959000 35638 9232 90000 1727 15000 280000 2564800 51085 656642 5922911 8500 42500 8500 50000 50000 119900 119900 501610 <p id="xdx_80B_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_z2oqmaELPBL1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Note 11 – <span id="xdx_827_zle4T4vEC8p5">Share Based Awards</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s Board of Directors has delegated authority to the Chief Executive Officer to grant stock options to employees who are not executive officers. Any issuance of restricted stock awards or restricted stock units must be approved by the Company’s Compensation Committee. Stock options are granted for employees on a monthly to quarterly basis. Restricted stock awards and restricted stock units are granted on a quarterly basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Stock Options</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the nine months ended September 30, 2026 and 2025, the Company’s Board of Directors approved the grant of <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--CounterpartyNameAxis__custom--CertainEmployeesMember_zuFm9JsUnHVa" title="Granted shares">3,075,000</span> and <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20250101__20250930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--CounterpartyNameAxis__custom--CertainEmployeesMember_z6gFQPGgVmPc" title="Granted shares">527,500</span>, respectively of stock options under the Plan to certain employees. The stock options are subject to certain vesting provisions. Standard vesting on stock options have a six-month cliff vesting in which the first two quarters vest at the six-month mark and quarterly thereafter over a total of four years, however, certain stock options may have immediate vesting or shorter periods as approved. Stock options contractual term range from 5 to 10 years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the activity for stock options outstanding:</p> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zxwXUiRUr0g9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share Based Awards (Details - Stock options activity)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BD_zoHNtkaftVV3" style="display: none"> Schedule of stock option activity</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Non-Qualified</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Options</b></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise Price</b></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Remaining</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Contractual Term</b></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Aggregate</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Intrinsic Value</b></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 32%">Outstanding - December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zsCUBwGlpw34" style="width: 13%; text-align: right" title="Non-Qualified options outstanding, beginning balance">739,684</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zxf22KnLH842" style="width: 13%; text-align: right" title="Weighted average exercise price, beginning balance">6.50</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zOL9Mnaojozb" title="Weighted average remaining contractual term">6.25</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_d0_c20251231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zzetlHfib1Ak" style="width: 13%; text-align: right" title="Aggregate intrinsic value">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zqfaW1rzTcUd" style="text-align: right" title="Non-Qualified options, granted">3,075,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zQCt3dVlyBBh" style="text-align: right" title="Weighted average exercise price, granted">18.85</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Forfeited/canceled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_ziBrbVvYpFHh" style="text-align: right" title="Non-Qualified options, forfeited/canceled">(127,500</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zokZq8BucHw" style="text-align: right" title="Weighted average exercise price, forfeited/canceled">11.09</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zebfgsHXAAsa" style="border-bottom: Black 1pt solid; text-align: right" title="Non-Qualified options, exercised">(146,755</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zikugJhZKF5h" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, exercised">5.11</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_d0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zJd0EaM1QHsl" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Outstanding – September 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zr994hKskbm3" style="border-bottom: Black 2.5pt double; text-align: right" title="Non-Qualified options outstanding, ending balance">3,540,429</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z54T1ceZQ03h" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending balance">17.13</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zyAjgfsPzmGi" title="Weighted average remaining contractual term">4.91</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zjRgtzH86hv7" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate intrinsic value">26,037,523</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable – September 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z4wQR8LBsjTa" style="border-bottom: Black 2.5pt double; text-align: right" title="Non-Qualified options, exercisable">127,636</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zRSzANPXwaOj" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, exercisable">8.24</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zXfxwVQUbdzd" title="Weighted average remaining contractual term, exercisable">5.53</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zU2H9UnKqIB" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate intrinsic value, exercisable">2,072,658</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zSGvFJvZcR6i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The range of assumptions used to calculate the fair value of options granted during the period ended September 30, 2026 was:</p> <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zlbdiZjvE565" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Share Based Awards (Details - Stock options assumptions)"> <tr style="vertical-align: bottom"> <td style="width: 82%"><span id="xdx_8B6_z8wZI9SW17Ib" style="display: none"> Schedule of stock options assumptions</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right"> </td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2026</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise Price</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_ziv5qBrutio2" title="Exercise price">12.34</span> – <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_z8OJzcCgwMq9" title="Exercise price">19.36</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock Price on date of grant</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--SharePrice_iI_c20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_zDWTlBkuQ001">12.34</span> – <span id="xdx_902_eus-gaap--SharePrice_iI_c20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_zRjMUR3ohTz5" title="Stock price on date of grant">19.36</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free interest rate</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_zCKsCYCDd0Rg">3.72</span>% – <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_zFjO3kqMMoLe" title="Risk-free interest rate">4.46</span>%</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend yield</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDNcZkoQemc8" title="Dividend yield">–</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected term (years)</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_zmgU2qtfmr37" title="Expected term (years)">2.5</span> - <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_zc6ThqiGEtb5" title="Expected term (years)">5.45</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_z5JRYO94i8y" title="Volatility">149.00</span>% – <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_zGVi5qr3uN6f" title="Volatility">151.22</span>%</span></td> <td> </td></tr> </table> <p id="xdx_8AC_zmcW0xc9gs97" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The total grant date fair value of stock options granted was $<span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedValue_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zUp1orghXBJk" title="Options granted, value">49,399,555</span> and $<span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedValue_c20250101__20250930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zoaMvFczQ3a6" title="Options granted, value">3,168,209</span> during the nine months ended September 30, 2026 and 2025, respectively. The Company recognized $<span id="xdx_903_eus-gaap--ShareBasedCompensation_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zOAXppfR3jd6" title="Stock-based compensation expense">3,253,087</span> and $<span id="xdx_902_eus-gaap--ShareBasedCompensation_c20250101__20250930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zFieZg3xJFc1" title="Stock-based compensation expense">714,731</span> in stock-based compensation expense related to stock options during the nine months ended September 30, 2026 and 2025, respectively. As of September 30, 2026, there was $<span id="xdx_906_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zPXnh1HjUVad" title="Unrecognized stock-based compensation expense">47,948,404</span> of unrecognized stock-based compensation expense related to unvested stock options to be recognized over the remaining vesting term through 2032.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Restricted Stock</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Restricted stock awards are equity grants in which the Company issues restricted common stock awards as of the grant date which are subject to certain vesting and clawback provisions. Restricted stock units are equity grants in which the Company issues a restricted stock unit subject to vesting requirements and common stock is not issued until the vesting requirements have been met. The following table presents the activity for restricted stock awards and restricted stock units outstanding:</p> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_zcuOuAOB9zPa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share Based Awards (Details - Restricted stock)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B0_zFqplwSFqY6h" style="display: none"> Schedule of restricted stock activity</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restricted Stock<br/> Awards</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Grant Date <br/> Fair Value - RSA</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restricted <br/> Stock Units</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Grant Date<br/> Fair Value - RSU</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 32%">Unvested - December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z5ZBxiybMZyf" style="width: 13%; text-align: right" title="Restricted stock outstanding, beginning balance">525,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zCp6iJ1W6Vs2" style="width: 13%; text-align: right" title="Weighted average grant date, beginning balance">9.67</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_d0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zkZQJTr6FkSh" style="width: 13%; text-align: right" title="Restricted stock outstanding, beginning balance">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_d0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zrw8hYVDDGg1" style="width: 13%; text-align: right" title="Weighted average grant date, beginning balance">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zRY24zunriu8" style="text-align: right" title="Restricted stock, granted">794,235</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zV6mHtWZm9wd" style="text-align: right" title="Weighted average grant date, granted">16.27</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z0IhsYksKUx8" style="text-align: right" title="Restricted stock, granted">108,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_znzH58124ePf" style="text-align: right" title="Weighted average grant date, granted">16.78</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Forfeited/canceled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zT1oxKRPsnlk" style="text-align: right" title="Restricted stock, forfeited/cancelled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_d0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zWdW5TBq9ssb" style="text-align: right" title="Weighted average grant date, forfeited/canceled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zb1fPJCBkchf" style="text-align: right" title="Restricted stock, forfeited/cancelled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zOuHooTW2uh6" style="text-align: right" title="Weighted average grant date, forfeited/canceled">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Vested</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_ztQIzuDBfg5j" style="border-bottom: Black 1pt solid; text-align: right" title="Restricted stock, vested">(592,568</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zUicHIMcO5i" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average grant date, vested">9.35</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zm6foayCqdFi" style="border-bottom: Black 1pt solid; text-align: right" title="Restricted stock, vested">(108,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zWOXH97o07Pa" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average grant date, vested">16.78</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Unvested – June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zQ5Q23h9pCJ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Restricted stock outstanding, ending balance">726,667</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zeTyYYBPzwWe" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average grant date, ending balance">9.96</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_d0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zX2Elh4y4aB" style="border-bottom: Black 2.5pt double; text-align: right" title="Restricted stock outstanding, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_d0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zno34vsbS6Qc" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average grant date, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zLfZ8SWe8R03" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The total value of restricted stock and restricted stock units was $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z5Oc3sM6yJYj" title="Value of restricted stock and restricted stock units granted">14,733,972</span> and $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20250101__20250930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zmWYVXtfcs91" title="Value of restricted stock and restricted stock units granted">13,021,600</span> granted during the nine months ended September 30, 2026 and 2025, respectively. The Company recognized $<span id="xdx_90F_eus-gaap--ShareBasedCompensation_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zLoDz7kJ6TG3" title="Stock-based compensation expense">11,820,067</span> and $<span id="xdx_902_eus-gaap--ShareBasedCompensation_c20250101__20250930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zEvwkw94RgZ8" title="Stock-based compensation expense">8,807,530</span> in stock-based compensation expense related to restricted stock and restricted stock units during the nine months ended September 30, 2026 and 2025, respectively. As of September 30, 2026, there was $<span id="xdx_905_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_iI_c20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zyOV4Wgk3jt" title="Unrecognized stock-based compensation expense">7,627,584</span> of unrecognized stock-based compensation expense related to unvested restricted stock to be recognized over the remaining vesting term through 2030.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Warrants</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table presents the activity for warrants outstanding as of September 30, 2026:</p> <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zYVOc0y4ODKe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share Based Awards (Details - Warrant activity)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BD_znwx0IlCrxG2" style="display: none"> Schedule of warrant activity</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Warrants</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Outstanding</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%">Outstanding - December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20260101__20260930_zzluSn4ZTE16" style="width: 13%; text-align: right" title="Warrants outstanding, beginning balance">350,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20260101__20260930_zzJMXI88md09" style="width: 13%; text-align: right" title="Weighted average exercise price warrants outstanding, beginning balance">9.70</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20260101__20260930_zE5m2T5fmatl" style="text-align: right" title="Warrants granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0_c20260101__20260930_zYobPFoZkiw8" style="text-align: right" title="Weighted average exercise price warrants, granted">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Forfeited/cancelled/restored</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_d0_c20260101__20260930_zx48p0XSnS66" style="text-align: right" title="Warrants forfeited/cancelled/restored">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d0_c20260101__20260930_znxoVv1LCjIh" style="text-align: right" title="Weighted average exercise price warrants, forfeited/cancelled/restored">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20260101__20260930_zMowAaR7ZNN5" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants exercised">(350,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue_c20260101__20260930_zk1kf0y738nf" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price warrants, exercised">9.70</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Outstanding – September 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_d0_c20260101__20260930_zGeodXuR0sH4" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_d0_c20260101__20260930_z8O8Oolmoa35" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price warrants outstanding, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zY8h1IXK8V8e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 9, 2026, <span id="xdx_90F_ecustom--WarrantsExercisedDuringPeriod_c20260108__20260109_zj0mcLFYqc98" title="Warrant exercised">350,000</span> warrants were exercised related to the July 2025 Registered Direct Offering and the Company received proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromWarrantExercises_c20260101__20260930_z9WU5T1zrS1g" title="Proceeds from warrant exercises">3,395,000</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 3075000 527500 <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zxwXUiRUr0g9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share Based Awards (Details - Stock options activity)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BD_zoHNtkaftVV3" style="display: none"> Schedule of stock option activity</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Non-Qualified</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Options</b></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise Price</b></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Remaining</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Contractual Term</b></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Aggregate</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Intrinsic Value</b></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 32%">Outstanding - December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zsCUBwGlpw34" style="width: 13%; text-align: right" title="Non-Qualified options outstanding, beginning balance">739,684</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zxf22KnLH842" style="width: 13%; text-align: right" title="Weighted average exercise price, beginning balance">6.50</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zOL9Mnaojozb" title="Weighted average remaining contractual term">6.25</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_d0_c20251231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zzetlHfib1Ak" style="width: 13%; text-align: right" title="Aggregate intrinsic value">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zqfaW1rzTcUd" style="text-align: right" title="Non-Qualified options, granted">3,075,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zQCt3dVlyBBh" style="text-align: right" title="Weighted average exercise price, granted">18.85</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Forfeited/canceled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_ziBrbVvYpFHh" style="text-align: right" title="Non-Qualified options, forfeited/canceled">(127,500</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zokZq8BucHw" style="text-align: right" title="Weighted average exercise price, forfeited/canceled">11.09</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zebfgsHXAAsa" style="border-bottom: Black 1pt solid; text-align: right" title="Non-Qualified options, exercised">(146,755</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zikugJhZKF5h" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, exercised">5.11</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_d0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zJd0EaM1QHsl" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Outstanding – September 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zr994hKskbm3" style="border-bottom: Black 2.5pt double; text-align: right" title="Non-Qualified options outstanding, ending balance">3,540,429</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z54T1ceZQ03h" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending balance">17.13</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zyAjgfsPzmGi" title="Weighted average remaining contractual term">4.91</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zjRgtzH86hv7" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate intrinsic value">26,037,523</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable – September 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z4wQR8LBsjTa" style="border-bottom: Black 2.5pt double; text-align: right" title="Non-Qualified options, exercisable">127,636</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zRSzANPXwaOj" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, exercisable">8.24</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zXfxwVQUbdzd" title="Weighted average remaining contractual term, exercisable">5.53</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zU2H9UnKqIB" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate intrinsic value, exercisable">2,072,658</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 739684 6.50 P6Y3M 0 3075000 18.85 127500 11.09 146755 5.11 0 3540429 17.13 P4Y10M28D 26037523 127636 8.24 P5Y6M10D 2072658 <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zlbdiZjvE565" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Share Based Awards (Details - Stock options assumptions)"> <tr style="vertical-align: bottom"> <td style="width: 82%"><span id="xdx_8B6_z8wZI9SW17Ib" style="display: none"> Schedule of stock options assumptions</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right"> </td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2026</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise Price</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_ziv5qBrutio2" title="Exercise price">12.34</span> – <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_z8OJzcCgwMq9" title="Exercise price">19.36</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock Price on date of grant</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--SharePrice_iI_c20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_zDWTlBkuQ001">12.34</span> – <span id="xdx_902_eus-gaap--SharePrice_iI_c20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_zRjMUR3ohTz5" title="Stock price on date of grant">19.36</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free interest rate</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_zCKsCYCDd0Rg">3.72</span>% – <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_zFjO3kqMMoLe" title="Risk-free interest rate">4.46</span>%</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend yield</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDNcZkoQemc8" title="Dividend yield">–</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected term (years)</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_zmgU2qtfmr37" title="Expected term (years)">2.5</span> - <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_zc6ThqiGEtb5" title="Expected term (years)">5.45</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_z5JRYO94i8y" title="Volatility">149.00</span>% – <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_zGVi5qr3uN6f" title="Volatility">151.22</span>%</span></td> <td> </td></tr> </table> 12.34 19.36 12.34 19.36 0.0372 0.0446 0 P2Y6M P5Y5M12D 1.4900 1.5122 49399555 3168209 3253087 714731 47948404 <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_zcuOuAOB9zPa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share Based Awards (Details - Restricted stock)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B0_zFqplwSFqY6h" style="display: none"> Schedule of restricted stock activity</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restricted Stock<br/> Awards</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Grant Date <br/> Fair Value - RSA</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restricted <br/> Stock Units</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Grant Date<br/> Fair Value - RSU</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 32%">Unvested - December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z5ZBxiybMZyf" style="width: 13%; text-align: right" title="Restricted stock outstanding, beginning balance">525,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zCp6iJ1W6Vs2" style="width: 13%; text-align: right" title="Weighted average grant date, beginning balance">9.67</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_d0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zkZQJTr6FkSh" style="width: 13%; text-align: right" title="Restricted stock outstanding, beginning balance">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_d0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zrw8hYVDDGg1" style="width: 13%; text-align: right" title="Weighted average grant date, beginning balance">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zRY24zunriu8" style="text-align: right" title="Restricted stock, granted">794,235</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zV6mHtWZm9wd" style="text-align: right" title="Weighted average grant date, granted">16.27</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z0IhsYksKUx8" style="text-align: right" title="Restricted stock, granted">108,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_znzH58124ePf" style="text-align: right" title="Weighted average grant date, granted">16.78</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Forfeited/canceled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zT1oxKRPsnlk" style="text-align: right" title="Restricted stock, forfeited/cancelled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_d0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zWdW5TBq9ssb" style="text-align: right" title="Weighted average grant date, forfeited/canceled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zb1fPJCBkchf" style="text-align: right" title="Restricted stock, forfeited/cancelled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zOuHooTW2uh6" style="text-align: right" title="Weighted average grant date, forfeited/canceled">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Vested</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_ztQIzuDBfg5j" style="border-bottom: Black 1pt solid; text-align: right" title="Restricted stock, vested">(592,568</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zUicHIMcO5i" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average grant date, vested">9.35</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zm6foayCqdFi" style="border-bottom: Black 1pt solid; text-align: right" title="Restricted stock, vested">(108,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zWOXH97o07Pa" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average grant date, vested">16.78</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Unvested – June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zQ5Q23h9pCJ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Restricted stock outstanding, ending balance">726,667</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zeTyYYBPzwWe" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average grant date, ending balance">9.96</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_d0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zX2Elh4y4aB" style="border-bottom: Black 2.5pt double; text-align: right" title="Restricted stock outstanding, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_d0_c20260101__20260930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zno34vsbS6Qc" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average grant date, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 525000 9.67 0 0 794235 16.27 108000 16.78 0 0 0 0 592568 9.35 108000 16.78 726667 9.96 0 0 14733972 13021600 11820067 8807530 7627584 <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zYVOc0y4ODKe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share Based Awards (Details - Warrant activity)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BD_znwx0IlCrxG2" style="display: none"> Schedule of warrant activity</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Warrants</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Outstanding</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%">Outstanding - December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20260101__20260930_zzluSn4ZTE16" style="width: 13%; text-align: right" title="Warrants outstanding, beginning balance">350,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20260101__20260930_zzJMXI88md09" style="width: 13%; text-align: right" title="Weighted average exercise price warrants outstanding, beginning balance">9.70</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20260101__20260930_zE5m2T5fmatl" style="text-align: right" title="Warrants granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0_c20260101__20260930_zYobPFoZkiw8" style="text-align: right" title="Weighted average exercise price warrants, granted">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Forfeited/cancelled/restored</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_d0_c20260101__20260930_zx48p0XSnS66" style="text-align: right" title="Warrants forfeited/cancelled/restored">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d0_c20260101__20260930_znxoVv1LCjIh" style="text-align: right" title="Weighted average exercise price warrants, forfeited/cancelled/restored">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20260101__20260930_zMowAaR7ZNN5" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants exercised">(350,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue_c20260101__20260930_zk1kf0y738nf" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price warrants, exercised">9.70</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Outstanding – September 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_d0_c20260101__20260930_zGeodXuR0sH4" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_d0_c20260101__20260930_z8O8Oolmoa35" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price warrants outstanding, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 350000 9.70 0 0 0 0 350000 9.70 0 0 350000 3395000 <p id="xdx_807_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z0y1fUlPg9Wb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline">Note 12 – <span id="xdx_826_zf3zVSe3T6B8">Related Party Transactions</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 13, 2026, the Company issued <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20260312__20260313__srt--CounterpartyNameAxis__custom--IndependentDirector1Member_z5uNn7fwgIVl"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20260312__20260313__srt--CounterpartyNameAxis__custom--IndependentDirector2Member_zy9PuGVg5iYf"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20260312__20260313__srt--CounterpartyNameAxis__custom--IndependentDirector3Member_za4wumGcXCaa" title="Vested shares">1,961</span></span></span> vested shares of common stock to each of three of its independent directors as compensation for the first quarter 2026; the fourth independent director elected to receive cash compensation. The shares were valued at an aggregate of $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20260312__20260313_zQ9XgMvYucG5" title="Shares aggregate value">120,013</span> and were immediately recognized as stock compensation expense.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 1, 2026, the Company paid $<span id="xdx_906_eus-gaap--RepaymentsOfRelatedPartyDebt_c20260330__20260402__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CEOAndTwoIndependentDirectorsMember_zvKh5C2EE2Ck" title="Payments for related party">217,943</span> to its investment committee, which includes the Chief Executive Officer and two independent Directors of the Company. The payment is based on a <span id="xdx_908_eus-gaap--RelatedPartyTransactionRate_dp_c20260330__20260402__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CEOAndTwoIndependentDirectorsMember_zgstCcqzCln2" title="Committee member interest rate">1</span>% per committee member based on the realized gains from investments during the previous quarter.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In January 2026, the Company received a $<span id="xdx_900_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_pn5n6_c20260101__20260131__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TealDronesMember_z8WryJoKpOF2" title="Received order from related party">2.1</span> million order in addition to several smaller orders from Teal Drones, which is a subsidiary of Red Cat Holdings, Inc. (“Red Cat”). Red Cat is a related party as Jeffrey Thompson is the Chief Executive Officer of Red Cat and is also on the Board of Directors of Unusual Machines. The order was delivered in the first half of 2026 and includes several different drone components manufactured and sourced from the Company. The Company recognized approximately $<span id="xdx_901_eus-gaap--Revenues_pn5n6_c20260101__20260930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TealDronesMember_zuTOkTzPuZce" title="Revenue">4.2</span> million in revenue from Red Cat for the nine months ended September 30, 2026. The Company had related party receivables of $<span id="xdx_90A_eus-gaap--ContractWithCustomerLiability_iI_pn5n6_c20260930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TealDronesMember_z5X0ICGK2Ijh" title="Related party receivables">1.9</span> million as of September 30, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 24, 2026, <span id="xdx_909_ecustom--WarrantAgreementDescription_c20260723__20260724__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AllanEvansMember_zS7ptaI896A3" title="Warrant agreement description">the Company entered into a warrant agreement with 8 Consulting LLC, on behalf of Dr. Allan Evans, the Company’s Chief Executive Officer, providing for the issuance of warrants to purchase up to 5,000,000 shares of the Company’s common stock at an exercise price of $25.00 per share, subject to shareholder approval. The warrants have a five-year term and vest in five equal tranches upon achievement of specified stock-price targets of $25, $40, $60, $80, and $100 per share. </span>The warrant award was approved by the Company’s shareholders on October 5, 2026. See Note 14 – Subsequent Events for additional information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 1961 1961 1961 120013 217943 0.01 2100000 4200000 1900000 the Company entered into a warrant agreement with 8 Consulting LLC, on behalf of Dr. Allan Evans, the Company’s Chief Executive Officer, providing for the issuance of warrants to purchase up to 5,000,000 shares of the Company’s common stock at an exercise price of $25.00 per share, subject to shareholder approval. The warrants have a five-year term and vest in five equal tranches upon achievement of specified stock-price targets of $25, $40, $60, $80, and $100 per share. <p id="xdx_801_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zJkvqWAW917h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline">Note 13 – <span id="xdx_822_zYjPIpLUJPZa">Commitments and Contingencies</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no currently no open commitments or contingencies as of September 30, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_zml98DyOqjrc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline">Note 14 – <span id="xdx_82E_zu1cHLPdVNl">Subsequent Events</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">CEO Warrant Award</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 24, 2026, the Company entered into a warrant agreement with 8 Consulting LLC, on behalf of Dr. Allan Evans, the Company’s Chief Executive Officer, providing for the issuance of warrants to purchase up to 5,000,000 shares of the Company’s common stock at an exercise price of $25.00 per share, subject to shareholder approval. The warrant award was approved by the Company’s shareholders on October 5, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The warrants have a five-year contractual term and vest in five equal tranches of 1,000,000 warrants each upon achievement of specified stock-price thresholds of $25, $40, $60, $80, and $100 per share, respectively, based on the average closing price of the Company’s common stock over 20 consecutive trading days.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is evaluating the accounting treatment of the award under ASC 718, Compensation-Stock Compensation, including the determination of the requisite service period. The grant-date fair value is expected to be determined using a Monte Carlo simulation model. The resulting stock-based compensation expense and recognition period will depend on the final assessment of the award’s substantive terms and applicable accounting guidance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Acquisition of Upgrade Energy</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 19, 2026, the Company completed its acquisition of Upgrade Energy, a manufacturer of battery products and related technologies for unmanned aircraft systems. The transaction purchase price is estimated at $52.0 million. At closing, the Company (i) issued Matthew Barnard, the former sole shareholder of Upgrade Energy, 1,792,012 shares of the Company’s common stock and (ii) paid him $1 million in cash. The common stock was valued at $13.9508 per share which was based on the preceding 5 day volume weighted average share price of the Company’s common stock prior to signing the definitive agreement. The Company estimated the common stock to be valued at approximately $25.0 million. This valuation for accounting purposes could be subject to change based on the Company’s common stock price at the time of closing. The Company agreed to pay Mr. Barnard up to an additional $26.0 million in cash based on the Company recognizing $10.0 million in revenue related to internally manufactured batteries during the first two years after the closing date. In connection with the closing, the Company entered into a two-year Employment Agreement to act as Chief Executive Officer at an annual base salary of $300,000 per year. The Company also entered into a Registration Rights Agreement with him agreeing to register the common stock it issued to him at the closing.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is in the process of determining the acquisition-date fair values of the assets acquired and liabilities assumed, including inventory, property and equipment, identifiable intangible assets and other working capital balances.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As the acquisition occurred subsequent to September 30, 2026, the transaction has not been reflected in the Company’s condensed consolidated balance sheet as of that date. The purchase consideration and fair value information will be disclosed when the information becomes available.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Rotor Lab Contingent Consideration</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Company’s acquisition of Rotor Lab Pty. Ltd. on September 3, 2025, the purchase agreement provides for contingent consideration based on qualifying revenue generated from specified internally manufactured motor products during the twelve-month earnout period ending September 2, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subsequent to September 30, 2026, the Company issued 137,260 shares of its common stock in settlement of the first earnout tranche, representing contingent consideration of $3.0 million.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The issuance represents settlement of contingent consideration associated with the prior acquisition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> false false false false Of the $18.7 million balance in Accounts Receivable as of September 30, 2026, approximately $1.9 million is from related parties. Of the $13.9 million in revenue for the three months ended September 30, 2026, approximately $2.0 million is from related parties. Of the $38.7 million in revenue for the nine months ended September 30, 2026, approximately $4.2 million is from related parties.